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Abstract 
Most of the fast excitatory transmission in the brain is conveyed by 
ionotropic glutamate α-amino-3-hydroxy-5-methyl-4-
isoxazolepropionic acid (AMPA) receptors, formed by tetrameric 
assemblies of different subunit (GluR1-GluR4) composition. 
Modulation of AMPA receptors enables profound changes in synaptic 
efficiency, underlying the maturation of neuronal networks throughout 
development and plasticity, but also glutamate-mediated excitotoxicity. 
Accurate tuning of AMPA function can be attained by subunit 
phosphorylation, affecting channel properties and receptor trafficking 
rates. Accordingly, activation of noradrenergic and dopaminergic 
metabotropic receptors positively modulates AMPA receptor function 
through increased PKA activity and GluR1 phosphorylation, an effect 
restricted to brain areas targeted by pathways relying on these 
neurotransmitters. In contrast, adenosine is ubiquitously present 
throughout the nervous system, being released by glia and neurons or 
derived from the extracellular catabolism of adenine nucleotides. The 
present work thus aimed at evaluating the modulation of postsynaptic 
AMPA receptors by high-affinity, G-coupled A1 and A2A adenosine 
receptors and its implications for long term potentiation (LTP), widely 
perceived as the cellular correlate for memory formation (chapter 5.1). 
The involvement of A2A (chapter 5.2) and A1 (chapter 5.3) receptor-
mediated tuning of glutamatergic transmission was further addressed in 
excitotoxicity conditions. Exogenous activation of A2A receptors by 2-
[4-(2-p-carboxyethyl)phenylamino]-50-N-ethylcarboxamidoadenosine 
(CGS21680) was found to significantly facilitate AMPA-evoked 
currents in CA1 pyramidal neurons, by a postsynaptic PKA-dependent 
mechanism leading to increased GluR1 membrane expression. The 
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functional impact of this modulation was evidenced by LTP facilitation 
at the CA3-CA1 synapse, following brief CGS21680 application. 
Moreover, endogenous A2A receptor activation was required for 
ischemia-induced facilitation of glutamatergic transmission, revealing a 
conserved regulatory mechanism between both forms of plasticity, 
which may be of interest for functional recovery (through circuit 
rewiring) from stroke. Additionally, results suggests that some (OSM), 
but not all (LIF) immunoregulatory cytokines of the IL-6 family can 
exert neuroprotection from hypoxia through upregulation of A1 
receptors, to tone down synaptic transmission and consequently, energy 
expenditure.  
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Resumo 
Os receptores ionotrópicos para o glutamato do tipo AMPA são 
responsáveis por mediar grande parte da transmissão excitatória rápida 
que tem lugar no sistema nervoso central. Estes receptores são 
constituídos por tetrâmeros, contendo diferentes combinações de 
subunidades (GluR1-GluR4) e a sua regulação é responsável por 
consideráveis alterações na eficiência da transmissão sináptica, 
inerentes à maturação de redes neuronais ao longo do desenvolvimento 
bem como a fenómenos de plasticidade. Contudo, os receptores AMPA 
são também moléculas-chave em situações de excitotoxicidade 
mediada por glutamato. Tanto a alteração da composição do tetrâmero, 
como variações no estado de fosforilação das suas subunidades, 
constituem mecanismos que permitem uma regulação eficaz da função 
destes receptores. De facto, há evidência de que à activação de 
receptores metabotrópicos para a dopamina ou noradrenalina se associa 
um aumento de função AMPA, através de um aumento na actividade da 
PKA e consequente exarcebamento do estado de fosforilação de 
subunidades GluR1. No entanto, este tipo de regulação da função 
AMPA encontra-se necessariamente restrito às áreas cerebrais que 
recebem inervação dopaminérgica ou noradrenérgica. O mesmo não 
acontece com a modulação pela adenosina, cuja presença é ubíqua no 
sistema nervoso, uma vez que pode ser libertada por células da glia e 
neurónios, através de locus pré-, pós- e não- sinápticos. Além disso, o 
catabolismo de nucleótidos de adenina, co-libertados com diferentes 
neurotransmissores, representa uma fonte de adenosina extracelular 
adicional. O trabalho experimental de que trata a presente tese teve 
assim como objectivo investigar uma possível modulação da 
componente AMPA pós-sináptica, através da activação dos receptores 
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de alta afinidade para a adenosina, do tipo A1 e A2A. Foram ainda 
abordadas as implicações deste mecanismo de regulação para o 
estabelecimento de potenciação a longo prazo (LTP) da eficiência 
sináptica, a qual é encarada como o substrato celular para a formação 
de novas memórias (capítulo 5.1). A ocorrência de uma possível 
modulação da transmissão glutamatérgica pelos receptores A2A 
(capítulo 5.2) e A1 (capítulo 5.3) em situações de excitotoxicidade foi 
estudada através da aplicação de modelos de isquémia e hipóxia. A 
grande maioria do trabalho experimental foi realizado em células 
piramidais da área CA1 do hipocampo, que representa uma população 
neuronal particularmente propensa a expressar alterações de eficiência 
sináptica de acordo com os níveis de actividade, mas que é também 
especialmente susceptível a morte por excitotoxicidade, após isquémia. 
As observações mais relevantes descritas na presente tese dizem 
respeito à facilitação significativa de correntes evocadas por ejecção de 
AMPA (correntes AMPA), observada após activação dos receptores 
A2A com um agonista selectivo (CGS 21680). Esta facilitação teve 
expressão por meio de um mecanismo dependente de PKA, mas não de 
síntese proteica, tendo sido reproduzida pela perfusão de um activador 
da adenilato ciclase (forskolina). Além disso, as acções do agonista A2A 
não foram afectadas aquando do bloqueio simultâneo dos receptores 
GABAA, NMDA e canais de sódio dependentes da voltagem, pelo que 
nenhum dos últimos parece desempenhar um papel na mesma. É ainda 
possível concluir que o efeito do agonista A2A terá um locus de 
expressão pós-sináptico, na medida em que se manteve, mesmo em 
condições de bloqueio do disparo de potenciais de acção. 
Efectivamente, observou-se que a perfusão de CGS 21680 conduziu a 
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um aumento na amplitude de correntes pós-sinápticas excitatórias 
espontâneas, o que sugere um acréscimo na capacidade de resposta 
(pós-sináptica) ao glutamato libertado. É sabido que a fosforilação pela 
PKA de subunidades GluR1 aumenta a probabilidade de abertura de 
receptores AMPA, além do que leva a um aumento do seu tráfego (em 
receptores que contenham subunidades GluR1) para porções extra-
sinápticas da membrana. Desta forma, quando se avaliou a expressão 
destas subunidades ao nível da membrana, verificou-se que tanto a 
expressão total, como a de subunidades fosforiladas se encontrava 
aumentada após tratamento com o agonista A2A. A relevância deste 
acréscimo na expressão membranar de receptores AMPA traduziu-se 
numa facilitação da LTP entre neurónios das zonas CA3 e CA1, após 
um curto tratamento com CGS 21680. Além disso, a modulação 
endógena da componente AMPA pós-sináptica revelou-se necessária à 
expressão de LTP, já que a última se encontrou francamente diminuída 
em situações de bloqueio dos receptores A2A. Face aos resultados 
obtidos na primeira parte deste trabalho, é pois possível inferir que, em 
condições de aumento súbito da adenosina extracelular proporcionadas 
por um exarcebamento da actividade neuronal, a activação de 
receptores A2A, facilita a fosforilação pela PKA de subunidades GluR1 
– aumentando a disponibilidade de receptores nas reservas 
membranares a partir das quais estes são recrutados para a sinapse, 
permitindo reforçar a transmissão sináptica. 
A exposição a períodos transitórios de hipóxia ou isquémia é suficiente 
para induzir um aumento mantido na eficiência sináptica que partilha 
muitos dos mecanismos inerentes à expressão de LTP, incluindo um 
ganho de função pela componente AMPA pós-sináptica.  
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Com o objectivo de investigar a contribuição por uma possível 
modulação pelos receptores A2A da transmissão glutamatérgica para 
esta forma de plasticidade, compararam-se os efeitos de breves insultos 
isquémicos, na presença e na ausência (controlo) de um antagonista 
selectivo dos receptores A2A da adenosina (SCH 58261). A sujeição ao 
episódio isquémico transitório começou por anular a transmissão 
sináptica, a qual recuperou após reoxigenação, progressivamente, até 
valores acima dos valores iniciais de referência. Estas observações 
validam portanto o recurso a este tipo de insulto isquémico transitório 
para o estudo de formas de plasticidade induzidas por isquémia. Para 
além disso, observou-se que esta facilitação da transmissão 
glutamatérgica era completamente perdida, aquando da inclusão de 
espermina na solução intracelular (com acesso ao compartimento 
citosólico), o que sugere que requererá a activação de receptores 
AMPA permeáveis ao cálcio (bloqueados por espermina intracelular). 
Estes resultados revelam assim mais um mecanismo comum à chamada 
“LTP induzida por isquémia” e à sua correspondente fisiológica (LTP), 
a qual depende também da inserção sináptica, transitória, de receptores 
AMPA permeáveis ao cálcio. Quando o insulto isquémico foi realizado 
na presença de um antagonista A2A, tão pouco se observou uma 
facilitação da transmissão glutamatérgica após isquémia. Estes dados 
são consistentes com um envolvimento endógeno dos receptores A2A 
nesta forma de plasticidade, à semelhança da contribuição que têm para 
a expressão de LTP. A recuperação da transmissão sináptica em 
condições de bloqueio dos receptores A2A manteve-se inalterada na 
presença de espermina intracelular, sugerindo o recrutamento de um 
mecanismo comum, em ambos os casos (bloqueio dos receptores 
AMPA permeáveis ao cálcio e bloqueio dos receptores A2A). Para uma 
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melhor compreensão dos mecanismos inerentes a este tipo de 
plasticidade, será necessária uma avaliação do intervalo de tempo pelo 
qual os receptores AMPA permeáveis ao cálcio permanecem na 
sinapse, bem como testar directamente a hipótese de que os receptores 
A2A modulem a inserção de receptores AMPA permeáveis ao cálcio. 
Ainda assim, esta segunda parte do presente trabalho tem o mérito de 
revelar um (novo) mecanismo comum a duas formas de plasticidade 
consideradas completamente distintas até recentemente, colocando em 
evidência um envolvimento relevante dos receptores A2A nas alterações 
da eficiência sináptica desencadeadas por isquémia. 
É desde há muito reconhecido o potencial neuroprotector que a 
activação de receptores A1 da adenosina oferece contra insultos de 
hipóxia e/ou isquémia, ainda que a aplicação terapêutica de agonistas 
A1 se encontre muito dificultada pela ocorrência de graves efeitos 
secundários. É plausível que a administração de moléculas capazes de 
modular a função destes receptores possa oferecer uma alternativa 
viável ao uso de agonistas A1. De facto, esta aplicação foi recentemente 
sugerida para a interleucina 6 (IL-6), capaz de proteger neurónios de 
dano por excitotoxicidade, através de um aumento nos níveis de 
receptores A1 e um consequente aumento da sua sensibilidade ao tónus 
adenosinérgico. Com o objectivo de avaliar se esta acção seria 
extensível a outros membros da mesma família de interleucinas, 
analisaram-se os efeitos do tratamento com oncostatina (OSM) e factor 
inibidor de leucemia (LIF) sobre a modulação da transmissão 
glutamatérgica dependente de receptores A1. Após tratamento com 
OSM, mas não com LIF, observou-se uma potenciação da inbição das 
respostas sinápticas glutamatérgicas induzida por perfusão de um 
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agonista selectivo de receptores A1 (CPA), o que é consistente com um 
ganho de função destes receptores. A relevância desta interacção para 
uma situação de modulação da transmissão sináptica aquando de um 
insulto excitotóxico, reflectiu-se numa maior inibição da transmissão 
glutamatérgica, dependente da activação de receptores A1, após 
sujeição a um episódio hipóxico transitório. Estes dados funcionais 
corroboram os resultados de colaboradores, que mostram que apenas o 
tratamento com OSM consegue aumentar os níveis de proteína e 
mRNA correspondentes ao receptor A1. No seu conjunto, os resultados 
sugerem que o acréscimo de função dos receptores A1 da adenosina é 
necessário à neuroprotecção exercida pelas citocinas IL-6 e OSM, mas 
não para a protecção mediada por LIF. No entanto, a pleiotropia de 
efeitos conhecida para esta família de interleucinas, bem como o tipo 
de protocolo usado para testar o seu envolvimento na neuroprotecção 
contra hipóxia (pré-tratamento), tornam prematura qualquer sugestão 
do seu uso como potenciais agentes terapêuticos.  
Do presente trabalho emerge desta forma a noção da modulação de 
receptores A1 como mecanismo redundante capaz de conferir 
propriedades de neuroprotecção a citocinas imunorreguladoras. Por 
outro lado e através da activação de receptors A2A, com consequente 
ganho de função AMPA, este trabalho mostrou como a adenosina é 
capaz de modular a plasticidade sináptica, o que se poderá revelar de 
particular interesse no estabelecimento de novos contactos sinápticos 
que ocorre em resposta a insultos isquémicos.  
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1 Introduction  
In the beginning of the 20th century, it was commonly accepted by the 
scientific community that synaptic communication relied upon bio-
electricity. One of the first clues that this might not be the case emerged 
from Ramón y Cajal´s cutting edge discoveries, revealing 
distinguishable gaps between communicating neurons, which 
questioned the possibility of electrical transmission through them. In 
1921, the seminal work by Otto Loewi with ex-vivo vagus nerve 
preparations came to confirm the notion that neurons could indeed 
communicate by releasing unknown chemical substances (Loewi, 
1921). Loewi dissected two beating hearts out of frogs, maintained 
them in saline solution and severed the autonomous innervation to one 
of them. By electrical stimulation of the vagus, the first heart was made 
to beat slower and when the liquid bathing it was applied to the second 
heart, a comparable decrease in heart rate was observed. This 
experiment elegantly showed that there had to be some soluble 
chemical, released upon vagus nerve stimulation, which was 
controlling the heart rate. Loewi´s Vagusstoff was later found to be 
acetylcholine, which was thus the first identified neurotransmitter. As 
for glutamate, its role as the principal excitatory neurotransmitter in the 
mammalian brain would slowly become established over the course of 
more than twenty years, perhaps because it seemed unlikely that this 
non-essential, highly abundant amino-acid, central to energy 
metabolism, could in addition function as a tightly regulated 
neurotransmitter. In 1954, Hayashi observed that glutamate injection 
into the brain or carotid arteries produced convulsions, leading him to 
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hypothesize it might also work as a transmitter molecule (Hayashi, 
1954). On the following years, Watkins and his co-workers further 
explored the actions of glutamate and related amino-acids upon 
populations of neurons (Curtis and Watkins, 1959; Curtis et al., 1960; 
Curtis and Watkins, 1961), which prompted them to propose the 
existence of different types of glutamate receptors, according to ligand 
selectivity. Interestingly, the realization that glutamate and other 
excitatory amino-acids exerted their excitatory actions via multiple 
receptors preceded their establishment as synaptic neurotransmitter 
receptors. Indeed, glutamate receptors were only definitely shown to be 
synaptic receptors in the late 1970´s, by the sensitivity of certain 
excitatory pathways in the spinal cord to specific NMDA receptor 
antagonists (Biscoe et al., 1977). By the early 1980´s, glutamate was 
commonly accepted to exert postsynaptic actions upon three families of 
ionotropic receptors which were named after their preferred agonists: 
N-methyl-D-aspartate (NMDA), α-amino-3-hydroxy-5-methyl-4-
isoxazolepropionic acid (AMPA) and kainate receptors. All of these 
constitute intrinsic cation permeable channels, albeit with variable 
permeabilities to sodium and calcium ions, depending on the type and 
subunit composition of the receptor (reviewed in Meldrum, 2000). 
Metabotropic, G-protein coupled, glutamate receptors (mGluRs) were 
not described until 1987, having been cloned in the early 1990´s 
(Schoepp and Conn, 1993) (Table 1).  
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Table 1 – Glutamate Receptor Classification, Subunit Composition and Pharmacology  
CPPG
Glutamate
L-AP4
mGluR4
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Metabotropic 
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Despite this wide variability of glutamate receptors, most of the fast 
excitatory transmission that takes place in the mammalian central 
nervous system is conveyed by AMPA receptors (Figure 1.1). 
Therefore, the presence and function of these receptors at synapses 
must be carefully regulated in order to ensure not only correct neuronal 
communication, as also the reinforcement of synaptic efficacy that is 
thought to underlie the formation of new memories (Bliss and 
Collingridge, 1993; Martin et al., 2000).  
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Figure 1.1.Steps in the process of chemical synaptic transmission. These steps occur in both 
vertebrates and invertebrates, during chemical neurotransmission at the neuromuscular junction 
as well as in central synapses. The example given applies to fast synaptic glutamatergic 
transmission, but also to that mediated by other neurotransmitters and corresponding 
postsynaptic ionotropic receptors. Adapted from Lisman et al., 2007. 
1.1 AMPA receptors 
AMPA receptors are ionotropic, ligand-gated receptors which undergo 
conformational changes upon glutamate binding, rendering them 
transiently permeable to cation influx and causing a net depolarization 
of the postsynaptic membrane that is responsible for propagating 
information at excitatory synapses throughout the brain. They are 
tetramers composed of four subunits (GluR1-GluR4), which combine 
in different stoichiometries to form ion channels with distinct 
functional properties (Hollmann and Heinemann, 1994) (see Figure 
1.1.1). Accordingly, expression of receptor subunits is developmentally 
regulated and is brain region specific (reviewed in Shepherd and 
Huganir, 2007). Furthermore, receptor subunit composition determines 
not only channel properties (single-channel conductance, 
desensitization kinetics), but also stoichiometric association with 
transmembrane AMPA receptor regulatory proteins (TARPs), which 
regulate receptor maturation and trafficking (Gereau and Swanson, 
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2008). Aside from that introduced from different subunit combinations, 
AMPA receptor diversity is also generated within each subunit, by 
variations arising from alternative splicing, RNA editing and post-
transcriptional modifications, such as phosphorylation and/or 
palmitoylation. Each AMPA receptor subunit comprises four 
hydrophobic domains, three of which traverse the membrane (TM1, 
TM3 and TM4), while one (M2) forms a re-entrant loop that faces the 
cytoplasm and contributes to the assembly of the cation permeable 
channel pore (reviewed by Santos et al., 2009) (Figure 1.1). Reflecting 
their most likely evolutionary origin, the structure of AMPA receptors 
is in accordance with the fusion of three gene segments that were once 
individual bacterial proteins. As such, the amino terminal is 
homologous to the bacterial leucine-isoleucine-valine–binding protein 
while the ligand-binding domain resembles a bacterial lysine-arginine-
orthinine binding protein (Gereau and Swanson, 2008). In turn, the two 
segments (S1 and S2) of the ligand-binding domain are interrupted by 
the ion channel pore, whose structure is similar to that of bacterial K+ 
channels. Both the extracellular and transmembrane regions share a 
high degree of homology between different AMPAR subunits (Gereau 
and Swanson, 2008). The same is not true for their carboxyl terminal 
(C terminal), which is the most variable region among different 
subunits and the site of subunit-governed protein interactions. Within 
the C terminal, different phosphorylation sites can also be found, which 
has implications for receptor trafficking and synaptic delivery (Esteban, 
2003).  
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Figure 1.2. Structure and composition of AMPA receptors. Structure of AMPAR subunits 
and the tetrameric channel they form. Individual subunits are composed of four transmembrane 
domains, and the channel consists of four subunits, which are usually two dimers. In the 
endoplasmic reticulum, two subunits combine to form an initial dimer, which requires 
interactions between amino terminals; this is followed by a second dimerization process relying 
upon association of membrane-spanning and extracellular loop regions (e.g., Zipp, 2007). 
Adapted from Shepherd and Huganir, 2007.  
1.1.1 Alternative splicing of AMPA receptor subunits 
Different post-transcriptional modifications can amplify the functional 
diversity of AMPA receptors, by generating multiple subunit isoforms. 
For instance, the mRNA for each AMPA receptor subunit can be 
alternatively spliced to produce either a flip or a flop isoform, a process 
which introduces variation within the extracellular portion of the 
protein, close to the final transmembrane domain (TM4). Although flip 
and flop subunit forms only differ in a few aminoacid residues, their 
incorporation affects receptor desensitization, as well as export from 
the endoplasmic reticulum (reviewed by Santos et al., 2009) and 
possibly even receptor formation and stoichiometry (Brorson et al., 
2004). Accordingly, the expression of flip and forms varies throughout 
development and across different neuronal types. The flop versions, 
which predominate in the adult brain, generally desensitize much more 
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rapidly than the flip forms in response to glutamate (Sommer et al., 
1990). In addition, alternative splicing affects the pharmacologic 
properties of the AMPA receptor channel, conditioning its differential 
sensitivity to allosteric modulators (Monyer et al., 1991).  
The intracellular, C terminal domains of GluR2 and GluR4 subunits 
may also undergo alternative splicing (Gallo et al., 1997). As a 
consequence, GluR2 and GluR4 can be expressed as both short- and 
long- tailed proteins. As such, GluR1, the predominant splice form of 
GluR4 and an alternative splice form of GluR2 (GluR2L) have longer 
cytoplasmic tails than GluR3, the predominant splice form of GluR2 
and the alternative splice form of GluR4 (GluR4c) (Santos et al., 2009) 
(see Figure 1.1.1.1). Importantly, receptors which comprise only short-
tailed subunits (e.g., GluR2/GluR3) are subject to constitutive 
trafficking to and from the synaptic membrane, unlike what occurs with 
those containing long-tailed subunits (e.g., GluR1/GluR2), whose 
synaptic targeting occurs in an activity-dependent way (Esteban et al., 
2003). Finally, alternative splicing of the C terminal regulates AMPA 
receptor function by conditioning binding to specific interacting 
proteins, as well as regulation by protein phosphorylation (Song and 
Huganir, 2002).  
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Figure 1.1.1.1. Localization of protein binding and phosphorylation sites in the C terminal 
of AMPA receptor subunits. In addition to the predominanf subunit forms expressed, 
alternatively spliced forms of GluR2 (Glu2L) and GluR4 (GluR4c) are also considered. Protein 
binding sites are indicated by boxes, adjacent to proteins with which they have been described 
to interact. Phosphorylation sites are underlined and evidenced by a larger font size. Adapted 
from Santos et al., 2009.    
1.1.2 RNA Editing of AMPA Receptor subunits  
Additional AMPA receptor diversity is generated by RNA editing, a 
process involving enzymatic deamination of ribonucleotides (adenosine 
residues) in pre-spliced mRNA encoding glutamate receptor subunits 
(Bass, 2002). This mechanism brings about the replacement of a gene-
encoded aminoacid by a different, non-coded one, thus allowing the 
assembly of receptors with novel physiological properties. In AMPA 
receptors, RNA editing mostly concerns the GluR2 subunit, where it 
mediates the conversion of a glutamine (CAG) to an arginine (CGG) 
codon in the ion channel pore region. As a result, edited GluR2 
subunits possess an arginine (R) in the M2 membrane spanning 
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segment at position 586, whereas GluR1, GluR3 and GluR4 subunits 
have a glutamine (Q) in the homologous position (Hammond, 2008). 
This process affects retention of GluR2 subunits at the endoplasmic 
reticulum and also the properties of the AMPA receptors they come to 
integrate. In fact, Q/R editing constitutes a major quality control 
checkpoint, detaining GluR2 subunits in the endoplasmic reticulum and 
diminishing the formation of GluR2 homomeric tetramers (see Santos 
et al., 2009). RNA editing is also a widespread mechanism for 
regulating both the calcium permeability and channel rectification 
properties of the ion channel. AMPA receptors containing Q/R edited 
GluR2 subunits display low single channel conductance and little 
permeability to calcium ions, dictated by the size and positive charge of 
the substitute arginine residue (Burnashev et al., 1992; Jonas and 
Burnashev, 1995). Most GluR2 subunits in the adult brain exist in their 
edited form and evidence suggests that deficient RNA editing of this 
subunit correlates with neuronal death in amyotrophic lateral sclerosis 
(Kwak and Kawahara, 2005), as well as with dysfunctional AMPA 
function after ischemia (Peng et al., 2006). In contrast, the remaining 
subunits mostly exist in their non-edited forms (Burnashev et al., 1992), 
which, when assembled into GluR2-free homomers or heteromers, 
display permeability to calcium and inward-rectifying properties due to 
the glutamine present in the pore-forming region. Calcium permeability 
is thus governed by the relative expression of GluR2 subunits, and the 
(GluR1+GluR3)/GluR2 ratio has been used as a predictor of the 
assembly of calcium-permeable AMPA receptors (see Pelligrini-
Gianpetro et al., 1997). Calcium permeable, GluR2-lacking AMPA 
receptors are also susceptible to blockade by endogenous, intracellular 
polyamines, which mediate channel blockade in a voltage-dependent 
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manner (Donevan and Rogawski., 1995; Washburn et al., 1997) (see 
Figure 1.1.2.1). In agreement with its elemental contribution for overall 
AMPA receptor function, the relative abundance of GluR2 at synaptic 
AMPARs has been shown to increase with development, in cultured 
CA1 neurons (Pickard et al., 2000). Indeed, in the adult hippocampus, 
the AMPA receptor pool is mostly composed of GluR2/GluR3 and 
GluR1/GluR2 complexes (Wenthold et al., 1996), causing 
approximately linear current-voltage relationships, with a mean 
reversal potential of 0 mV (Jonas and Sakmann, 1992).  
 
Figure 1.1.2.1. Model accounting for the differential dependence of calcium permeability 
and inward rectification on GluR2 abundance. The essence of the model is that the ring of 
carbonyl oxygens in GluR2-lacking AMPA receptors (A) contributes to or forms a binding site 
for permeating divalent cations. Internal polyamines also interact with this ring of polar 
residues. Incorporation of a single positively charged arginine into the Q/R site (B) disrupts the 
ring of carbonyl groups, which is postulated to eliminate the divalent ion binding site. This 
arginine also neutralizes a negative charge at the internal channel mouth by formation of a salt 
bridge between its guanidinium group and the carboxyl group of the aspartate, which reduces 
the number of anionic binding sites for internal polyamines and thus decreases their affinity for 
the channel. As more arginines are incorporated into the Q/R site (C), the number of negative 
charges at the channel mouth decreases, and hence polyamine affinity for the internal blocking 
site, is progressively reduced. Adapted from Washburn et al., 1997. 
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1.1.3 AMPA receptor subunit phosphorylation 
After synthesis, AMPAR subunits are subject to post-translational 
modifications such as glycosylation, phosphorylation and 
palmitoylation. Each AMPA receptor subunit can be N-glycosylated at 
4-6 different sites of its extracellular domain, a modification which 
protects from proteolytic clivage but that is not required for ligand 
recognition and does not seem to significantly affect receptor assembly 
or trafficking (Jiang, 2006). Although it has been proposed that this sort 
of protein modification may be involved in receptor maturation and 
transport, its functional repercussions are still unclear. AMPA receptor 
subunits can also undergo palmitoylation of cysteine residues in their C 
terminal and M2 domain, with consequences for postsynaptic receptor 
trafficking and membrane expression (see Santos et al., 2009). 
Phosphorylation of AMPA receptor subunit residues can occur under 
resting conditions or as a reponse to changes in synaptic activity. With 
the exception of GluR3, all AMPAR subunits have been reported to 
undergo phosphorylation on several amino acid residues of their C 
terminal, by a variety of kinases (Jiang et al., 2006). For instance, 
phosphorylation of GluR2 subunits at Serine 880 by PKC has been 
implicated in AMPA receptor internalization during NMDA-
independent Long Term Depression (LTD) of synaptic transmission in 
the cerebellum (Chung et al., 2003). Interestingly, phosphorylation of 
Tyrosine 876 (Tyr 876) by Src family tyrosine kinases can also 
facilitate rapid internalization of GluR2-containing membrane AMPA 
receptors (Hayashi and Huganir, 2004). In both cases, subunit 
phosphorylation modulates the receptor´s ability to bind regulatory 
proteins that assist in its trafficking to and from the membrane. The 
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function of a third potential PKC phosphorylation site (Ser 863) 
identified on the C-terminal of the GluR2 subunit (Hirai et al., 2000) 
remains unknown. GluR4 subunits comprise two phosphorylation sites 
in their intracellular C terminals. One of them, Serine 842, can be 
phosphorylated in vitro by PKA, PKC and CaMKII (Carvalho et al., 
1999) and its phosphorylation by PKA has been shown to be both 
required and sufficient for synaptic delivery of homomeric receptors 
(Esteban et al., 2003). Phosphorylation of Ser 842 by PKC can also 
increase calcium influx through activated AMPA receptors, in cultured 
retinal neurons (Carvalho et al., 1998). In addition, threonine 830 
represents a potential phosphorylation site for PKC (Carvalho et al., 
1999). As for GluR1 subunit phosphorylation, it has been the subject of 
intense research, prompted by the pivotal role that GluR1-containing 
receptors have been shown to play in hippocampal plasticity 
(Zamanillo et al., 1999; Shi et al., 1999). As a result of such research, 
four phosphorylation sites have been described to occur in the C-
terminal of GluR1 subunits. These are serine 831 (Ser 831), which can 
be phosphorylated by both PKC (Roche et al., 1996) and CaMKII 
(Mammen et al., 1997); serine 845 (Ser 845), a PKA phosphorylation 
site (Roche et al., 1996); serine 818 (Ser 818, Boehm et al., 2006) and 
threonine 840 (Thr 840, Munton et al., 2007; Lee et al., 2007), which 
are two additional PKC phosphorylation sites that were recently 
discovered. Phosphorylation of Ser 845 by PKA has been shown to 
facilitate receptor peak open probability (Banke et al., 2000) and lead to 
long term potentiation (LTP) of naïve synapses (Lee et al., 2000), while 
its dephosphorylation associates with decreased synaptic strength 
underlying LTD (Ehlers, 2000). Phosphorylation of Ser 831 by CamKII 
enhances single channel conductance (Derkach et al., 1999) and 
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intervenes in the recruitment of silent synapses, as well as in synaptic 
transmission facilitation during LTP (reviewed by Palmer et al., 2005). 
Of note is the fact that although both Serine 831 and Serine 845 are 
required for AMPAR delivery into synapses, transgenic mice with 
mutations in both phosphorylation sites still display reduced LTP (Lee 
et al., 2003a). Recently, a third regulatory phosphorylation site has 
been implicated in AMPA receptor trafficking underlying LTP. 
Phosphorylation of Serine 818 (by PKC) was shown to increase after 
LTP and pharmacological induction of its phosphorylation could enable 
synaptic incorporation of GluR1-containing AMPA receptors, possibly 
through modified interaction with candidate proteins capable of 
modulating receptor trafficking (Boehm et al., 2006). Although it is still 
not clear how do the above identified phosphorylation events on GluR1 
subunits interact to produce synaptic potentiation, it is possible that a 
conjunctive phosphorylation by Ser 845, Ser 831 and Ser 818 may be 
required (Boehm et al., 2006). Finally, LTP induction has no effect on 
GluR1 phosphorylation at Threonine 840 (Delgado et al., 2007). In 
turn, dephosphorylation of this site, secondary to NMDA receptor 
activation and protein phosphatase 1/2A activity, has been shown to 
correlate with changes in synaptic strength during hippocampal LTD 
(Delgado et al., 2007). As these examples illustrate, different 
phosphorylation sites are associated with distinct alterations in AMPA 
receptor properties and/or trafficking pattern. However, in what 
concerns the role played by phosphorylation sites in the C terminal of 
GluR1 subunits, all of them have been shown to affect some form of 
synaptic plasticity (Lee et al., 2000; Esteban, 2003; Boehm et al., 2006; 
Delgado et al., 2007).  
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1.1.4 AMPA receptor trafficking  
Most AMPARs are thought to be synthesized in the neuronal cell body, 
far away from the dendritic spines whose receptor population they 
ultimately integrate. Before reaching this synaptic target, they must 
thus accomplish a series of trafficking steps, which include regulated 
exit from the endoplasmic reticulum and active transport through the 
microtubular cytoskeleton. All of these processes involve intricate 
networks of protein-protein interactions, between subunit domains and 
different sets of anchoring and regulatory proteins. The impact that 
interaction with these regulatory proteins had for AMPA receptor 
trafficking became clear with the study of the stargazer mouse, a 
spontaneous mutant that displays head tossing and ataxic gate and 
absence epilepsy (Ziff, 2007). In these animals, lack of functional 
stargazin compromises surface delivery of functional AMPA receptors 
in cerebellar granule cells, a phenotype that could be rescued by 
expressing the wild-type protein. Interestingly, when using a version of 
stargazing that lacked a binding site for post-synaptic density 95 (PSD-
95), only AMPA receptor delivery to non-synaptic sites was recovered, 
demonstrating that stargazin´s ability to restore receptor delivery to 
synapses requires a secondary interaction with this scaffolding protein 
(Chen et al., 2000). Besides stargazin (or γ−2), seven other related 
proteins (γ−1, γ−3 to 8) constitute the transmembrane AMPA receptor 
regulatory protein (TARP) family (see Ziff, 2007). TARPs belong to 
the group of interacting proteins that lack a PDZ (post-synaptic density 
95-discs large-zona occludens 1) domain, as well as NSF (N-
ethylmaleimide-sensitive fusion protein) or the 4.1 protein. The second 
major group of proteins that govern AMPA receptor surface expression 
Introduction 
 15 
is constituted by proteins with PDZ domains. PDZ domains are one of 
the best characterized protein interaction modules, responsible for 
mediating protein interactions by recognizing and binding peptide 
epitopes within their interacting partners. Widely expressed, PDZ 
domains were first recognized as sequence repeats in the primary 
structures of the PSD-95, disk-large and zona occludens-1 proteins and 
were named accordingly (Kurakin et al., 2007). Each PDZ doman binds 
only one ligand and binding selectivity is thought to result from 
variations in the size and geometry of the peptide-binding region 
(Palmer et al., 2005). Well known examples of PDZ-domain containing 
proteins are GRIP/ABP (glutamate receptor interacting protein/AMPA 
receptor binding protein) and PICK1 (protein interacting with C kinase-
1). Frequently, PDZ-domain containing proteins function as scaffolds 
at the post-synaptic density, where they mediate organization and 
maintenance of large macromolecular complexes (see Figure 1.1.4.1).  
 
Figure 1.1.4.1. Schematic representation of the role played by different interacting 
proteins upon AMPAR trafficking. Pathway (a) represents GluR1 trafficking and pathway 
(b) represents GluR2 trafficking. AMPAR complexes exit from the ER/Golgi associated with 
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stargazin (1). GluR1-containing AMPARs are inserted at extrasynaptic sites through an 
activity-dependent mechanism (3a). Stargazin binds PSD95, which localizes the complex at the 
synapse where the receptor can bind other scaffolding proteins such as 4.1N (4a). Stargazin can 
then be released. GluR2-containing AMPAR are inserted at synaptic sites through a constitutive 
mechanism (3b). PICK1 facilitates the transport of the receptor possibly both to and from the 
plasma membrane but is removed from the AMPAR by the NSF/SNAP (SNAP, soluble NSF 
attachment protein) when the receptor reaches the plasma membrane. NSF/SNAP/PICK1 form 
a transient complex with GluR2-containing AMPAR (not shown on this schematic). AMPA 
receptors are stabilized at the membrane by scaffolding proteins. Phosphorylation by PKC 
prevents interaction between ABP/GRIP and GluR2 (4b) and favors the PICK1/GluR2 
interaction (5b). AMPA receptors are then internalized following a coupling with PICK1, and 
AMPAR/PICK1 complex are destabilized by NSF/SNAP when the receptor reaches its 
destination (6b). GluR2-containing AMPARs can then interact with an intracellular pool of 
ABP/GRIP, possibly in the endosome (7b), and get recycled to the membrane through 
interaction with PICK1 (8b) or targeted to lysosomes (9b) and degraded (10b). Adapted from 
Kittler and Moss, 2006. 
 
As illustrated in Figure 1.1.4.1, local receptor insertion and removal 
from synapses is a dynamic process. In fact, AMPA receptors are 
continuously being delivered and removed in and out of synapses in 
response to neuronal activity, adjusting synaptic strength during brain 
development and experience-dependent plasticity (reviewed by 
Esteban, 2003). Interestingly, receptor cycling dynamics between 
intracellular receptor stores and the cell surface is largely dependent 
upon receptor subunit composition. In fact, while GluR2–GluR3 
oligomers are continuously being shipped to synapses in a manner 
independent of neuronal activity (Shi et al., 2001), synaptic delivery of 
GluR1–GluR2 (Esteban et al., 2003) and GluR4-containing receptors 
(Zhu et al., 2000) requires increased synaptic activity and consequent 
NMDA receptor activation. The first trafficking pathway thus allows 
the number of AMPARs at synapses to be preserved despite protein 
turnover (constitutive pathway), whereas the second (regulated 
pathway) enables activity-dependent regulated synaptic delivery of 
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GluR1–GluR2 receptors to synapses, during plasticity (Malinow et al., 
2000) (Figure 1.1.4.2).  
 
Figure 1.1.4.2. Constitutive and regulated trafficking of AMPARs at synapses. Left. 
AMPAR oligomers containing GluR1 or GluR4 subunits are added into synapses in an activity-
dependent manner (regulated delivery) during long-term potentiation (LTP). GluR2–GluR3 
oligomers are continuously cycling (constitutive pathway) in and out of synapses. Right. The 
activity-dependent (regulated) removal of AMPARs from synapses (LTD) is likely to affect all 
receptor populations. Adapted from Esteban, 2003. 
 
There is also a marked discrepancy between the trafficking profile of 
extrasynaptic and synaptic receptors. Indeed, if extrasynaptic receptors 
constitute a highly mobile population, synaptic AMPA receptors 
behave as a rather immobile pool under basal conditions. This notion 
can be derived from elegant experiments using focal glutamate 
uncaging and irreversible AMPAR blockade, coupled to patch-clamp 
recordings, which have shown that rapid delivery of AMPARs from 
internal stores is restricted to nonsynaptic sites (Adesnik and Nicoll, 
2005). In these experiments, the authors used a photoreactive AMPA 
receptor antagonist which, when irradiated with UV light, promptly and 
irreversibly blocks surface receptors. Therefore, the unsilencing of 
AMPA receptor-mediated responses can only occur when these are 
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replaced by spare AMPA receptors, present at intracellular stores. 
Hence, by using patch-clamp recordings to follow the ‘recovery’ of 
AMPA receptor-mediated currents immediately after a global or focal 
photoinactivation of surface receptors, a direct and quantitative 
measurement of the exocytosis and lateral diffusion of native AMPA 
receptors could be attained. When applying this method to evaluate 
delivery of internal AMPA receptors to synapses, recovery of sucrose-
evoked synaptic AMPA currents was found not to occur until several 
hours after the insult. Furthermore, this timecourse was independent of 
neuronal activity, since it was unchanged in the presence of 
tetrodotoxin. Interestingly, when measuring the recovery of AMPA-
mediated currents from extrasynaptic membrane patches (pulled from 
the soma), a ~ 40% recovery of the initial current value was observed 
within 30 min. Subsequenty, it was shown that recovery of 
extrasynaptic currents could also occur by lateral diffusion, in the 
second timescale, as was observed when blocking receptors from only a 
small patch of membrane and measuring recovery of responses to focal 
glutamate release in whole-cell configuration (previously shown to 
impair receptor delivery from internal pools). Comparably fast lateral 
diffusion has also been shown by others to occur in dendrites (Tardin et 
al., 2003). Overall, the work of Adesnik and Nicoll (2005) helps devise 
a model in which diffusion along the surface is a primary route for 
targeting AMPA receptors to the synapse, with which receptors from 
internal stores cycle on a much slower timescale, possibly because of 
the closely packed structure of the postsynaptic density (see Figure 
1.1.4.3). This trafficking pattern has most obvious implications for 
LTP, where regulated delivery of receptors is crucial for synaptic 
reinforcement (Triller and Choquet, 2005). 
Introduction 
 19 
 
Figure 1.1.4.3. A Model of Basal AMPA 
Receptor Trafficking. A large intracellular 
pool of AMPA receptors exchanges rapidly 
(1) with extrasynaptic somatic AMPA 
receptors, and these newly inserted AMPA 
receptors then travel laterally (2) out to 
dendrites to reside stably at synapses. The 
lateral diffusion of perisynaptic receptors into 
the synapse may be regulated by accessory 
synaptic proteins (3). The exchange of 
intracellular receptors with synaptic receptors 
is slow (4). Adapted from Adesnik and 
Nicoll, 2005. 
 
In CA1 pyramidal neurons, the extrasynaptic pool of AMPARs is 
almost exclusively composed of GluR1-containing receptors and 
knock-out animals for this subunit display significant plasticity 
impairments (Andràsfalvy et al., 2003). One may hypothesize that any 
mechanism that brings about increased delivery of AMPARs to the 
extrasynaptic contingent can potentially enhance the ability of that 
synapse to be reinforced, by increasing the number of receptors 
available for synaptic tagging. Accordingly, D1 dopamine receptor 
activation has been shown to significantly promote LTP in cultured 
hippocampal neurons, by increasing the size of the GluR1 extrasynaptic 
pool in a PKA-dependent way (Gao et al., 2006). Likewise, exposure to 
noradrenaline and emotional stress can drive GluR1 phosphorylation at 
Ser 845 and Ser 831, leading to synaptic delivery of GluR1-containing 
AMPA receptors, thus lowering the threshold for LTP (Hu et al., 2007). 
PKA phosphorylation of GluR1 subunits has been shown to cause 
AMPA receptor externalization from internal stores to membrane 
extrasynaptic pools (Oh et al., 2006). In fact, a two-step model for 
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delivery of GluR1-containing AMPARs to synapses during activity-
dependent LTP proposes that phosphorylation of the Ser 845 residue by 
PKA can traffic AMPARs to extrasynaptic sites, making them available 
for subsequent delivery to synapses during activity-dependent 
plasticity, by lateral diffusion (see Figure 1.1.4.4). In turn, there is 
ample proof that synaptic insertion of GluR1-containing AMPARs 
contributes to the synaptic strengthening observed during LTP 
induction (Malinow and Malenka, 2002; Bredt and Nicoll, 2003; 
Malenka and Bear, 2004). 
 
Figure 1.1.4.4. Two-step model for synaptic delivery of AMPARs during LTP. Under basal 
conditions (left panel), GluR1 has a low phosphorylation at Ser-845. Constitutive recycling 
occurs between the surface and internal pools (1) and the synaptic and extrasynaptic pools (2) 
of AMPARs. Increasing Ser-845 phosphorylation (Step 1) stimulates trafficking of internal 
GluR1-containing AMPARs to extrasynaptic sites on the surface membrane, which primes 
AMPARs for synaptic incorporation (3). During strong synaptic activation (Step 2), synaptic 
NMDARs are activated, resulting in increased intracellular calcium (4). Calcium triggers the 
activation of signaling cascades, which drives GluR1-containing AMPARs to synapses from 
extrasynaptic sites by lateral diffusion (5). Thus, the two-step model for synaptic delivery of 
AMPARs consists of delivery of GluR1-containing AMPARs to extrasynaptic sites in a 
phospho-Ser-845- dependent manner (Step 1, the priming step), followed by synaptic 
incorporation of AMPARs, which requires synaptic NMDAR activation and calcium (Step 2). 
Adapted from Oh et al., 2006. 
 
It should be noted that the elemental role played by the trafficking of 
GluR1-containing receptors in adult animals is, at earlier stages, 
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attributable to GluR4-containing ones (Esteban, 2003). Both subunits 
are composed of long intracellular C terminals, which share 
considerable aminoacid homology and a conserved PKA 
phosphorylation site (Ser 845 for GluR1 and Ser 842 for GluR4; 
Esteban et al., 2003), consistent with the similar trafficking behavior 
they follow. Thus, early in the postnatal development of the 
hippocampus, regulated delivery of AMPARs involves GluR4-
containing receptors and PKA-mediated phosphorylation of GluR4 
subunits is necessary and sufficient for triggering receptor delivery to 
synapses (Esteban et al., 2003). As GluR4 subunit expression declines 
and that of GluR1 increases with age (Zhu et al., 2000), regulated 
delivery of AMPARs then requires GluR1 phosphorylation by PKA, 
but at this stage, activation of a second signaling cascade (involving 
CaMKII activity) is further required for receptor delivery (Esteban et 
al., 2003). The greater elaboration of cellular processes and 
transduction pathways involved in AMPAR delivery underlying 
plasticity that is observed in adult animals is in agreement with the 
empirical observation that it is more difficult to induce and express 
synaptic plasticity, later in life (Rosenzweig and Barnes, 2003).  
1.1.5 Synaptic Plasticity 
In 1949, Donald Hebb proposed that “When an axon of cell A is near 
enough to excite a cell B and repeatedly or persistently takes part in 
firing it, some growth process or metabolic change takes place in one or 
both cells such that A’s efficiency, as one of the cells firing B, is 
increased” (Hebb, 1949). To this day, Hebb´s law stands for the 
paradigm of information storage in the brain being encoded by changes 
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in the strength of synaptic transmission between communicating 
neurons. At the time, Hebb´s postulate did not receive much 
consideration from neurophysiologists in the field, such as Ben Burns 
or John Eccles, for whom the “Hebb synapse” was little more than a 
self-evident conceptual embodiment of the post-tetanic potentiation 
(PTP) they had already observed in spinal neurons (reviewed in Bliss, 
2003). As the name implies, PTP corresponds to a large enhancement 
of synaptic efficacy observed after brief periods of high frequency 
synaptic activity. Too brief to possibly account for the neural basis of 
memory, PTP led Burns´ student Tim Bliss away from the spinal cord 
pathways and into the cortical networks that were presumably the 
neural seat of memory (Eccles, 1966). In fact, it seemed plausible that 
the spine apparatuses, which were much more prevalent on neocortical 
and hippocampal pyramidal cells, formed part of the cellular machinery 
underlying memory (Hamlyn, 1963). Discouraged by contradictory 
results observed from working with highly complex cortical networks, 
Bliss turned to the hippocampus for need of simplification. Soon after 
and together with Terje Lömo, Bliss delivered a single tetanus to the 
perforant path in the intact rabbit hippocampus, obtaining a huge 
potentiation of the evoked synaptic response in the dentate gyrus that 
persisted for hours (Bliss and Lömo, 1973). That they grasped the 
potential significance of these early findings could be read from the 
cautious suggestion that such activity-dependent, sustained change in 
synaptic efficiency might be “potentially useful for information 
storage” (Bliss and Lömo, 1973). Meanwhile, long term potentiation 
(LTP) has been observed in a variety of other neural structures, such as 
the cerebellum (Jörntell and Hansel, 2006), the amygdala or the corpus 
striatum (Chapman et al., 2003), among others. Some suggest LTP may 
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even take place at all excitatory synapses in the mammalian brain 
(Malenka and Bear, 2004). In addition to its longevity, LTP has other 
characteristics that make it an attractive candidate mechanism for the 
storage of information in the brain. First of all, it is an input-specific 
process, since a single pathway can be potentiated without affecting 
inactive neighbouring inputs to the same cell (Andersen et al., 1980). 
Secondly, LTP abides stimulus cooperativity, the synaptic property by 
which many concurrent weak stimulations of converging afferent fibres 
can cooperate to induce LTP in the postsynaptic cell. Finally, the 
property of stimulus associativity can be derived from the fact that mild 
afferent stimulation that is subthreshold for inducing LTP can lead to 
LTP at a given synapse, provided it is paired with a strong LTP-
inducing stimulation at a neighboring synapse (Kemp and Manahan-
Vaughan, 2007). The latter feature is particularly interesting when 
memory formation is conceived as the means by which one can 
associate events or entities in the outside world. Interestingly, the same 
properties that argue for LTP as being the cellular correlate of memory 
formation have also been found to apply for long term depression 
(LTD) of synaptic transmission (see Kemp and Manahan-Vaughan, 
2007) that ensues prolonged low frequency (0.5-3 Hz) afferent 
stimulation (Malenka and Bear, 2004). Like LTP, LTD has been shown 
to occur in many brain areas, including the cerebellar cortex, neocortex, 
hippocampus, striatum and nucleus accumbens (Artola and Singer, 
1993). It is thought that LTD results from a subtreshold calcium entry 
into the postsynaptic cell, which is lower than that necessary to induce 
LTP and it has been proposed that, by counterbalancing LTP, LTD 
might serve to create a higher signal-to-noise ratio that would 
maximally sharpen the ability of synapses to store frequency-based 
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information (Stanton, 1996). This view is challenged by evidence that 
LTD and LTP encode separate aspects of declarative memory in the 
hippocampus and that LTD may play a fundamental role in spatial 
learning (Kemp and Manahan-Vaughan, 2007). Noteworthy, in 
addition to undergoing sustained changes in efficiency, synapses can 
also express short-term forms of plasticity, such as the aforementioned 
post-tetanic potentiation (PTP) and paired-pulse facilitation (PPF). In 
PPF, the postsynaptic response to a second stimulus is enhanced 
relative to the first, provided that the interstimulus interval is brief 
enough (around 50-60 ms; see Thomson, 2000) for residual calcium 
from the first stimulus to augment presynaptic transmitter release 
evoked by the second stimulus. Still, long term potentiation and long 
term depression remain the most widely studied physiological models 
of memory formation in the mammalian brain. Recently, evidence 
emerged that in vivo experience can indeed generate LTD (of responses 
in the visual cortex, by brief monocular deprivation; Rittenhouse et al., 
1999) or LTP (in the ventral tegmental area, by cocaine injection; 
Ungless et al., 2001) in specific synapses of the brain. In particular, the 
work by Gruart and colleagues (2006) has shown that it is possible to 
observe LTP in the hippocampus of mice in the process of learning 
something, providing a definite relationship between activity-dependent 
synaptic plasticity and associative learning in behaving animals. These 
studies highlight the importance of continuing to pursue the 
mechanisms underlying such modifications in synaptic strength.  
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1.1.5.1 AMPA receptors in Synaptic Plasticity: NMDA receptor-
dependent LTP in the CA1 area  
In line with its initial discovery in the hippocampus, NMDA receptor-
dependent LTP in the CA1 region of the hippocampus represents the 
most extensively studied form of synaptic plasticity. With regards to 
the cellular events that underlie this form of LTP, considerable 
evidence points towards changes in presynaptic transmitter release, 
postsynaptic responses and changes in synapse structure. The 
contribution made by each side of the synapse (pre- or post- synaptic) 
remains a highly debated subject, but there is now little doubt as to the 
importance of postsynaptic modifications in AMPA receptor function 
and localization, during LTP (Malenka and Nicoll, 1999). Lingering 
doubts on the subject were definitely cast away with the discovery that 
some excitatory synaptic contacts are actually “silent” synapses, 
containing only NMDA receptors at the postsynaptic density level. 
Since depolarization is required to relieve the Mg2+-mediated blockade 
of NMDA receptors that occurs at resting potentials, these NMDA 
receptor–only synapses are functionally silent at hyperpolarized 
membrane potentials. Thus, even when transmitter is released, they are 
not be able to yield a measurable response, unless recordings were to be 
attained at positive membrane voltages. The “unsilencing” of such 
synapses has been shown to follow LTP induction, upon which AMPA 
receptor–mediated currents can then be detected (Liao et al., 1995). 
Since their original discovery in the hippocampus, silent synapses have 
now been described throughout the central nervous system. In most 
locations, silent synapse prevalence is high in the first postnatal days 
and gradually declines towards the second postnatal week, as synaptic 
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connections mature (see Kerchner and Nicoll, 2008). These entities 
may therefore constitute the immature stage of a synaptic contact which 
will, or will not, be reinforced throughout development. It should be 
noted that compelling evidence also points to a presynaptic component 
in the expression of early LTP, when using confocal microscopy and 
calcium-sensitive dyes to study LTP at individual visualized CA1 
synapses (Emptage et al., 2003). In fact, it has been proposed that 
presynaptic microstructural changes in the early stages of long-lasting 
plasticity occur in a coordinated fashion to postsynaptic alterations 
(Antonova et al., 2001), which might be accomplished by a retrograde 
messenger communicating from the postsynaptic neuron back to the 
presynaptic terminal (Malenka and Bear, 2004). Indeed, current models 
accept that postsynaptic LTP is triggered postsynaptically, by activation 
of NMDA receptors prompting a rise in intracellular calcium, to which 
ensues local activation of signaling pathways that ultimately bring 
about changes in the number, function and sub-cellular localization of 
AMPA receptors. By depending on both activation by glutamate and 
membrane voltage, the NMDA receptor thus functions as a coincidence 
detector, providing a molecular basis for Hebbian LTP. In fact, only 
when there is coincident pre- and post- synaptic activity, will calcium 
entry be allowed to trigger plasticity (Malenka and Nicoll, 1999). 
Consistent with this view of a regulatory role for NMDARs in 
plasticity, are the early findings that NMDA receptor antagonists can 
completely block the generation of LTP, despite having minimal effects 
on basal synaptic transmission (Collingridge et al., 1983). In addition to 
prompting kinase activation and AMPAR phosphorylation with 
consequences for AMPA receptor trafficking and function, activation 
of NMDA receptors is upstream of changes in gene transcription and 
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protein synthesis, required to stabilize synaptic potentiation over time 
(West et al., 2002). Involved pathways include the mitogen-activated 
protein kinase (MAPK) cascade, leading to regulation by 
phosphorylation of specific transcription factors such as cAMP 
response element-binding protein (CREB) (Wang et al., 2007) and 
activation of gene expression programs behind synapse formation and 
restructuring (Rao and Finkbeiner, 2007). Interestingly, evidence has 
emerged that AMPA receptors are also able to induce nuclear gene 
expression in an activity-dependent manner (Rao and Finkbeiner, 2007) 
(Figure 1.1.5.1).  
 
Figure 1.1.5.1.1. NMDA and AMPA receptors regulate synapse formation, growth and 
stabilization. During bouts of synaptic activity, NMDA receptors initiate signaling cascades 
that lead to modifications of the activated synapse and activation of MAPK and nuclear gene 
expression. Nascent gene products promote synapse formation, represented as a second 
dendritic spine apposed to the presynaptic terminal. In this model, metabotropic signaling by 
synaptic AMPA receptors regulates transcription and dendritic mRNA translation, thereby 
promoting the growth and stabilization of the newly formed spine. Adapted from Rao and 
Finkbeiner, 2007. 
 
Classical LTP models assigning regulatory roles to NMDA receptors 
and effector functions to AMPA receptors have been further questioned 
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by recent data showing that, for a short period after LTP is triggered, 
calcium-permeable AMPA receptors are targeted to the synapse, where 
they remain until their gradual replacement by GluR2-containing 
AMPARs, over a period of about 25 minutes (Figure 1.1.5.2). 
Furthermore, calcium signaling through these transiently synaptic 
calcium-permeable AMPA receptors seems to be required for 
solidifying and maintaining the increase in synaptic strength that 
follows LTP, in CA1 hippocampal pyramidal neurons (Plant et al., 
2006). It thus becomes apparent that, in addition to materializing the 
sustained increase in synaptic strength that occurs during LTP, AMPA 
receptors are also able to regulate both LTP induction and expression 
profile changes that stabilize synaptic changes over time and may even 
exert influences opposed to those of NMDA receptors, thus expanding 
the complexity of adaptive responses of neurons to synaptic activity 
(Rao and Finkbeiner, 2007).  
 
 
Figure 1.1.5.1.2. Changes in the subunit composition of AMPARs during LTP in CA1 
pyramidal neurons. (a) Normally, synapses contain heteromeric AMPARs consisting of 
GluR1-GluR2 and GluR2-GluR3. Pools of spare AMPARs, including GluR1 homomers, are 
shown in the spine cytoplasm and in the extrasynaptic membrane. (b) Immediately after LTP, 
GluR1 homomers are inserted into the synapse and thus provide a new source of Ca2+ that 
seems to be required for maintaining the increase in synaptic strength. (c) About 25 minutes 
after LTP triggering, GluR1 homomers have been replaced by GluR2-containing receptors. 
Adapted from Kauer and Malenka, 2006. 
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Still, it is becoming increasingly clear that this prototypical form of 
NMDA receptor-dependent LTP in the CA1 area shares only some of 
the properties and mechanisms of other, different forms of LTP that 
characterize particular synapses throughout the brain. For instance, 
LTP at mossy fiber synapses does not require NMDA receptor 
activation (Harris and Cotman, 1986) and seems to involve increased 
presynaptic PKA activity (Villacres et al., 1998), leading to sustained 
modulation of neurotransmitter release machinery. Similarly, LTP in 
corticothalamic synapses has been shown to be reversible, of 
presynaptic expression and to require PKA activity, but not NMDA 
receptor activation (Castro-Alamancos and Calcagnotto, 1999). Even in 
the CA1 region, non-hebbian plasticity can be induced by repetitive 
postsynaptic depolarization (in the absence of coincident presynaptic 
and postsynaptic activity) and trigger a form of LTP that is occluded by 
induction of “conventional” NMDA receptor-dependent LTP (Kato et 
al., 2009). What is more, the latter is well known to have different 
molecular requirements, across development (Esteban et al., 2003). 
This prompts an absolute need to clarify at which synapses are 
plasticity phenomena being studied, during which developmental stage 
and the conditions in which they are triggered. LTP studies must thus 
specify the stimulation protocol used, the age of experimental animals 
used, as well as which receptors and pathways are targeted by the 
induction protocol. Throughout the present work, data specifically 
concern NMDA receptor-dependent LTP in the CA1 region of the 
hippocampus, in young animals.  
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The various forms that LTP may assume emphasize the importance of 
ensuring that neurons have the ability to express long-lasting activity-
dependent synaptic modifications, as one of the key mechanisms by 
which experience modifies neural circuit behavior. The redundancy of 
plasticity processes used by neurons to adapt to changes in synaptic 
activity is illustrated by the fact that many of the cellular and molecular 
mechanisms that ensure the plastic remodeling of synaptic circuits after 
ischemia are common to those underlying NMDA receptor-dependent 
CA1 LTP (Di Filippo et al., 2008). 
1.2 Excitotoxicity: AMPA receptors in ischemia  
The neurotoxic potential of glutamate is known since the 1950s, when 
Hayashi reported that injecting glutamate into the brain produced 
convulsions (Hayashi, 1954), a couple of years before Lucas and 
Newhouse found that injection of L-glutamate into mice retinas would 
destroy its inner neural layers (Lucas and Newhouse, 1957). Over a 
decade later, Olney observed that subcutaneous injections of 
monosodium glutamate elicited acute neuronal necrosis in several 
regions of the developing brain, including the hypothalamus (Olney, 
1969). He would subsequently be responsible for coining the term 
excitotoxicity, to describe the process by which excitatory amino acids 
elicit cell death (Olney, 1986). Neuronal injury by excitotoxicity is 
most frequently caused by excessive activation of glutamate receptors 
and it underlies cell death after epileptic convulsions, stroke, spinal 
cord trauma or head injury (Faden et al., 1989; Dirnagl et al., 1999; 
Vincent and Mulle, 2009). Excitotoxicity is in addition a hallmark of 
several neurodegenerative disorders, such as Parkinson’s disease, 
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Alzheimer’s disease, Huntington’s disease, amyotrophic lateral 
sclerosis and multiple sclerosis (reviewed by Dong et al., 2009) and has 
even been proposed to facilitate tumor growth (Rothstein and Brem, 
2001). Considerable interest has thus focused on the cellular and 
molecular mechanisms that underlie glutamate receptor-mediated 
neuronal death. In what concerns hypoxia and ischemia specifically, 
excitotoxicity is triggered by shortage of substrate delivery (oxygen, 
glucose) secondary to some sort of cerebral blood flow restriction. In 
humans, such a scenario is most frequently associated with ischemic 
stroke. When deprived of oxygen and glucose, ischemic neurons 
increase their consumption of ATP, which decreases energy stores and 
compromises ATP-dependent maintenance of the resting potential by 
the sodium/potassium pump. As a result, anoxic depolarization spreads 
through neuronal and glial cells alike (Somjen, 2001). In neurons, 
depolarization triggers activation of presynaptic voltage-dependent 
calcium channels and glutamate release, while in astrocytes, 
depolarization causes glutamate transporter reversal (reviewed by 
Dirnagl et al., 1999). The resultant build-up of extracellular glutamate 
brings about overactivation of ionotropic AMPA, NMDA and kainate 
glutamate receptors, with a consequent increase in the influx of sodium 
and calcium ions (see Figure 1.2.1). Excessive calcium influx, is not 
only directly caused by NMDA receptor activation, as it also occurs 
secondarily to an increase in the levels of intracellular sodium, through 
the sodium/calcium exchanger. Activation of voltage-gated calcium 
channels constitutes a third source of calcium entry into the 
postsynaptic neuron (reviewed by Lee et al., 1999).  
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Figure 1.2.1. Excitotoxic cell death. Glutamate binds to and opens specific ionotropic receptor 
channels on postsynaptic neurons. Gating of these channels provokes an influx of calcium ions 
inside the cell either directly (through glutamate receptors that conduct both calcium and 
sodium) or indirectly (through the secondary activation of voltage-gated calcium channels). 
The sharp increase of intracellular calcium concentration is a principal death-signalling event 
that is involved in both necrosis and apoptosis. EAAT2, excitatory amino acid transporter 2. 
Adapted from Syntichaki and Tavernarakis, 2003. 
 
Prompted by excessive activation of glutamate receptors, there is a rise 
in the levels of free intracellular calcium, that unleashes the activation 
of several intracellular pathways and enzymes (proteases, 
phospholipases, endonucleases) as well as increased generation of free 
radicals that overwhelms scavenging mechanisms leading to membrane 
damage by lipid peroxidation (Choi, 1999). In turn, ischemia-induced 
oxidative stress leads to the phosphorylation and membrane 
translocation of sodium/potassium/chloride co-transporters (NKCC), 
which mediate electroneutral ion influx (1 Na+:1 K+:2 Cl-) into 
astrocytes (see Jayakumar and Norenberg, 2010). Passive entry of 
water molecules then causes cell swelling leading to edema, which can 
directly damage endangered neurons by further restricting blood flow. 
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Indirectly, cell edema raises the intracranial pressure and this can 
complicate most gravely if herniation occurs and the brain stem is 
compressed, in which case the functions of crucial regulatory centers, 
such as those controlling breathing and heart rate, are lost (Snell, 2009). 
In the ischemic territory, the core of brain tissue that is exposed to the 
most severe blood flow restriction rapidly succumbs to necrotic death. 
The area surrounding this central ischemic territory, where blood flow 
is reduced but some energy metabolism remains, is often called the 
grey area (or ischemic penumbra), the at-risk ring of cells that may or 
may not undergo apoptosis on the course of several hours to days 
(reviewed by Broughton et al., 2009). Interestingly, the generalized 
increase in neuronal excitability that occurs in this area may be useful 
for establishing new synaptic contacts between surviving neurons 
which may recover, at least partly, some of the functions formerly 
ensured by the ischemic core population. The process of structural 
remodeling, which shares many of the mechanisms involved in 
physiological plasticity (Di Filippo et al., 2008) is believed to underlie 
spontaneous functional recovery from stroke (Murphy and Corbett, 
2009). Reducing cell death by delayed excitotoxicity and positively 
modulating plasticity phenomena in the ischemic penumbra thus 
represent the main goals for therapeutic intervention in stroke patients. 
In what concerns delayed cell death by apoptosis, two general pathways 
are considered. Organized cell death can either be initiated by internal 
events, such as mitochondria disruption and release of cytochrome c 
with downstream caspase activation (intrinsic pathway); or it can result 
from activation of “death receptors” by their specific ligands (extrinsic 
pathway). The intrinsic pathway depends upon a calcium influx trigger, 
which can have several sources: (1) activation of group 1 metabotropic 
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glutamate receptors, (2) activation of NMDA receptors, (3) activation 
of voltage-sensitive calcium channels, (4) de-activation of extrusion 
and/or sequestration systems and (5) activation of calcium-permeable 
AMPARs (Tanaka et al., 2000). In fact, it has long been known that 
glutamate receptor antagonists can reduce injury derived from hypoxic 
and ischemic insults, both in vitro (Rothman, 1984) and in vivo (Simon 
et al., 1984). Curiously, post-ischemic blockade of AMPA, but not that 
of NMDA receptors, protects against ischemia-induced delayed cell 
death of CA1 pyramidal cells, even when antagonists are given as late 
as 24h after the insult (Nellgard and Wieloch, 1992; Sheardown et al., 
1993). In addition, when compared to NMDA receptor antagonists, 
treatment with AMPAR antagonists seems to afford wider therapeutic 
time windows, suggesting the latter receptors may remain active for a 
longer timescale (Turski et al., 1998). Both findings argue for an 
important role played by AMPAR in delayed cell death (Weiss and 
Sensi, 2000). And indeed, compelling evidence suggests that specific 
neurological insults (such as ischemia) can drive a selective decrease in 
GluR2 subunit expression, prompting formation of calcium-permeable 
AMPA receptors which exacerbate glutamate toxicity (Pellegrini-
Giampetro et al., 1997). According to this concept (also known as the 
GluR2 hypothesis), insulted neurons which normally express calcium-
impermeable AMPARs, are not able to adapt to the acute increase in 
permeability to calcium that is due to newly synthesized GluR2-lacking 
AMPA receptors. This hypothesis fits nicely with data from transient 
forebrain ischemia models in rodents, where GluR2 mRNA expression 
becomes markedly reduced in the CA1 pyramidal area, a region most 
vulnerable to ischemia (Choi, 1995). The fact that there are viable 
neuronal populations in the hippocampus which already comprise a 
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considerable proportion of GluR2-lacking receptors, such as 
GABAergic interneurons (McBain and Dingledine, 1993), does not 
necessarily contradict the GluR2 hypothesis. In fact, the sustained 
expression of calcium-permeable AMPARs may be compensated for, 
by a higher ability for Ca2+ buffering and extrusion or by altered 
desensitization of AMPA currents (reviewed by Pellegrini-Giampetro 
et al., 1997). Furthermore, it seems this mechanism is also extendable 
to other neuropsychiatric conditions and disorders (see Table 3).  
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Table 3 - Studies supporting the central role played by GluR2 subunits in different 
models of neuronal injury (Pellegrini-Giampetro et al., 1997) 
Condition Cell type Reference 
GluR2 expression is preferentially reduced prior to cell death 
Transient global ischemia CA1 pyramidal cells 
Pellegrini-Giampetro et al., 
1992 
Status epilepticus CA3 pyramidal cells Friedman et al., 1994 
Mutant spastic rats Cerebellar purkinje cells  Margulies et al., 1993 
Schizophrenia 
Parahippocampal pyramidal 
cells 
Eastwood et al., 1995 
Amyiotrophic lateral 
sclerosis 
Spinal motor neurons Virgo et al., 1996 
Ca2+-permeable AMPARs are formed prior to cell death 
Developing brain Retinal ganglion cells Rörig and Grantyn, 1993 
Transient global ischemia CA1 pyramidal cells Gorter et al., 1997 
Editing-deficient GluR2 mice CA3 pyramidal cells Brusa et al., 1995 
Activation of Ca2+-permeable AMPARs is neurotoxic 
Primary cultures Cerebellar Purkinje cells Brorson et al., 1994 
Primary cultures Neocortical neurons Turetsky et al., 1994 
Cell line Oligodendroglial lineage Yoshioka et al., 1995 
 
Aside from calcium-mediated toxicity, GluR2-lacking AMPARs 
additionally allow the influx of Zn2+ ions, released during excitatory 
synaptic transmission. Once in the cytosol, Zn2+ interferes with 
mitochondrial metabolism, disrupting the mitochondrial membrane 
potential and affecting reactive oxygen species formation, further 
aggravating neuronal damage (reviewed by Weiss and Sensi, 2000).  
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Still, regardless of all that is already known about the mechanisms 
underlying ischemia-induced neuronal death, therapeutic approaches in 
stroke patients are currently limited to early treatment with tissue 
plasminogen activator, used as a clot lytic (Del Zoppo et al., 2009). For 
instance, in what concerns therapeutic strategies related to glutamate 
receptors, it has not been easy to extrapolate the neuroprotective 
potential of AMPA receptor blockade from animal models to clinical 
use in stroke patients (Besancon et al., 2008). While some suggest new 
therapeutic targets other than glutamate receptor antagonists should be 
considered (Besancon et al., 2008), it is possible that the failure to 
translate results from the bench to the bedside is due to weaknesses in 
experimental stroke study design that can potentially be corrected 
should specific recommendations be followed (Dirnagl, 2006). A more 
serious problem concerns the significant fraction of stroke patients that 
developed severe side-effects of reduced consciousness ranging from 
stupor to coma, when treated with AMPA receptor antagonists (Walters 
et al., 2005). Considering that excitatory synaptic transmission 
throughout the nervous system crucially depends on maintaining 
physiological AMPA receptor function, these side-effects may prove 
difficult to overcome. 
In alternative, it is possible that pharmacological modulation of AMPA 
receptor function could represent a viable option to the use of 
antagonists. Candidate molecules would be expected to be able to 
endogenously affect synaptic transmission, either through regulation of 
channel properties or receptor delivery rates to the membrane, both of 
which can be regulated by phosphorylation. Activation of signaling 
pathways targeting the phosphorylation of AMPA receptor subunits 
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would therefore constitute a pre-requisite for such a candidate 
molecule. A widespread expression pattern, matching that of AMPA 
receptors themselves, would constitute a second major pre-requisite. 
Adenosine, an ubiquitous molecule involved in homeostatic 
coordination of brain function that is intensely released following 
neuronal damage, fulfills both requirements.  
1.3 Neuromodulation by adenosine  
Purines and purine nucleotides are essential components of all living 
cells. Indeed, ATP is used as the general currency in energy 
conversions by organisms ranging from bacteria to mammals, while 
adenosine serves as precursor to nucleic acid synthesis. Similarly to 
what occurs with glutamate, to the central function that ATP and 
adenosine play in metabolism, adds an elemental role in both 
intracellular and extracellular signaling, made possible by their 
ubiquitous expression across animal evolution. Yet, while ATP may 
function as a neurotransmitter in some brain areas (Burnstock, 2007), 
adenosine is neither stored nor released as a classical neurotransmitter. 
Instead, it reaches the extracellular space by several non-exocytotic 
mechanisms, where it functions as an ubiquitous signaling substance 
capable of influencing synaptic transmission and passive membrane 
properties, ultimately ensuring energy homeostasis maintenance 
(Sebastião and Ribeiro, 2009), much as it does in other excitable 
tissues, such as the heart, where its actions were first described (Drury 
and Szent-Györgyi, 1929). In the heart as in the brain, by decreasing 
cellular activity and enhancing the delivery of metabolic substrates 
through arteriolar dilatation, adenosine enables the maintenance of an 
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efficient ratio of energy expenditure to energy supply (Ribeiro et al., 
2003). In what concerns synaptic transmission, rather than exerting 
direct actions, adenosine tunes neuronal communication by influencing 
neurotransmitter release, as well as the actions of neurotransmitters and 
other neuromodulators, thus setting the tone in several physiological 
(sleep, learning, memory) and pathological processes, such as epilepsy, 
stroke or addiction (Sebastião and Ribeiro, 2009). Its actions are 
mediated by the activation of G protein –coupled seven transmembrane 
domain receptors, which are widely expressed throughout the 
mammalian nervous system, by both neurons and glial cells (Fields and 
Burnstock, 2006). 
1.3.1 Adenosine receptors 
Early evidence for the occurrence of adenosine receptors first arose 
from the work of Satin and Rall (1970) showing that the ability of 
adenosine to increase cAMP levels in the brain could be blocked by 
theophylline. At that time, theophylline was only known as a 
phosphodiesterase inhibitor and its treatment was expected to promote 
cAMP accumulation in brain slices. Not only did it not affect cAMP 
levels, theophylline actually prevented the 20-30 fold increase in cAMP 
that was caused by adenosine (Satin and Rall, 1970). This data led the 
authors to question the site of action targeted by both compounds and 
made them raise the hypothesis that they might interact with 
extracellular structures. Similar results were then observed at the 
neuromuscular junction, where theophylline was found to prevent the 
decrease in neurotransmitter release induced by adenosine (Ginsborg 
and Hirst, 1972). In this study, adenosine was used as a tool to enhance 
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the levels of cAMP, as a means to test the involvement of cAMP in 
transmitter release. The fact that adenosine decreased, rather than 
increased, transmitter release came as the first baffling result. The 
second was that theophylline´s effect could not be explained by a direct 
action of theophylline upon neurotransmitter release towards increased 
quantal content, since the inhibitory effect of adenosine did not depend 
on the initial quantum content values (Ginsborg and Hirst, 1972). If 
anything, treatment with theophylline should increase assay sensitivity 
to detect inhibitory effects by adenosine. Both studies therefore 
suggested that adenosine could be acting through a membrane receptor, 
susceptible to extracellular blockade by theophylline. Meanwhile, the 
ability of adenosine to modulate neurosecretory mechanisms, soon 
shown to be mimicked by co-released ATP (Ribeiro and Walker, 1973; 
1975), drove fruitful research in the field. Subsequently, Geoffrey 
Burnstock came up with the first nomenclature for purinergic receptors 
(Burnstock, 1976). Acknowledging the occurrence of distinct types of 
receptors for adenosine in neurons, van Calker and co-workers (1979) 
further proposed their subdivision into either inhibitory A1 or excitatory 
A2 receptors. Nearly at the same time, Londos and colleagues (1980) 
came to a similar proposal, subdividing adenosine receptors as either 
Ra (stimulatory) or Ri (inhibitory), but this nomenclature would not 
prevail. Several years later, receptor cloning studies would come to 
reveal the expression of four types of adenosine receptors - A1, A2A, 
A2B and A3 - in a variety of species, including man (see Dunwiddie and 
Masino, 2001). Importantly, while A1 and A2A receptors display high 
affinity for adenosine and are expected to exert important regulatory 
functions in physiological conditions, A2B and A3 receptors are low-
affinity receptors most likely to play a role in pathological conditions 
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featuring increased extracellular concentrations. Noteworthy, A3 
receptors display high affinity for adenosine in humans, unlike what 
occurs in the rat (see Dunwiddie and Masino, 2001). In addition, 
receptor subtypes that most frequently couple to Gs proteins (A2A and 
A2B) mostly impart excitatory actions as opposed to those preferably 
coupled to Gi/Go proteins (A1 and A3 receptors). Indeed, in the central 
nervous system, as well as in the periphery, activation of A1 receptors 
exerts inhibitory effects upon synaptic transmission and neuronal 
excitability, while A2A and A2B receptor activation is responsible for 
excitatory actions (Sebastião and Ribeiro, 1996). These actions can be 
ascribed, at least in part, to the modulation of K+ and Ca2+ channels that 
has been shown to follow adenosine receptor activation (see Figure 
1.3.1.1.). Activation of adenosine receptors can also trigger a broad 
range of signaling cascades, in a way which is attributable, at least in 
part, to their G protein specificity (Fredholm et al., 2001). For instance, 
A2A receptors are most frequently coupled to adenylate cyclase 
activation and consequent cAMP formation leading to PKA activation, 
but they can also couple to different G proteins (Fredholm et al., 2001). 
Which signal transducing pathway is operated, may depend on both the 
nature of the effector system and the availability of G proteins and 
kinases in the receptor´s vicinity. Accordingly, presynaptic PKA- 
(Cristóvão-Ferreira et al., 2009) and PKC- mediated (Lopes et al., 
2002; Pinto-Duarte et al., 2005) A2A receptor actions have been 
identified in the rat hippocampus. 
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Figure 1.3.1.1. Adenosine receptors can couple to several G proteins. The possible effects 
of G-protein coupling for each adenosine receptor subtype are also listed. Adapted from 
Dunwiddie and Masino, 2001 and Rees et al., 2003. 
 
Adenosine receptors can also influence the action of other 
neuromodulators, by regulating the activation of receptors for 
neuropeptides, such as calcitonin gene-related peptide (CGRP) and 
vasoactive intestinal peptide (VIP). Other targets for regulation by 
adenosine receptor activation include nicotinic acetylcholine receptors, 
as well as NMDA and metabotropic glutamate receptors (see Sebastião 
and Ribeiro, 2000). In accordance with the plethora of functions that is 
tuned by the adenosinergic tonus, adenosine receptor expression is 
brain-region specific (Ribeiro et al., 2002) and varies through 
development (e.g., Shaw et al., 1986). In what concerns receptor 
distribution, the A1 receptor is highly expressed in the cerebral cortex, 
hippocampus and cerebellum, while the A2A receptor is strongly 
expressed by striatopallidal GABAergic neurons and is found at much 
lower levels in other brain regions (Figure 1.3.1.2). A3 receptors (which 
are high-affinity adenosine receptors in the human brain), are expressed 
at an intermediate level in the human cerebellum and hippocampus (see 
Ribeiro et al., 2003). 
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Figure 1.3.1.2.  Distribution of high affinity adenosine receptors (A1, A2A and human A3) 
in the rat brain. Relative adenosine receptor expression is shown for the main regions of the 
central nervous system where adenosine has been proposed to interfere with brain dysfunction 
and disease. Higher levels of expression are indicated by larger alphabets. Adapted from 
Ribeiro et al., 2002.  
1.3.2 Regulation of extracellular adenosine levels 
Appropriate regulation of extracellular adenosine abundance in the 
brain is crucial for neural processing, since small changes in adenosine 
levels can profoundly affect the degree of synaptic inhibition mediated 
by A1 receptors. In the hippocampal slice preparation, endogenous 
extracellular adenosine levels have been estimated to fall within a 140-
200 nM range (Dunwiddie and Masino, 2001), concentrations which 
suffice for activation of high-affinity adenosine receptors only. Two 
major sources of adenosine in the extracellular compartment can be 
considered. On the one hand, conditions of increased presynaptic 
stimulation favor ATP release and adenosine formation results from 
ATP catabolism by a cascade of ectoenzymes, the ecto-5-nucleotidases 
family (Figure 1.3.2.1). This pathway of adenosine formation leads to 
preferential activation of A2A receptors (Correia-de-Sá et al., 1996). On 
the other hand, at rest or upon low frequency stimulation, A1 receptor 
activation is prompted by adenosine released through equilibrative 
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nucleoside transporters (ENTs) (Correia-de-Sá et al., 1996). Indeed, 
ENTs keep adenosine levels in balance between the extracellular and 
intracellular compartment, by either favoring adenosine influx or efflux 
according to its gradient across the cell membrane. Nonetheless, 
enhancement of extracellular adenosine levels can be achieved by 
transporter inhibitors such as dipyridamole and nitrobenzylthioinosine 
or by targeting enzymes involved in the intracellular adenosine 
metabolism, such as adenosine kinase, which phosphorylates adenosine 
into AMP (Sebastião and Ribeiro, 2009). As such, adenosine kinase 
inhibition by iodotubercidin markedly enhances extracellular adenosine 
levels, with consequences for hippocampal synaptic transmission 
(Diógenes et al., 2004). Interestingly, it was recently reported that 
empirical symptomatic treatment for Parkinson´s disease, by deep brain 
stimulation, also relies on an increase in the extracellular adenosine 
concentration (Bekar et al., 2008).  
 
Figure 1.3.2.1. The metabolism of extracellular ATP is regulated by several 
ectonucleotidases. These include members of the E-NTPDase (ectonucleoside triphosphate 
diphosphohydrolase) family and the E-NPP (ectonucleotide 
pyrophosphatase/phosphodiesterase) family. Ecto-5′-nucleotidase (Ecto-5′-NT) and alkaline 
phosphatase (AP) catalyse the nucleotide degradation to adenosine. Adapted from Fields and 
Burnstock, 2006. 
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The extracellular adenosine concentration is also known to greatly 
increase under conditions of enhanced energy requirements and 
consequent depletion of the intracellular ATP stores. Such scenarios are 
commonly associated with exacerbated neuronal activity during 
seizures and with shortage of metabolic substrates, owing to blood flow 
restriction, causing ischemia. When the intracellular concentration of 
adenosine rises enough to exceed extracellular levels, direct adenosine 
efflux is prompted by equilibrative transporters (Dunwiddie and 
Masino, 2001). In fact, after 5 min of severe ischemia, adenosine is 
released in large amounts reaching extracellular concentrations of 25–
30 µM, as measured from hippocampal slices (Pearson et al., 2006). 
Once in the extracellular space, adenosine dampens neuronal activity 
by at least four different cellular mechanisms: 1) pre-synaptic inhibition 
of neurotransmitter release, 2) synaptic inhibition of calcium influx 
through voltage dependent calcium channels, 3) inhibition of NMDA 
receptors, and 4) activation of G-protein dependent inwardly rectifying 
K+ channels (GIRKs) that mediate membrane hyperpolarization (De 
Mendonça et al., 2000). These modulatory actions suppress neuronal 
activity, preserve ATP stores and protect neurons from excitotoxicity 
(Dunwiddie and Hoffer, 1980) and are mainly attributable to A1 
receptors (de Mendonça et al., 2000). A1 adenosine receptors have also 
been implicated in preconditioning, the process by which exposure to a 
brief episode of mild hypoxia or ischemia affords protection from 
subsequent insults of greater severity. In the brain, preconditioning 
involves adenosine release, activation of A1 receptors and that of ATP-
sensitive K+ channels (Heurteaux et al., 1995) and possibly 
downregulation of pro-apoptotic factors (Ordonez et al., 2010). A 
central role for A1 adenosine receptors in adenosine-mediated 
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neuroprotection is also consistent with several reports of A1 receptor 
agonists being able to protect from neuronal damage, in both ex vivo 
and in vivo animal models of excitotoxicity (de Mendonça et al., 2000). 
Furthermore, administration of adenosine amine congener (ADAC, an 
A1 receptor agonist) can diminish neuronal damage after global 
forebrain ischemia, even when given a few hours after the initial insult 
(Bischofberger et al., 1997). Unfortunately, therapeutic usage of A1 
receptor agonists as possible neuroprotective agents in ischemia has 
been hindered by severe peripheral side effects, which include sedation, 
bradycardia and hypotension (White et al., 1996). Also, ischemia itself 
can induce changes in the adenosinergic system, by triggering 
downregulation of A1 receptor levels in insulted areas (reviewed by de 
Mendonça et al., 2000). Alternative therapeutic approaches, aiming at 
upregulating A1 receptor numbers in excitotoxicity conditions, could 
hopefully prove useful to enhance protection by adenosine. 
Accordingly, the pleiotropic cytokine interleukin 6 (IL-6), which is not 
neuroprotective by itself, has been shown to enable neuronal rescue 
from glutamate-induced death, by enhancing adenosine A1 receptor 
expression (both mRNA and protein) in mouse cortical neurons (Biber 
et al., 2008). Interestingly, neuroprotection may be a common feature 
of other members of the IL-6 cytokine family, such as leukemia 
inhibitory factor (LIF) and oncostatin M (OSM), since all IL-6-type 
cytokines rely upon gp130 receptor subunits for signaling, which leads 
to many shared redundant functions (Heinrich et al., 2003; Kamimura 
et al., 2003) (see Figure 1.3.2.2).  
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Figure 1.3.2.2. Receptor complexes activated by different members of the IL-6 cytokine 
family. gp130 homodimers associate with specific interleukin receptors such as the IL-6 
receptor to mediate the actions of IL-6. Leukemia inhibitory factor (LIF) binds to heterodimers 
of LIF receptor (LIFr) and gp130. LIFr–gp130 heterodimers can also associate with other 
receptor subunits to bind ciliary neurotrophic factor (CNTF) and cardiotrophin 1 (CT-1). The 
oncostatin M receptor (OSMr) forms heterodimers with gp130 to bind oncostatin M (OSM). 
The signal-transducing subunit gp130 is found in all complexes, and is responsible for the 
intracellular activation of the Janus-activated kinase–signal transducer and activator of 
transcription (JAK–STAT) and the mitogen-activated protein kinase (MAPK) pathways. 
Adapted from Bauer et al., 2007. 
 
It is not known, however, whether neuroprotection by LIF or OSM can 
also be indirectly exerted, through an increase in A1 receptor levels. 
There is much less consensus as to the role played by adenosine A2A 
receptors in ischemia (e.g. de Mendonça et al., 2000), but several 
studies suggest their activation may exert deleterious effects (Chen et 
al., 2007). Accordingly, A2A receptor antagonists have been shown to 
be neuroprotective in in vivo models of cerebral ischemia (Gao and 
Phillis, 1994; Melani et al., 1996) and A2A knockout mice are less 
sensitive to injury, as observed in a transient focal ischemia model 
(Chen et al., 1999a). Still, unlike what happens with A1 receptors, not 
much is known concerning the mechanism(s) through which adenosine 
A2A receptors may modulate ischemia-induced cellular damage. 
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Recently, A2A receptor blockade was shown to delay the occurrence of 
anoxic depolarization brought about by severe ischemia in the CA1 
area, with beneficial consequences for neuronal survival (Pugliese et 
al., 2009). Although the underlying cellular mechanisms were not 
pursued, the authors noted that the time window of A2A receptor-
mediated protective effects was comparable to that previously observed 
when treating hippocampal slices with glutamate receptor antagonists 
(Tanaka et al., 1997). It was thus proposed that the protection afforded 
by A2A antagonists might involve an impairment in A2A receptor-
mediated potentiation of glutamatergic transmission at pre- and/or 
postsynaptic sites (Pugliese et al., 2009).  
 
As depicted above, regulation of glutamate receptor function and 
expression, in particular that of AMPA receptors, is crucial for 
sustained changes in synaptic transmission efficiency, underlying 
plasticity. In fact, long-term potentiation of synapses greatly relies upon 
tuning both AMPA receptor trafficking and subunit composition, 
ultimately setting the amount of signal generated by a postsynaptic 
neuron, in response to a given presynaptic stimulus. Many of these 
changes in AMPA receptor function are also observed in ischemia 
conditions, when extracellular glutamate build-up unleashes 
overactivation of postsynaptic neurons, with deleterious consequences. 
Bearing in mind that pathology most frequently arises when 
physiological processes escape regulational mechanisms, it is 
reasonable to expect that key mediators in LTP expression also prove to 
be elemental in excitotoxicity establishment. Any such candidate 
molecule targeting AMPA receptor function is likely to be of 
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therapeutic interest. Therefore, a main objective of the present work 
was to understand how adenosine, acting through high-affinity A1 and 
A2A receptors, might affect AMPA receptor-mediated excitatory 
synaptic transmission. 
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2 Aim 
 
The experimental work described in this thesis was designed to address 
a putative modulation by adenosine of AMPA receptor-mediated 
excitatory synaptic transmission in the hippocampus. In order to 
accomplish this general aim, three specific objctives were pursued:  
  
I. To assess a putative modulation of postsynaptic AMPA 
receptor-mediated responses by A2A adenosine receptors in CA1 
pyramidal cells, as well as transduction pathways involved and 
implications for synaptic plasticity.  
II. To grasp the consequences of A2A receptor-induced modulation 
of hippocampal glutamatergic synaptic responses for ischemia-
induced changes in synaptic transmission. 
III. To clarify whether modulation of A1 receptor function 
constitutes a common intermediary strategy for neuroprotection 
afforded by different IL-6 type cytokines. 
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3 Techniques 
3.1 Patch-clamp Recordings 
The first known electrophysiology experiments date back to the 1660´s, 
when the Dutch microscopist Jan Swammerdam developed a 
neuromuscular preparation of the frog leg inducing muscle contraction 
upon “irritation” (Stillings, 1975). In fact, by using a silver wire to 
deliver nerve “irritation”, Swammerdam actually came close to 
discovering the nature of signal propagation between nerves and 
muscles. Yet, it would not be until 1791 that experimental support for 
the electric nature of the nerve impulse would emerge from Luigi 
Galvani´s fundamental work “De viribus electricitatis in motu 
musculari commentarius”. Using the inferior limbs and crural nerves of 
the frog and inserting a metal wire across the exposed spinal cord, 
Galvani recognized the electrical excitation of the nerve-muscle unit, as 
well as the relationship between stimulus intensity and muscle 
contraction. His continuing studies culminated in the first 
demonstration of a propagating action potential (Galvani, 1841; 
Piccolino, 1998) and the elaboration of Galvani´s theory on animal 
electricity, according to which biological tissues are kept in a state of 
“disequilibrium” that enables their response to external stimuli. Even 
more impressive were his prescient thoughts on animal electricity 
resulting from the accumulation of positive and negative charges on the 
external and internal surfaces of the muscle (or nerve fiber) and the 
possibility that water-filled channels might be responsible for 
mediating the current flow required for tissue excitation (reviewed in 
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Piccolino, 1998). As it was, Galvani´s pioneering experiments marked 
the beginning of an “instrumental period” during the course of which 
the full potential of electrophysiology would progressively be revealed. 
Some of the major instrumental breakthroughs concern the early use of 
electromagnetic galvanometers, which enabled Hermann von Helmoltz 
to estimate the speed of nerve impulse propagation (Helmholtz, 1850) 
and Émile du Bois-Reymond to measure the drop in potential 
difference between cut and intact tissue surfaces that accompanies the 
excitation of nerve and muscle (du Bois-Reymond, 1884). By 
developing the differential rheotome, Julius Bernstein introduced 
accurate temporal resolution and made the first true recordings of 
resting and action potentials; he also confirmed Helmoltz data of nerve 
conduction velocity being approximately 25-30 m/s. Bernstein further 
reported that the whole “negative fluctuation” (action potential) lasted 
0.8 to 0.9 ms and that it could even lead to “sign reversal” (action 
potential overshoot), a finding he unfortunately failed to pursue 
(reviewed by Nilius, 2003). Interestingly, Bernstein explained 
intracellular negativity at rest (around –60mV) as resulting from the 
membrane being selectively permeable to K+, in these conditions. 
According to his theory, a nerve impulse would originate from a 
sudden, non-selective, increase in membrane permeability to all ions; 
this “membrane breakdown” would be responsible for bringing the 
potential difference to zero (Bernstein, 1902). Charles Overton, on the 
other hand, hypothesized Bernstein´s “negative fluctuation” was 
dependent upon selective Na+ and K+ exchange between the 
extracellular and intracellular compartments (Overton, 1902).  The 
question was definitely settled by Alan Hodkin and Andrew Huxley, 
who uncovered the ionic basis of the action potential in the giant squid 
Techniques 
 53 
axon and proved the latter hypothesis right. Initially, Hodgkin and 
Huxley took advantage of intracellular electrode technology to measure 
the potential inside a squid nerve at rest (~ -45 mV) and at the peak of 
an action potential (~ +40 mV), showing that polarity could indeed 
reverse in its course (Hodgkin and Huxley, 1939). At the time, they had 
no idea of what caused the overshoot (Huxley, 2002). So, after the War 
had ended, they pursued the subject and found that the charge carried 
outward by K+ efflux was enough to restore the resting potential after a 
spike, which was compatible with active extrusion of sodium or some 
other internal cation during the rising phase of the action potential 
(Hodgkin and Huxley, 1947). In order to study how an action potential 
might be generated by ionic currents under the influence of membrane 
potential changes, they employed the voltage-clamp technique, which 
had just been developed by Cole (1949). By performing simple voltage 
steps under different extracellular ionic compositions, Hodgkin and 
Huxley were able to divide the recorded current into components 
carried by Na+ and K+, which were fitted according to their time and 
voltage dependence, thus enabling a reconstruction of the action 
potential (Hodgkin and Huxley, 1952). Their pioneering work 
emphasized the importance that activation and deactivation of sodium 
and potassium channels had for action potential generation, prompting 
a quest to measure ion currents through single ion channels. Sakmann 
and Neher made the first recordings of single-channel currents, from 
denervated frog muscle fibers, by using glass pipettes of narrow tip 
(Neher and Sakmann, 1976). The high resistance that developed 
between the pipette tip and the patch of cell membrane to which it was 
pressed, in the order of 50 MΩ, was called a “seal” and consequently, 
“patch-clamp” was born. The technique would soon be revolutionized 
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by the discovery that application of gentle suction enabled the 
formation of a giga-seal, a tight and stable mechanical contact with a 
resistance of 10-100 GΩ (hence, giga-seal), which considerably 
reduced background noise and increased time resolution (Sigworth and 
Neher, 1980). Furthermore, this “improved” patch-clamp technique 
(Hamill et al., 1981) enabled the formation of excised membrane 
patches and also allowed access to the cytosol and the study of signal-
transduction mechanisms, when performed in the whole-cell 
configuration (Figure 3.1.1). Even though much work in single-channel 
currents is done in the cell-attached mode, this configuration can not 
provide any information on the resting potential of the cell, nor are the 
extra- or intra –cellular solutions changed easily. Excised membrane 
patches, either inside-out or outside-out patches, may provide a suitable 
option, in which one can manipulate the intracellular or extracellular 
solutions, respectively. Still, whole-cell recording is by far the most 
widely configuration, for by establishing electrical continuity between 
the pipette solution and the cell interior, it enables small, mammalian 
cells, to be voltage or current-clamped. Using this configuration, 
macroscopic currents flowing through the “whole” membrane are 
recorded. In contrast, when working with excised patches or in the cell-
attached configuration, only the current passing through the channels 
contained within the tip of the recording electrode can be recorded. It is 
interesting how the whole-cell recording configuration, initially thought 
of as a by-product of the patch-clamp technique, grew to become one of 
the most crucial and widespread techniques to approach the function 
and regulation of excitable cells. Even more curious is the fact that 
whole-cell recording does not even fit into the strict definition of 
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“patch-clamp”, as in it, the clamp is applied to a whole cell and not a 
small patch of membrane.  
 
Figure 3.1.1. Patch-clamp recordings can be performed under four different 
configurations. When the pipette is sealed to the cell membrane, single channel currents can be 
recorded in cell-attached patch mode. The seal is so stable that the patch can even pulled off the 
cell and dipped in variety of tested solutions (inside-out or excised-patch mode). If the cell-
attached patch is deliberately ruptured by suction, the whole-cell configuration is achieved; 
pulling the pipette away from the cell in the whole-cell configuration results in the formation of 
an outside-out patch. A major advantage of the whole-cell configuration is the possibility of 
introducing specific inhibitors or even fluorescent dyes, selectively into the recorded cell. 
Patch-clamp recordings typically use glass micropipettes with open tip diameters (~1 µm) 
much wider than those used to impale cells in traditional intracellular recordings (“sharp 
microelectrodes”). Image source: www.bem.fi (modified from Hamill et al., 1981).  
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3.1.1 Applications and technical pitfalls of the patch-clamp 
technique  
The advent of patch-clamp was first crucial for providing insight into 
unitary conductance and kinetic behavior of ion channels already partly 
investigated by classical voltage-clamp experiments in the giant squid 
axon. For instance, it was possible to separate the processes of ion 
permeation through a single channel from those regulating its opening 
and closure (“channel gating”). Indeed, while the amplitude of the 
single channel current gives the experimenter a measure of ion 
permeation through a particular channel type, gating kinetics can be 
estimated from the intervals between transitions (conformational 
changes enabling the channel to switch between closed and open 
states). In turn, open channel probability is measured by the fraction of 
time the channel stays open, which will determine the amplitude of the 
current that would be measured in whole-cell configuration, given by: 
single channel current times the open probability times the number of 
channels (Ogden et al., 1994). Secondly, patch-clamp recordings in the 
whole-cell configuration allowed a shift in preferred cell models  for 
electrophysiology (from large muscle fibers and giant axons to small 
round mammalian cells), by enabling the application of voltage-
clamping to cells that were too small for two electrode voltage-clamp.  
Simply put, the voltage-clamp method allows ion flow across a cell 
membrane to be measured as electric current, whilst the membrane 
voltage is held under experimental control with a feedback amplifier. 
The usefulness of this technique comes first from allowing the 
experimenter to distinguish between membrane ionic and capacitive 
currents; but also because it is much easier to interpret membrane 
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currents flowing through membrane areas kept under uniform, 
controlled voltage. The latter aspect is particularly relevant considering 
that the gating of most ionic channels is controlled by membrane 
voltage. Initially, voltage-clamp experiments used a two electrode 
negative feedback circuit, one to record voltage and the other to pass 
current needed to maintain the command membrane potential (Figure 
3.1.2). Briefly, the voltage electrode is connected to a pre-amplifier that 
feeds the signal to the clamping amplifier, which also receives an input 
from the signal generator that determines the command potential. The 
clamping amplifier then subtracts the recorded membrane potential 
from the command potential and sends an output through the current 
electrode. Whenever the cell deviates from the holding voltage, the 
clamping amplifier generates a signal corresponding to the difference 
between the command potential and the actual voltage of the cell, 
producing a current that is equal and of opposite polarity to that 
flowing through the cell membrane. Continuous monitoring of current 
injection thus gives the experimenter an accurate reproduction of the 
currents flowing across the membrane. Two electrode clamps can be 
applied to cells that are large and robust enough to allow insertion of 
two electrodes without causing damage (Meech and Standen, 1975), 
such as snail and molluscan giant neurons.  
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Figure 3.1.2. Two-electrode voltage-clamp schematic circuit. The cell (usually an oocyte or 
a molluscan giant neuron) is impaled with two microelectrodes, one to record voltage and the 
other to pass current. A preamplifier records membrane potential and the clamping (or 
feedback) amplifier passes current to control this potential. 
 
While two-electrode voltage clamp amplifiers traditionally employ 
voltage followers, the patch clamp amplifier is a sensitive current-to-
voltage converter, with a high gain set by the large feedback resistor, Rf 
(Figure 3.1.3) (Ogden et al., 1994). The high gain patch-clamp 
operational amplifier is connected on the circuit so that the current 
flowing through the membrane at a given moment is measured as a 
voltage drop across the feedback resistor. Indeed, a patch-clamp 
amplifier containing a feedback resistor of 50 GΩ allows minute 
currents (10-12 A) to be measured. For instance, a 1 pA current flowing 
through a single channel will, according to Ohm´s law, produce a 
voltage drop across Rf given by V = 50·109 · 1·10-12 V = 50·10-3 V= 50 
mV.  
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Figure 3.1.3. Schematic diagram of the headstage current/voltage amplifier. The gain 
(Vo/ip, in mV/pA) is set by the feedback resistor (Rf), according to Vo = -Rf ● ip + Vref . The 
potential inside the pipette can be held at a steady state level, or it can be changed in a step-
wise manner (Vref). The current/voltage converter, as any other operational amplifier, is 
composed of an array of transistors and other components fabricated on a single chip of semi-
conductor material. Its behavior follows 4 basic rules. First, the open-loop voltage gain (before 
any negative feedback is applied) is very high, typically 106. The input resistance of the 
amplifier can be considered infinite, so current flow into the inputs is negligible. In turn, the 
amplifier´s output resistance is considered to be null, meaning that there will be very little 
output voltage change when the output loads current changes. Finally, the output voltage can go 
positive or negative with respect to ground, but its amplitude is limited to +/- the voltage supply 
to the amplifier. Introduction of a feedback circuit ensures that the inverting input of the 
amplifier (-) is always at the command voltage (Vref). As the inputs draw no current, any 
current entering the inverting input (from the cell) must be removed via the feedback resistor. 
Adapted from Ogden et al., 1994.  
 
However, delivery of fast changing commands (such as the leading 
edges of rectangular pulses used to monitor formation of a giga-seal) 
will originate large currents, due to charging capacitance associated 
with the pipette walls and the cell membrane. Because these may 
saturate the amplifier for large voltage steps, compensation circuits are 
usually employed to offset both the “fast” (mainly due to charging the 
pipette) and “slow” (attributable to the cell) components of the 
capacitive transients. The usual procedure consists of cancelling the 
fast capacitive transients once a giga-seal is attained (in cell-attached 
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mode), as these tend to change little throughout a patch-clamp 
recording. Slow capacitive transients will only become an issue once 
the whole-cell configuration is established and access is gained to the 
behavior of the “total” neuronal membrane as a capacitor.  
As illustrated in Figure 3.1.4, a common procedure is to use a 5 mV 
square test pulse to monitor the establishment of a giga-seal, which is 
always the starting point for any patch-clamp recording. Briefly, with 
the recording electrode in the bath and filled with intracellular solution, 
one measures the current passed by the electrode in response to the 5 
mV pulse (Figure 3.1.4A). Acording to Ohm´s law, the size of this test 
pulse current gives the experimenter a measure of the electrode´s tip 
resistance. Subsequently, changes in the size of the test pulse current 
will account for changes in the electrode´s resistance. As the electrode 
tip touches the cell surface, there is a slight decrease in the size of the 
test pulse current that mirrors the increase in resistance to current flow 
(Figure 3.1.4B). This can be used as a signal to release the positive 
pressure (continuously injected through the pipette tip to keep it free of 
matrix and cell debris) and apply gentle suction. In alternative, one can 
use differential infra-red interference (DIC) optics to guide the 
electrode´s approach and contact to the target cell. In this case, the 
appearance of a dark dimple in the site of contact with the membrane 
constitutes the signal to release the positive pressure and apply gentle 
suction. Usually, together with gentle suction, delivery of a negative 
command potential (as the experimenter switches the recording mode 
to voltage-clamp) aids in the formation of a seal. As the experimenter 
succeeds in pulling a small patch of membrane into the pipette tip and 
as the size of the test pulse current decreases until virtually no current 
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flows between electrode tip and cell surface, a giga-seal is formed (R > 
1 GΩ) (Figure 3.1.4C). After nulling the fast capacitive transients 
(Figure 3.1.4D) break-in is achieved by applying strong, consecutive 
pulses of suction. As the whole-cell configuration is attained, the 
resistance to current flow falls and the slow capacitive transients 
(caused by charging of the cell´s membrane) become evident (Figure 
3.1.4E). 
 
Figure 3.1.4. Test pulses produce different current responses as one proceeds through the 
establishment of a whole-cell voltage clamp recording. The physical relationship between 
the patch electrode and the cell is illustrated schematically on the left. The size of the current 
change produced by the test pulse goes down as the resistance across the patch electrode tip 
goes up. Thus, a reduction in test-pulse current indicates closer contact between the electrode 
tip and the cell. (A) The electrode is just above the cell, not in direct contact, so the resistance is 
low (1 to 10 MΩ) and the test pulse current is large. (B) The electrode touches the cell surface, 
the resistance goes up slightly, and the test pulse current gets smaller. (C) A giga-seal has 
formed as the result of gentle suction, which pulls a small patch of membrane up into the 
electrode tip. The resistance is high (>1 GΩ), so except for the transients, the test pulse current 
is virtually flat. (D) The electrode capacitance transient is nulled. (E) Break-in is achieved by 
strong suction that removes the patch of membrane in the electrode tip, but leaves the seal and 
cell intact. The resistance goes down and large capacitance transients are seen. Perfusion of the 
cell interior begins. (F) The whole-cell capacitance transient is nulled. Since steps D and F are 
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purely electrical adjustments, the diagram of the cell and patch pipet is the same as in C and E, 
respectively. Adapted from: www.currentprotocols.com 
 
Once in whole-cell recording configuration, another important source 
of error concerns the access resistance between the cell interior and the 
amplifier, which emerges from the restriction in current flow that 
occurs across the tip of the recording electrode (see Figure 3.1.5). Thus, 
the simple action of measuring membrane voltage through a recording 
electrode introduces an artifact, according to which current passing 
from the cell to the amplifier will cause a voltage drop across the 
electrode resistance. This has two immediate consequences for voltage-
clamp efficiency: first, it prevents any voltage step applied through the 
recording electrode from reaching the full command amplitude and 
secondly, it leads to an underestimation of the transmembrane currents 
that are “seen” by the amplifier. Also, once the whole-cell 
configuration is established, the series resistance (also called access 
resistance) becomes in series with the cell membrane, which behaves as 
a capacitor, thus combining with it to form a low-pass RC filter. Again, 
this will introduce artifacts both in signals coming from, as in those 
going to, the voltage-clamped cell. In fact, in response to a square 
voltage step delivered through the recording electrode, there will be a 
slow exponential charging of the cell membrane potential characterized 
by the time constant derived from τ=RsCm (Figure 3.1.5). For a series 
resistance of 10 MΩ and a cell capacity of 12 pF, settling of the clamp 
follows τ=120 µs. Conversely, from the recording electrode 
perspective, current injection at the beginning of the square step will 
describe slow capacitive transients, also characterized by τ=RsCm 
(Figure 3.1.5). In fact, because a capacitor requires current flow to 
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change its voltage, it is first necessary to charge the parasitic membrane 
capacitance, in order to measure a change in membrane potential at the 
amplifier. Although these transients only change what is recorded and 
not the cell behavior itself (contrary to the voltage change applied to 
the membrane), they do introduce a low pass filtering effect that may 
distort events with durations close to τ, such as the rising phase of an 
action potential or even the rise time of synaptic currents.   
Cm Rc
ic im
Rs ip
Vp
a b
 
Figure 3.1.5. Equivalent circuit of whole-cell recording. (a) Equivalent circuit of whole cell 
recording.  Current im flows in the cell resistance Rc and ic in the capacitance. Pipette current, 
ip=im+ic, flows in the series resistance Rs between pipette and cell and produces a voltage error 
Vp−Vc=ipRs. (b) Time course of changes of Vc and ip following a step of Vp. Modified from 
Ogden et al., 1994. 
 
To compensate for these errors, which assume particular relevance 
when studying the activation of voltage-gated channels or the rise time 
of fast synaptic currents, feedback circuitry can be used to nullify the 
“slow” capacity transients, by injecting a symmetrical, matching, 
amount of current into the recording pipette. However, as noted above, 
capacity compensation will only subtract capacitive currents from the 
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amplifier output; it will not compensate for the slow change in cell 
membrane potential that arises from the combination of Cm with Rs. 
The only solution to obtain a better voltage clamp is to use separate 
resistance compensation based on positive feedback circuitry, which 
adds a signal proportional to the current extracted from the output 
signal, to the command potential. This positive feedback will increase 
the pipette voltage when current flows and the voltage error thus tends 
to be greatest, functioning as though the recording electrode had a 
smaller resistance. The caveat of this procedure is that Rs frequently 
fluctuates during long recordings (either as the membrane tip gets 
clogged or as the ruptured membrane patch reseals), compromising 
accurate compensation. Also, if the frequency with which Rs 
compensation is added to the command potential is too high, the 
underlying circuit reverberates, which can lead to electroporation of the 
neuronal membrane. For these reasons, an alternative strategy to 
diminish the errors introduced by series resistance is simply to use as 
low as possible resistance pipettes and to choose small cells, which will 
contribute with a smaller Cm.  
Finally, patch-clamp recordings in the whole-cell configuration have 
the disadvantage of prompting cell perfusion with the pipette solution, 
since its volume exceeds by far that of the cytosolic compartment. This 
is associated with a rundown of responses relying upon second 
messenger activation, such as intracellular calcium release. Rundown 
of responses can be avoided by performing patch-clamp recordings 
using antibiotic-containing pipette solution (Horn and Marty, 1988), in 
what is known as the perforated patch technique. When the pore-
forming antibiotic proteins assemble in the membrane patch contained 
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within the pipette tip, access to the cell interior is attained without 
cytosol dialysis – but at the expense of even higher series resistance 
and lower recording stability than that typically obtained in whole-cell 
configuration. 
If one is aware of the technique´s pitfalls and tries to minimize the 
errors introduced (e.g. by keeping Rs constant throughout the 
experiment), then whole-cell patch-clamp recordings constitute an 
excellent tool to address a number of processes underlying neuronal 
communication. The signals amenable to recording can be divided into 
those corresponding to passive cell properties (input resistance, 
membrane time constant) and those ascribed to active cell properties. 
The latter include a range of signals (from action potentials to 
macroscopic currents mediated by voltage-dependent ion channels) that 
can further be categorized into synaptic and non-synaptic responses. 
Non-synaptic responses can be evoked by local agonist application and 
are most frequently composed of mixed post - and non –synaptic 
components (e.g AMPA-evoked currents). Recording of synaptic 
responses can be used to study spontaneous events (miniature 
excitatory or inhibitory postsynaptic currents, recorded after blockade 
of activity-dependent release) or afferent-evoked postsynaptic currents, 
upon electrical stimulation of presynaptic fibers projecting to the 
recorded neuron. In the latter case, brain slice preparations are most 
frequently used, since these preserve, to some extent, physiological 
circuit anatomy. 
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3.2 Acute brain slice preparations  
By definition, electrophysiology studies the electrical properties of 
biological cells and tissues, through measurements of voltage changes 
or electrical current flows, on a wide variety of scales - from single ion 
channel proteins to complex field potentials measured in whole tissues 
like the heart. In practical terms, this requires the placing of a recording 
electrode on a preparation of biological material, which can range from 
living organisms (in vivo recordings) down to dissociated cells from 
excised tissue. Early patch-clamp recordings elected large muscle fibres 
(Neher and Sakmann, 1976), giant axons or isolated mammalian cells 
(Maruyama and Petersen, 1982) as preferred preparations, which 
proved quite useful to the evaluation of single-channel currents. But the 
essence of crucial subjects, such as the connectivity between different 
neuronal populations, their intrinsic properties and morphologies, or the 
occurrence of various forms of synaptic plasticity, would only become 
attainable with the development and establishment of the brain slice 
preparation. In the early 1950´s, Professor Henry McIlwain was 
actively engaged in quantitative studies of the energy metabolism in the 
brain. Having identified the need for brain tissue preparations, he 
gradually devised several apparatuses for obtaining brain slices, which 
within a few years led to the creation of mechanical choppers allowing 
mass production of slices. What is more, he applied 
electrophysiological techniques to confirm that his slices were 
metabolically active and contained neurons with healthy resting 
membrane potentials (Li and McIlwain, 1957; Yamamoto and 
McIlwain, 1966). These early reports elegantly demonstrated the 
groundbreaking notion that brain tissue could actually be kept alive and 
healthy outside the body. This idea, which had a strong impact on the 
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scientific community, resulted in an explosion of research performed 
on central nervous system physiology and pharmacology. Nowadays, 
the brain slice preparation remains a powerful tool for 
electrophysiologists, enabling them to accurately determine the 
environment of the slice; have visual control of where recording and 
stimulating electrodes are placed; study the effects of drugs applied in 
know concentrations – either to the entire slice or just some portions of 
it - and also the possibility of preserving the tissue for later biochemical 
or anatomical analysis. Together with the development of cutting 
solutions with compositions that minimized excitotoxic damage (e.g. 
with decreased calcium and increased magnesium concentation) during 
slice preparation, introduction of vibrating microtomes for tissue 
processing greatly increased the success of patch-clamp recordings 
from acutely prepared brain slices (see Aitken et al., 1995). The brain 
slice preparation has been particularly exploited in hippocampal 
research.  
3.2.1 The hippocampal slice model 
The hippocampus lies within the medial temporal human lobe and its 
distinctive, curved shape has fascinated early anatomists, who have 
named it after the seahorse monster of Phoenician and Greek 
mythology, as well as after the ram’s horns of the Egyptian god 
Ammon. Its general layout holds across the full range of mammalian 
species, although its general morphology does vary. For instance, in the 
primate brain, but not in that of rodents, the anterior end of the 
hippocampus is expanded to form the pes hippocampus.  
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The hippocampal formation has traditionally been included in the 
limbic system, a loose classification term that included a group of 
structures lying in the border zone between the cerebral cortex and the 
hypothalamus – forming a unified “limbic lobe” (Broca, 1878).  
 
Figure 3.2.1.1. The great limbic lobe of Broca. In the above drawings where the lateral and 
medial surfaces of the brains of rabbit (A), cat (B), and monkey (C) are drawn roughly to scale, 
the limbic lobe is represented in black. The figure illustrates that the limbic lobe, as Broca 
pointed out, forms a common denominator in the brains of all mammals. Note how the lobe 
surrounds the brain stem, a situation that suggested Broca's use of the term "limbic." Modified 
from McLean, 1954. 
It is now known that the limbic system actually involves many other 
structures beyond this border zone, which cooperate for the control of 
emotion, behavior and drive, as well as towards a reference role in 
memory (Snell, 2009). As such, the limbic system is now considered to 
comprise the subcallosal, cingulated and parahippocampaly gyri, the 
hippocampal formation, amygdaloid nucleus, mamillary bodies and the 
anterior thalamic nucleus. In particular, the hippocampal formation is 
composed of the hippocampus, the dentate gyrus and the 
parahippocampal gyrus.  
Macroscopically, the hippocampal formation is formed of two C-
shaped interlocking cell layers: the granular cell layer of the dentate 
gyrus and the pyramidal cell layer of the Ammon´s horn (hippocampus 
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proper) and the subiculum (which, together with the entorrhinal cortex, 
is a component of the parahippocampal gyrus) (Lopes da Silva et al., 
1990). 
The hippocampus proper is composed of multiple subfields. Though 
terminology varies among authors, the terms most frequently used are 
dentate gyrus and the cornu ammonis (or Ammon´s horn). The cornu 
ammonis (CA) is usually differentiated into the CA1, CA2, and CA3 
areas and it can be structured depthwise, according to seven clearly 
defined strata (or layers). The alveus is the most superficial layer of the 
hippocampus and it contains the axons from CA1 pyramidal neurons, 
which will subsequently constitute the fimbria and the crus of the 
fornix, forming one of the major outputs of the hippocampus, directed 
to the mammilary bodies. Below the alveus, the stratum oriens contains 
the cell bodies of inhibitory basket cells and horizontal trilaminar cells. 
The stratum oriens also contains the basal dendrites of pyramidal 
neurons, onto which synapse efferent fibers from other pyramidal cells, 
septal fibers and commissural fibers from the contralateral 
hippocampus. Deep to the stratum oriens, there is the stratum 
pyramidale, where the cell bodies of the pyramidal neurons can be 
found. This stratum also contains the soma of many interneurons, 
including axo-axonic (or chandelier) cells, bistratified cells, and radial 
trilaminar cells. Still, the predominant structure in this layer 
corresponds to the cell bodies of pyramidal neurons, which are 
exclusively found here. Below the stratum pyramidale and in the CA3 
area only, one can find the thin stratum lucidum (or mossy fiber layer), 
through which mossy fibers from the dentate gyrus granule cells course 
towards CA3 pyramidal neurons. The stratum radiatum contains septal 
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and commissural fibers as well as the Schaffer collateral fibers that 
project from CA3 onto CA1 pyramidal neurons. A considerable 
proportion of dendritic inputs to pyramidal neurons therefore locates to 
this stratum (see Figure 3.2.1.2). Some interneurons that can be found 
in more superficial layers can also be found in the stratum radiatum, 
including basket cells, bistratified cells, and radial trilaminar cells. The 
underlying stratum lacunosum still contains Schaffer collateral fibers, 
as well as perforant pathway fibers, which project from the superficial 
layers of the entorhinal cortex onto all the fields of the hippocampal 
formation (Witter et al., 2000). Because of its small size, this thin 
stratum can be grouped with the subjacent stratum moleculare, into a 
single stratum called stratum lacunosum-moleculare (Lopes da Silva et 
al., 1990). The stratum moleculare is the deepest stratum of the 
hippocampus and it contains the synaptic connections between 
perforant pathway fibers and the distal, apical dendrites of pyramidal 
cells. Below the stratum moleculare, the hippocampal sulcus (or 
fissure) separates the CA1 field from the dentate gyrus.  
In the dentate gyrus, similar strata can also be considered. These are the 
polymorphic layer (or CA4 area or hilar region), the stratum 
granulosum and the stratum moleculare. The polymorphic layer is the 
most superficial layer of the dentate gyrus and it contains many 
interneurons, as well as efferent fibers from the dentate gyrus granule 
cells onto the CA3 pyramidal cell layer. The stratum granulosum 
contains the cell bodies of the granule cells. In the inner third of the 
stratum moleculare, commissural fibers from the contralateral dentate 
gyrus, as well as inputs from the medial septum, form synapses with 
the proximal dendrites of granule cells. The external two thirds of the 
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stratum moleculare constitute the deepest strata and they contain the 
perforant pathway fibers that will synapse onto the distal apical 
dendrites of granule cells.  
 
stratum lacunosum-moleculare
stratum pyramidale
alveus
stratum oriens
stratum radiatum
Hippocampal 
sulcus
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Dentate gyrus
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EC III
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CA3
CA1SubEC deep
a
b
 
Figure 3.2.1.2. Diagram of a transverse hippocampal slice. (a) The drawing contemplates 
the discrete strata that comprise the hippocampal formation, as well as the cell types between 
which the main synaptic connections are established. These are also summarized in the lower 
inset. DG: dentate gyrus. Sub: subiculum. EC: entorhinal cortex. (b) Hippocampal slice section 
depicting the different strata contained in the CA1 and dentate gyrus areas. The drawing in (a) 
is modified from Rámon y Cajal, 1909. 
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As evidenced by the early drawings of Rámon y Cajal, the major 
pahways of signal flow through the hippocampal formation constitute a 
loop, in which most external input originates from (and ultimately 
comes back to) the entorhinal cortex. In fact, the fibers of the perforant 
pathway, which arise from the layers II and III of the entorhinal cortex, 
profusely project onto the dentate gyrus and CA3 area, or to the CA1 
area, respectively (reviewed by Witter and Amaral, 2004). From the 
dentate gyrus granule cells, efferent fibers send information onto CA3 
pyramidal cells, which in turn send their axons to CA1 pyramidal 
neurons through a set of fibers known as the Schaffer collaterals. From 
the CA1 area, axons project mainly onto to the entorrhinal cortex, but 
can also project to subicular neurons which in turn, send their afferents 
onto the entorrhinal cortex. Per Andersen called this major pathway of 
information (dentate gyrus-CA3-CA1) the trysynaptic circuit 
(Andersen et al., 1969; 1971) (see Figure 3.2.1.2, lower inset). He also 
noted that all these connections were preserved when the hippocampus 
was cut transversally to its long axis (Andersen et al., 1969). Not only 
was this concept the basis of Andersen´s lamellar hypothesis (according 
to which the hippocampus was composed of a series of parallel strips 
operating independently), as it additionally found expression in the 
introduction of the hippocampal slice preparation by Skrede and 
Westgaard (1971). Aside from preserving the main physiological 
circuits intact, 400–500 µm thick transverse slices were subsequently 
shown to remain alive for several hours, when kept in an oxygenated 
bath of artificial cerebrospinal fluid. This slice preparation thus enabled 
access to different hippocampal areas by experimental drugs that could 
easily be washed out of the slice, together with easy placement of 
recording and stimulating electrodes. Also, by belonging to the three-
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layered arquicortex, the hippocampus provided a relatively simplified 
version of the remaining cerebral cortex, therefore constituting an 
appealing option for early plasticity studies – a trend that persists to 
these days (reviewed by Cooke and Bliss, 2006).  
Finally, other than the essential trisynaptic glutamatergic circuit 
initially described by Andersen and colleagues (1969; 1971), the 
hippocampus proper comprises also several local inhibitory circuits, 
mediated by different kinds of GABAergic interneurons – which, 
despite representing less than 10% of the neuronal hippocampal 
population, exert a prominent regulation of overall excitability (see 
Freund and Buzsáki, 1996). It should also be noted that several 
subcortical structures impinge their outputs onto the hippocampus, as is 
the case of the amygdala, the thalamus, the hypothalamus, the ventral 
tegmental area, the medial septal nucleus or the reticular formation 
(Nieuwenhuys et al., 2008). As a consequence, a wide variety of 
neurotransmitters subserve neuronal communication in the 
hippocampus (Lopes da Silva et al., 1990). 
In order to better address the complexity underlying hippocampal 
function, one can use a multidisciplinary approach by combining 
functional evaluation of hippocampal transmission (e.g. by performing 
electrophysiological recordings of afferent-evoked responses) to 
analytical techniques applied to hippocampal samples. 
3.3 Western Blot analysis 
The basic principle behind electrophoresis and western blot analysis 
dates back to Faraday's law of electrolysis, according to which the mass 
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of a substance altered at an electrode during electrolysis is directly 
proportional to the quantity of electricity transferred at that electrode 
(Faraday, 1834). Arne Tiselius used it to develop the Tiselius 
apparatus, which first allowed electrophoretic separation of colloidal 
solutions (Tiselius, 1937). This device was composed of a U-shaped 
cell filled with buffer solution and electrodes immersed at its ends. On 
applying voltage, the compounds of a given mixture of charged 
components, for instance sample proteins, migrated to the anode or 
cathode depending on their charges. However, this initial apparatus was 
not able to accurately differentiate electrophoretically similar 
compounds, for their mobility through solutions. The limitation was 
addressed by new electrophoresis methods, which used solid or gel 
matrices to separate compounds into discrete and stable bands (zones), 
in what was defined as zone electrophoresis. Indeed, the introduction of 
starch (and later polyacrylamide) gels enabled the efficient separation 
of proteins, making it possible with relatively simple technology to 
analyze complex protein mixtures (reviewed by Vesterberg, 1989). A 
further breakthrough occurred when Towbin and colleagues (1979) 
used electrophoresis to transfer sample proteins from a polyacrylamide 
gel to a sheet of nitrocellulose - much like had previously been done 
with DNA samples, by virtue of the Southern Blot technique. In the 
nitrocellulose membrane, immobilized proteins kept the original gel 
pattern and became easily detectable by immunological procedures 
(Towbin et al., 1979). The foundations were laid for the Western Blot 
technique (Burnette, 1981) as we now know it. The technique remains 
to this day widely used to study the presence, abundance, relative 
molecular mass and post-translational modifications of specific 
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proteins; as well as a valuable immunodiagnostic research tool in 
medicine.  
Application of a Western Blot protocol encompasses several steps, 
divided into three fundamental work stages: separation of a protein 
mixture by means of gel electrophoresis; protein transfer onto a 
membrane (actual blot); and detection of target proteins. Preceding 
these steps is tissue preparation, which involves mechanical processing 
of solid tissues (using a homogenizer or sonication methods) and 
treatment with different detergents to enhance cell lysis and protein 
solubilization. In order to minimize protein digestion, protease and 
phosphatase inhibitors are usually added to the medium and mechanical 
processing is performed at low temperatures, typically 0-4ºC. After 
discarding the undigested material, tissue homogenates are frozen and 
stored. Prior to analysis by Western Blot, protein denaturation is 
achieved by mixing the sample protein mixture with SDS-containing 
Laemmli buffer (Laemmli, 1970) and exposing it to 95ºC for 5 min. 
Each component of the Laemmli buffer serves a specific purpose in 
protein sample preparation. For instance, beta 2-mercaptoethanol 
reduces intra and inter-molecular disulfide bonds in the proteins, 
facilitating their segregation according to overall size but not shape; 
whilst sodium dodecyl sulfate (SDS detergent) imposes to each protein 
the same overall negative charge and affects hydrophobic bonds within 
the protein, compromising protein structure (Figure 3.3.1). Again, this 
allows proteins to be separated according to size (molecular weight) 
and not by charge. Other components include glycerol, which increases 
the density of the sample, easing its application to the gel; and 
bromophenol blue, a dye which serves as a migration indicator.  
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Figure 3.3.1. Effect of the anionic detergent SDS on proteins. (A) Structural formula of SDS 
(sodium dodecyl sulfate). The molecule can be divided into a hydrophobic and a hydrophilic 
area. (B) The form-giving hydrophobic areas (*) within the protein are dissolved, so that it is 
only present in stretched linear form. Through this, the strongly charged SDS overlaps the self-
charge of the proteins. Adapted from Luttman et al., 2006.  
3.3.1 Gel Electrophoresis 
According to the sample and the nature of the gel used, protein 
separation can be made by isoelectric point, protein shape, or molecular 
weight. Most commonly, separation of protein mixtures is attained 
using SDS polyacrylamide gel electrophoresis (SDS-PAGE), which 
separates proteins according to their molecular mass (measured in 
Kdaltons). As referred, SDS confers homogeneous negative charge to 
sample proteins and destabilizes bonds relying upon hydrophobic 
interactions. As higher protein structures are lost, proteins assume a 
linearized form. Combined with previous reduction of disulphide 
bridges by β-mercaptoethanol in the sample Laemmli buffer, SDS 
enables complete denaturation of sample proteins, as well as allows 
migration of negatively charged proteins onto the positively charged 
electrode through the polyacrylamide mesh of the gel. Indeed, the gel is 
formed by a polymer of acrylamide monomers, organized into a 3D 
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network, by means of a cross-linking agent 1,2-
Bis(dimethylamino)ethane (TEMED). Because of the tight meshes 
formed, smaller protein molecules move faster upon charge application 
compared to larger ones, resulting in clearly separated protein bands 
according to overall size. Depending on the molecular mass of the 
protein mixture to be separated, the acrylamide content of the gel is 
adjusted so as to enable optimal band resolution. As such, the lower the 
acrylamide concentration, the better the resolution of lower molecular 
weight proteins. In the discontinuous version of the SDS-PAGE, 
proteins first migrate through a stacking gel, which concentrates them 
in a sharp band before they can access the actual separation gel (Figure 
3.3.1.1). It should be noted that the acrylamide concentration is not the 
only determinant of protein detection sensitivity, in SDS-PAGE. In 
fact, the thickness of the gel and the amount of protein that is loaded 
also importantly impact how sensitive the method is. Indeed, when gel 
thickness exceeds 2 mm, protein transfer onto membranes becomes less 
effective.  
 
Figure 3.3.1.1. Discontinuous SDS-PAGE electrophoresis procedure. Samples are first 
loaded into wells in the gel, with one lane being usually reserved for a marker or ladder 
(commercially available mixture of proteins of defined molecular weights, stained to form 
visible, coloured bands). When voltage is applied, proteins migrate into it at different speeds, 
according to molecular weight, causing smaller proteins to progress further along the gel. 
Image source: imb-jena.de. 
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3.3.2 Protein Transfer to a membrane (blot) 
Upon protein separation into discrete bands, different methods are 
available for transferring proteins onto membranes, such as simple 
diffusion (Kurien and Scofield, 1997), electrophoresis (Towbin, 1979) 
or vacuum-assisted solvent flow (Peferoen et al., 1982). Of these, 
electrophoresis is most commonly performed; either in a suitable tank 
(wet blot) or according to the semi-dry method (Luttman et al., 2006). 
Wet blots have the advantage of applying less heat to the preparation 
and favour protein integrity, but they require larger quantities of 
transfer buffer. The transfer buffer itself provides electrical continuity 
between the electrodes and must therefore be conductive; typical 
transfer buffers contain Tris base, glycine, methanol and SDS. It also 
provides a chemical environment that preserves protein solubility 
without impairing the protein adsorption to the membrane, during 
transfer. Indeed, by relaxing protein binding to SDS, methanol further 
improves protein transfer, being also important for stabilizing gel 
dimension. However, most buffers undergo Joule heating during 
transfer, which may prompt the need to use cooled transfer buffer or for 
surrounding the transfer tank with ice. The choice of an appropriate 
blotting membrane also greatly affects protein transfer. Nitrocellulose 
and polyvinylidene fluoride (PVDF) membranes are the types most 
frequently used and pore size is adjusted to the molecular weight of the 
protein to be blotted, since transfer efficacy for small proteins decreases 
with increasing pore size. In a wet blot, membranes are first soaked in 
transfer buffer and then are placed above the gel and jammed between 
layers of porous foam sponge sheets and filter papers, in a gel cassette 
(Figure 3.3.2.1.).The whole structure is placed inside a transfer tank, 
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completely submerged in cold transfer buffer and is then connected to a 
power source, allowing protein blotting towards the cathode, to which 
the membrane is oriented. Current application and transfer time are 
balanced to enable optimal transfer; long transfer times are usually 
better suited for tank systems, although they require cooling of the unit 
and/or internal recirculation of the transfer buffer. This is preferable to 
using large currents, which may cause proteins to migrate rapidly 
through the membrane but without being adsorbed.  
Cassette holder
Foam pad
Filter paper
Gel
Membrane
Filter paper
Foam pad
(+) Anode(-) Cathode
 
Figure 3.3.2.1. Protein Blotting procedure. In a typical wet blot, a sandwich structure is 
placed in a tank filled with transfer buffer. Proteins migrate from the negative (gel) to the 
positive (membrane) pole. Picture source: komabiotech.co.kr. 
 
By the end of the blotting process, Ponceau S dye can be used to 
provide visual proof of a successful transfer, after which it can easily be 
washed off the membrane. Blotted proteins are then amenable to 
detection. 
Modulation of AMPA receptors by adenosine 
 80 
3.3.3 Protein Detection  
During the detection process, the membrane is "probed" for a protein of 
interest, in a two-step process that involves the binding of a primary 
antibody raised against that given protein, whose signal is amplified by 
binding of secondary antibody molecules linked to a reporter enzyme, 
which when exposed to an appropriate substrate prompts a visible 
reaction. But before blotted proteins can actually be detected, it is first 
necessary to minimize nonspecific binding of exogenous protein onto 
the membrane. This is attained by incubating the membrane with a 
given protein (e.g., 5% non fat milk powder in TBS solution, for 1 h) 
that will cover nonspecific binding sites, thus diminishing the 
background signal upon protein detection and increasing its sensitivity. 
After blocking, the membrane is incubated in a dilute solution of 
primary antibody (few µg/mL), under gentle agitation. The primary 
antibody is most frequently diluted in powdered milk or bovine serum 
albumin (BSA), whichever is previously used to block unspecific 
binding. Incubation time and temperature influence antibody binding 
efficiency. Indeed, incubation at room temperature enables stronger 
binding, not only specific (target protein) but also non-specific binding 
(background noise) and this may be counterbalanced by shorter 
incubation times. The membrane is then rinsed of unbound primary 
antibody, after which it is then exposed to a secondary antibody, 
directed at a species-specific portion of the primary antibody. Because 
several secondary antibody molecules bind each primary antibody 
available, the signal is amplified and protein sensitivity detection 
increased. The secondary antibody is usually linked to biotin or to a 
reporter enzyme such as alkaline phosphatase or horseradish 
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peroxidase. In the latter case, protein-bound antibodies become 
detectable by cleavage of a chemiluminescent agent, with formation of 
a luminescent reaction product. The luminescent signal, proportional to 
the amount of target protein blotted, can then be used to impress 
photographic film placed upon the membrane. It is also possible to use 
radioactive labeled secondary antibodies, which has the advantage of 
increasing detection sensitivity. Data analysis includes protein size 
estimation, which is attained by comparing stained bands to those 
corresponding to the molecular weight marker loaded onto the gel. The 
amount of target protein detected is scaled to the expression of a 
structural protein (such as actin or tubulin), in control and test lanes. 
This correction controls for possible differences in the amount of 
protein loaded into each well or inconsistent blotting efficiency. Protein 
levels are then evaluated through densitometric analysis of protein 
bands, using imaging software. 
3.4 Protein Biotinylation  
Combination of SDS-PAGE with protein tagging can be used as a way 
to reduce sample complexity and enhance the ability to discriminate 
changes at the level of a subpopulation of proteins within a complex 
cell lysate. One such strategy relies upon protein biotinylation, which 
may be used to selectively tag surface proteins in a given biological 
preparation. In fact, cell surface biotinylation has emerged as an 
important tool for studying the expression and regulation of membrane 
receptors (Huh and Wenthold, 1999) and transporters specifically 
expressed at the plasma membrane, differentiating them from the 
protein population localized to organelle membranes.  
Modulation of AMPA receptors by adenosine 
 82 
Proteins can be biotinylated either chemically or enzimatically. 
Enzymatic biotinylation targets specific lysine residues within a certain 
protein sequence. Indeed, biotin functions as a co-enzyme in several 
carboxylase-mediated reactions, such as those underlying fatty acid 
synthesis, branched-chain amino acid catabolism and gluconeogenesis. 
In these reactions, biotin covalently binds to specific lysine residues in 
carboxylases, in a process (biotinylation) that requires ATP and is 
catalyzed by holocarboxylase synthetase (Zempleni et al., 2009). As a 
consequence of its small size (244 Da), biotin can bind proteins without 
significantly affecting their biological activity.  
By contrast, in chemical biotinylation, different reactive groups can be 
incorporated into the valeric acid side chain of commercially available 
biotin molecules, which enables unspecific biotinylation of amine 
residues, carbohydrates or sulfhydryl groups, according to the reactive 
group in question. A most frequently used form, sulfo-N-
hydroxysuccinimide esters of biotin (sulfo-NHS-biotin), can establish 
stable amide bonds with primary amine groups (present on lysine side 
chains), therefore functioning as a non-specific protein labeling agent 
(Figure 3.4.1). As such, this method introduces a tag into any 
polypeptide bearing an exposed lysine residue. Furthermore, since 
sulfo-NHS-biotin molecules readily dissolve in polar solutions and are 
charged by the sulfonate group on the succinimidyl ring, they cannot 
permeate the cell membrane. This makes them into a suitable tool for 
selective “tagging” of surface proteins.  
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Figure 3.4.1. Reaction of Sulfo-NHS-LC-biotin with a primary amine. Amine reactive 
Sulfo-NHS ester reacts rapidly with any primary amine-containing molecule to attach the biotin 
label via a stable amide bond. In turn, the sulfonate group attached to the biotinylation reagent 
increases its water solubility, which renders the compound cell-impermeable and also allows 
biotin labeling to be done under more physiologic conditions. The Sulfo-NHS reactive group is 
attached to the valeric acid side chain of biotin by a linker of variable length.  The purpose of 
this linker or “spacer arm” is to make biotin more accessible for streptavidin binding. Image 
source: www.piercenet.com. 
 
Following cell surface biotinylation, tagged proteins need to be isolated 
from the original sample, which is accomplished by exploring the 
highly-stable interaction of biotin with two related proteins, avidin and 
streptavidin. Indeed, biotin can bind very tightly to the tetrameric 
protein avidin, with an equilibrium dissociation constant (Kd) in the 
order of 10−15, close to the strength of a covalent bond (Green, 1963). 
Most frequently, however, biotin-based techniques rely on conjugation 
with streptavidin, a bacterial protein which displays less non-specific 
binding than avidin, while also binding biotin with comparable affinity 
(Chaiet and Wolf, 1964). Each avidin/streptavidin molecule has four 
binding sites for biotin. 
Surface biotinylation studies have mostly been performed on either cell 
lines or dissociated neuronal primary cultures, ever since their initial 
description in the epithelial polarity field (Sargiacomo et al., 1989). 
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Application of the technique was recently extended to more 
physiological preparations, namely, to acute hippocampal slices 
(Thomas-Crussels et al., 2003). Since then, several studies have used it 
to measure alterations of the surface protein pool, as a way to 
investigate net effects of receptor trafficking mechanisms (e.g., Oh et 
al., 2006; Rial Verde et al., 2006). Slices can be prepared as for 
electrophysiology experiments and after recovery, are placed in 
adequate incubation chambers, in the presence of excess biotinylation 
reagent. In these conditions, an incubation period of 45 min can ensure 
penetration of biotin throughout 350 µm slices (Thomas-Crussels et al., 
2003). In order to block all reactive biotin in excess, slices are then 
exposed to buffers containing amines (lysine or glycine), which will 
compete with the biotinylation reaction. In between treatments, slices 
are washed with phosphate buffered saline (PBS) or another buffer 
solution. Mechanical tissue disruption is performed on ice and in the 
presence of protease inhibitors to guard against proteolysis. Generally, 
cells are lysed and membrane-solubilized in a buffer containing a non-
ionic detergent. Undigested material and extra debris are then removed 
from the homogenate sample, by centrifugation. After discarding the 
precipitated, undigested material, the soluble fraction can then be 
incubated with streptavidin agarose beads. Usually, precipitation of 
biotinilated proteins with streptavidin is performed over night and 
under gentle agitation, so as to maximize recovery of tagged 
polypeptides. The whole-cell fraction can then be separated from 
streptavidin-biotin complexes by centrifugation. After washing away 
unbound beads, biotinilated proteins can be eluted by resuspending the 
bead pellet in a small volume of Laemmli buffer, containing a 
percentage of SDS. Further dissociation of tagged polypeptides from 
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streptavidin is attained by heating the samples to 95-100 ºC, followed 
by centrifugation to precipitate the beads away from the eluted proteins 
(supernatant). Proteins tagged in this way, corresponding to the surface 
component of the cellular population contained in the hippocampal 
slice, can then be loaded to a gel and separated by electrophoresis.  
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4 Materials and Methods 
Experiments were conducted using acute hippocampal slices prepared 
either from young (3-4 weeks old) male Wistar rats, or from adult 
C57Bl6 male mice, with at least 10 weeks of age (Harlan Iberica, 
Spain). The animals were kept under standardized temperature, 
humidity and lighting conditions, and had access to water and food ad 
libitum. All animal procedures were carried out according to the 
European Community Guidelines for Animal Care (European 
Communities Council Directive - 86/609/EEC).  
4.1 Tissue Preparation  
The animals were sacrificed by decapitation under deep halothane or 
isofluorane anaesthesia. The brain was quickly removed, hemisected 
and one hippocampus used to obtain transverse slices (300 µm-thick), 
cut on a vibratome (VT 1000 S; Leica, Nussloch, Germany) in ice-cold 
dissecting solution containing (in mM): sucrose 110; KCl 2.5; CaCl2 
0.5; MgCl2 7; NaHCO3 25; NaH2PO4 1.25; glucose 7, oxygenated with 
95% O2 and 5% CO2, pH 7.4. Slices were first incubated for 30 min at 
35°C in artificial cerebrospinal fluid (aCSF), containing (in mM): NaCl 
124; KCl 3; NaH2PO4 1.25; NaHCO3 26; MgSO4 1; CaCl2 2; and 
glucose 10, pH 7.4, gassed with 95% O2 and 5% CO2, and used after 
recovering for at least 1 hour at room temperature.  
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4.2 Patch-clamp recordings 
Individual slices were fixed with a grid in a recording chamber (1 ml 
plus 200 µl dead volume) and were continuously superfused at 2-3 
ml/min with aCSF. Unless stated otherwise, drugs were added to this 
superfusion solution and reached the recording chamber within 
approximately 1 min.  
Patch pipettes had resistance of 4–7 MΩ when filled with an internal 
solution containing (in mM): K-gluconate 125; KCl 11; CaCl2 0.1; 
MgCl2 2; EGTA 1; HEPES 10; MgATP 2; NaGTP 0.3 and 
phosphocreatine 10, pH 7.3, adjusted with NaOH (1 M), 280–290 Osm. 
In some experiments, and where specified, H-89 (1 µM), GF109203X 
(1 µM), cycloheximide (10 µM) or spermine (500 µM) were added to 
the pipette solution, so as to impair PKA or PKC activity, postsynaptic 
protein synthesis or calcium-permeable AMPA receptors, respectively. 
In these experiments, a 30 min period, prior to drug application, was 
allowed for diffusion of the inhibitor into the intracellular milieu of 
recorded cells. 
Whole-cell patch-clamp recordings were obtained from CA1 pyramidal 
cells or stratum radiatum interneurons, which were visualized with an 
upright microscope (Zeiss Axioskop 2FS) equipped with infrared video 
microscopy and differential interference contrast optics. Recordings 
were performed at room temperature (22−24°C). Pyramidal cells were 
functionally distinguished from interneurons by their slower firing 
frequencies, longer action potentials and for featuring spike-frequency 
adaptation (Madison and Nicoll, 1984; Schwartzkroin, 1975) during a 
500 ms step depolarization up to -40 mV. Current recordings were 
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performed in voltage-clamp mode (Vh = -70 mV) with either an EPC-7 
(List Biologic, Campbell, CA) or an Axopatch 200B (Axon 
Instruments) amplifier. The junction potential was not compensated for 
and offset potentials were nulled before giga-seal formation. Small 
voltage steps (5 mV, 50 msec) were delivered before current recordings 
to monitor the access resistance. The holding current was also 
constantly monitored throughout the experiment and when any of these 
parameters varied by more than 20%, the experiment was rejected. The 
current signal was filtered using built in 2 or 3 and 10 kHz three-pole 
Bessel filters and data were digitized at 2, 5 or 10 kHz, under the 
control of either the LTP (Anderson and Collingridge, 2001), winLTP 
0.94 (Anderson, 1991-2006) or pClamp 10 (Molecular Devices) 
software programs. Data were analysed using either the off-line 
reanalysis version of winLTP or Clampfit 10.2 software.  
4.2.1 AMPA-evoked postsynaptic currents  
Postsynaptic currents (PSCs) were elicited once every 2 min by 
pressure ejection (5-10 psi, 4-20ms, pneumatic picopump, PV 820 WPI 
Instruments, or Toohey Spritzer) of AMPA (60-120 µM) through a 
micropipette positioned near the soma of the recorded cell. 
4.2.2 mEPSC Recordings 
Miniature excitatory postsynaptic currents (mEPSCS) were recorded in 
aCSF supplemented with tetrodotoxin (TTX, 0.5 µM) and bicuculline 
(bicc, 20 µM), except where otherwise indicated. Analysis of miniature 
events was performed with the Clampfit 10.2 software, by scanning 
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gap-free recordings for asymmetric events with the rise time shorter 
than the decay time and amplitudes > background, using template-
based event search (Clements and Bekkers, 1997). mEPSC data were 
sampled at 10 KHz and an offline low-pass Gaussian filter (400 Hz 
with a -3dB cut-off) was used. mEPSC frequency and amplitudes were 
established by analyzing two 10 min periods, one immediately before 
addition of the test drug to the superfusion medium and the other of the 
final 10 min period recorded in its presence. mEPSC frequency ranged 
between 0.16 and 2.5 Hz and the average number of events analyzed in 
each recording was 418±59 (mean±SEM from 18 experiments). To 
address the possibility of rundown or loss of sensitivity of AMPA 
receptors during whole-cell recordings of spontaneous miniature 
excitatory currents (Wang et al., 1991), test drugs were applied at least 
30 minutes after establishment of the whole-cell configuration, a time 
at which the decline of miniature events has been shown to be 
minimum (Sokolova et al., 2006). 
4.2.3 EPSC recordings and LTP  
Afferent-evoked excitatory postsynaptic currents (EPSCs) were elicited 
by 0.2 ms rectangular pulses, delivered once every 30 s through a 
concentric electrode (Harvard) placed in the Schaffer 
Collaterals/comisural afferents of the CA1 area. Averages of four 
consecutive individual recordings were used for analysis, so as to 
match the time course of experiments with AMPA-mediated PSCs. 
EPSCs were recorded from CA1 pyramidal neurons at Vh=-70 mV, in 
aCSF containing bicuculline (20 µM, to prevent activation of 
postsynaptic GABAA receptors and therefore minimize the influence of 
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GABAergic transmission) and with an external Mg2+ concentration of 1 
mM, so that most of the EPSC response corresponded to the AMPA 
component of glutamatergic transmission. Long term potentiation 
(LTP) of EPSCs was induced by coupling depolarization to 0 mV for 
15s with the delivery of four brief high-frequency tetani (50 pulses at 
50 Hz) spaced by 4s intervals (Chen et al., 1999b), in aCSF containing 
an external Ca2+ concentration of 4 mM and no bicuculline, except 
otherwise indicated. Data were not included for analysis when pairing 
failed to result in a ≥40% potentiation in the first two minutes after 
paired stimuli delivery.  
4.2.4 Hypoxia induction 
Hypoxia was induced by substituting the artificial cerebrospinal fluid 
(aCSF) by an identical aCSF pre-equilibrated with 95% N2 / 5% CO2 
for 4 min. This manipulation reduces bath oxygen tension in the 
recording chamber from ≈ 600 mmHg to ≈ 250 mmHg (Sebastião et al., 
2001). Each slice was subjected to a single period of hypoxia, since the 
effects of hypoxia may be modified by subsequent episodes in the same 
slice (Schurr et al., 1986; Pérez-Pinzón, 1999). 
4.2.5  Oxygen/glucose deprivation 
In vitro ischemia was induced by replacing 10 mM glucose-containing 
aCSF with that containing 7mM sucrose (3mM glucose), gassed with 
95% N2 / 5% CO2, for 10 min (Rossi et al., 2000).  
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4.3  Protein biotinylation 
Whole-cell and membrane protein extracts were prepared from control 
and test slices, which were incubated under oxygenation, for 40 
minutes in the presence or absence of a test drug. Two slices per group, 
per experiment, were used. Slices were then washed three times with 
ice-cold PBS/Ca2+/Mg2+ buffer composed of (in mM): 136.9 NaCl, 2.7 
KCl, 4.3 NaH2PO4.2(H2O), 1.5 KH2PO4, 1 CaCl2, 0.5 MgCl2, and 
incubated with EZ-Link sulfo-NHS-LC-biotin (1mg/mL, Pierce) for 1 
hour, at 4ºC using gentle agitation, which has been shown to ensure a 
complete biotinylation in hippocampal slices even thicker (400 µm) 
(Thomas-Crussels et al., 2003) than those presently used (300 µm). 
Biotin was dissolved in a biotinylation buffer composed of (in mM): 10 
TEA, 2 CaCl2, 150 NaCl, pH 7.4. Slices were washed three times with 
cold PBS/Ca2+/Mg2+ buffer and then incubated with 100 mM glycine in 
PBS/Ca2+/Mg2+ buffer, for 30 minutes at 4ºC, so as to quench free 
biotin. After washing again three times with cold PBS/Ca2+/Mg2+ 
buffer, slices were lysed on ice, by mechanical homogenization in 
RIPA (lysis buffer composed of 50 mM Tris base pH8, 1 mM EDTA, 
150 mM NaCl, 0.1% SDS, 1% NP40), supplemented with protease 
inhibitor cocktail tablets (Roche). Samples were centrifuged at 13000 
rpm (16060 G; Biofuge Fresco, Heraeus, UK) for 10 minutes (at 4ºC) 
and the supernatant was separated from the pellet (discarded as 
undigested material) and further processed. The protein content of each 
sample was then determined, using the Bradford method (Bradford, 
1976); average protein concentration was 1.34± 0.20 mg/mL for control 
samples and 1.36 ± 0.26 mg/mL for those treated with the A2A receptor 
agonist. Samples were left to incubate with streptavidin (Sigma, 2 
µL/10 µg of sample protein) overnight at 4ºC, in orbital agitation. 
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Samples were centrifuged at 14000 rpm for 10 minutes and the 
supernatant (whole-cell fraction of both control and test samples) was 
stored in the freezer for further immunoblot analysis. The pellet 
(biotinilated proteins conjugated with streptavidin - surface membrane 
fraction) was then washed 3 times with RIPA, by 10 min 
centrifugations at 13000 rpm, after which 70 µL of Laemli buffer (350 
mM Tris-HCl pH 6.8; 600 mM DTT; 30% glycerol; 10% SDS and 
0.012% Bromophenol Blue) were added to the sample, before a 5 min 
incubation at 95ºC. After a 10 min centrifugation at 13000 rpm, the 
supernatant was collected (containing membrane proteins free of 
streptavidin-biotin conjugates) and stored for immunoblot analysis. 
4.4 Immunoblot analysis 
Samples processed as above were run on standard 8% sodium dodecyl 
sulphate poliacrylamide gel electrophoresis (SDS-PAGE) and 
transferred to nitrocellulose membranes (Amersham). After blocking 
for 1 hr with a 5% milk solution, membranes were then probed using 
anti-phospho-Ser-845-GluR1 (1:1500 or 1:2000, Chemicon), anti-
GluR1 (1:4500, Upstate) or anti-ß-actin (1:5000, Abcam) primary 
antibodies, with which they were left to incubate overnight, at 4ºC. 
Incubation with anti-rabbit IgG-HRP conjugated secondary antibodies 
(1:7500, Biorad) was performed at room temperature, for 1 hour. 
Development of signal intensity was done using the ECL Plus Western 
Blotting Detection System (Amersham) and quantifications were 
attained by densitometric scanning of the films, performed with the 
Image J software. β-actin density was used as a loading control.   
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4.5 Drugs  
CPA (N6-cyclopentyladenosine, Tocris), CGS 21680 (2-[4-(2-p-
carboxyethyl)phenylamino]-5’-N-ethylcarboxamidoadenosine, Sigma), 
SCH 58261 (7-(2-phenylethyl)-5-amino-2-(2-furyl)-pyrazolo-[4,3-e]-
1,2,4-triazolo[1,5-c]pyrimidine, Sigma-Aldrich) and H-89 (N-[2-((p-
bromocinnamyl)amino)ethyl]5-isoquinolinesulfonamide, Sigma-
Aldrich) were made up in 5 mM stock solutions in dimethylsulfoxide 
(DMSO). DPCPX (8-cyclopentyl-1,3-dipropylxanthine, Sigma-
Aldrich) was also prepared as a 5 mM stock solution, in DMSO. TTX 
(Tetrodotoxin, Tocris), AMPA (RS-alpha-amino-3-hydroxy-5-methyl-
4-isoxazolepropionic acid, Sigma-Aldrich) and DL-APV (2-amino-5-
phosphonovaleric acid, Tocris) were made up in water, in 1, 10 and 25 
mM stock solutions, respectively. Cycloheximide (Tocris) was also 
prepared in water, in a 10 mM stock solution. GF109203X 
(bisindolylmaleimide I, Tocris) and bicuculline (Sigma-Aldrich) were 
made up in DMSO, in 1 and 100 mM stock solutions, respectively. 
CNQX was either prepared as a 100 mM stock solution in DMSO (6-
cyano-7-nitroquinoxaline-2,3-dione, Tocris), or as a 10 mM stock 
solution in water (CNQX  -disodium salt, Ascent). Forskolin (Sigma-
Aldrich) was prepared in DMSO, in a 10 mM stock solution. Aliquots 
of all stock solutions were kept at -20ºC until use. The maximum 
DMSO concentration used in the perfusion solution (0.0026%, v/v) was 
devoid of effects on AMPA-PSCs amplitude.   
4.6 Preparation of recombinant cytokine samples 
Mouse recombinant Oncostatin M (OSM, Sigma) was prepared in PBS 
containing 0.1% BSA (stock concentration: 25 µg/mL) and applied to 
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acute slices at a final concentration of 10 ng/mL. Human recombinant 
Leukemia factor (LIF) was provided at a stock concentration of 10 
µg/ml in PBS (Millipore) and used at a final concentration of 10 
ng/mL. 
4.7 Statistical Analysis 
Results are expressed as the mean±SEM of n experiments. Statistical 
significance was either assessed by two-tailed Student’s t test; or by 
performing one-way ANOVA followed by Dunnett´s post hoc test for 
comparison between multiple experimental groups. A p value of less 
than 0.05 was considered to account for significant differences. 
Analyses were conducted with the GraphPad Software. 
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5 Results 
5.1 Activation of A2A Adenosine Receptors Facilitates AMPA 
receptor-mediated responses in CA1 Pyramidal Neurons with 
consequences for synaptic plasticity 
 
Rationale:  
Most of the fast excitatory transmission that takes place in the central 
nervous system is mediated by ionotropic glutamate AMPA receptors 
and their modulation is thus accountable for profound changes in 
synaptic efficiency. Accordingly, an increase in the number of 
AMPARs available at synaptic membranes, via activity-driven changes 
in AMPAR trafficking, is widely accepted as a major mechanism for 
long term potentiation (LTP) of excitatory transmission (Malenka and 
Bear, 2004). Activity-dependent release of adenosine and of its 
precursor, ATP, into the synaptic cleft, is well established to bring 
about fine-tuning of synaptic transmission (Sebastião and Ribeiro, 
2000). Indeed, through activation of high affinity A1 receptors, 
adenosine depresses the release of excitatory neurotransmitters, being 
part of a negative feedback loop capable of refraining neuronal 
excitability. As for A2A receptors, after first evidence that they could 
enhance synaptic transmission (Sebastião and Ribeiro, 1992), the 
underlying mechanism has been proposed to rely upon attenuation of 
A1 receptor-mediated inhibition of excitatory transmission (Cunha et 
al., 1994). Since then, attention has mainly focused on A2A receptor-
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mediated presynaptic actions. These include facilitation of glutamate 
release by restraining the inhibitory actions of A1 receptors (Lopes et 
al., 2002), with which they colocalize in subsets of glutamatergic nerve 
terminals (Rebola et al., 2005a). Reports on postsynaptic actions of A2A 
receptors in the hippocampus comprise depolarization associated with 
changes in input resistance, compatible with potassium-channel 
inhibition (Li and Henry, 1998) and attenuation of A1 receptor-
mediated postsynaptic inhibition of cell firing (O’Kane and Stone, 
1998). Also, there is indirect evidence for a nonpresynaptically 
mediated facilitation of the early phase of afferent evoked synaptic 
potentials, which was interpreted as a postsynaptic facilitation of 
AMPA receptor function, dependent on activation of AC-coupled A2B 
receptors (Kessey and Mogul, 1997). However, the low affinity of A2B 
receptors for adenosine makes them less likely to play a relevant role at 
synapses under physiological conditions (Ribeiro et al., 2002). 
Strikingly, no study has directly evaluated whether postsynaptically 
located A2A receptors could influence AMPA receptor functioning, 
even though their high affinity for adenosine prompts activation under 
non-pathological conditions. Moreover, A2A receptors are positively 
coupled to adenylate cyclase (Furlong et al., 1992; Fredholm et al., 
2001) and AMPA receptor subunits are substrate for PKA dependent 
phosphorylation (Banke et al., 2000) with consequences for receptor 
cycling (Ehlers, 2000) and membrane delivery (Oh et al., 2006), 
therefore to plasticity phenomena (Oh et al., 2006; Esteban et al., 
2003). In what concerns their distribution in the hippocampus, A2A 
receptors are expressed in presynaptic terminals, in the postynaptic 
density and in the cell body of pyramidal neurons, as indicated by 
immunocytochemistry (Rebola et al., 2005b) and in situ hybridization 
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(Lee et al., 2003b) studies. They thus occur in proximity of 
postsynaptic AMPA receptors. The work described in this chapter was 
designed to address a putative modulation by A2A receptors of AMPA 
receptor functioning, as well as consequences for synaptic transmission 
and plasticity phenomena. 
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Exogenous activation of A2A adenosine receptors facilitates AMPA-
evoked currents in CA1 pyramidal neurons but not in stratum 
radiatum interneurons 
In order to elucidate whether modulation of synaptic transmission by 
adenosine in the hippocampus might include A2A receptor-mediated 
regulation of postsynaptic AMPA receptor-mediated responses, whole-
cell recordings of agonist-evoked AMPA currents or electrically-
evoked excitatory postsynaptic currents (EPSCs) were combined with 
exogenous application of A2A receptor ligands. AMPA-evoked currents 
were recorded from either CA1 pyramidal cells or stratum radiatum 
interneurons (Figure 5.1.1).  
 
Figure 5.1.1. Patch-clamp recordings of AMPAR-mediated currents. AMPA receptor-
mediated currents were recorded from CA1 pyramidal cells (A-C) or stratum radiatum 
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interneurons (D-F), from acutely prepared hippocampal slices. Cells were visually identified by 
their characteristic morphological features (A,D) and functionally, by firing patterns obtained in 
response to current injection through the recording electrode (B,E), as described in Methods; 
note accommodation of firing frequency in pyramidal cells (B) but not in interneurons (E). 
Stratum radiatum interneurons were further identified by their position relative to the CA1 
pyramidal layer, as evidenced by a magnification (D) 1/4X from that used to establish patch-
clamp recordings (A). Local pressure application (5-10 psi; 4-20 ms) of AMPA (60-120 µM) 
onto the soma of recorded cells was used to elicit macroscopic postsynaptic excitatory currents 
(C1,F) mediated by AMPA-type glutamate receptors, which were completely abolished by 
superfusion of the selective AMPA receptor antagonist CNQX (50 µM, C2). 
 
Whole-cell recordings of agonist-evoked currents were first employed 
to address a putative modulation of postsynaptic AMPA currents by 
addition of a selective A2A receptor agonist (CGS 21680) to the 
superfusion medium, in CA1 pyramidal cells. In these conditions, 
application to the hippocampal slice of CGS 21680 (30 nM; Jarvis et 
al., 1989) significantly enhanced the peak amplitude of AMPA-evoked 
currents recorded from CA1 pyramidal neurons. Recorded currents 
started to increase only about 10–15 min after starting CGS 21680 
perfusion, with the maximum effect being observed at the end of about 
50 min (Figure 5.1.2A). This enhancement was not reversible at least 
within 30 min after starting drug removal from the bath. Current 
amplitude enhancement by CGS 21680 (30 nM) was observed in 8 out 
of 11 cells (73%). Absence of response to CGS 21680 also occurred in 
subsequent sets of experiments, with the percentage of non-responding 
cells usually being less than 1/3 of total cells tested. Data from all cells 
was, however, pooled together when calculating averaged effects of the 
A2A receptor agonist. This method was preferred because it avoids bias 
while calculating effects, though it may lead to underestimation of CGS 
21680 actions in responding cells. Accordingly, to keep information on 
the effects obtained in individual cells available, statistical panels 
Modulation of AMPA receptors by adenosine 
 100 
shown throughout the chapter report pooled averaged results as well as 
effects in individual cells. An average increase of 26.9±6.9% (n=11, 
P<0.05, as compared with baseline values) in the peak amplitude of 
AMPA currents was attained 36–40 min after adding CGS 21680 (30 
nM) to the superfusion medium. However, as shown in Figure 5.1.2A, 
AMPA currents continued to undergo an enhancement beyond this time 
point so that 54–60 min after addition of CGS 21680, current amplitude 
enhancement reached 45.2±5.9% (n=8). In most of the experiments 
described in the present chapter, CGS 21680 was applied for 40–50 
min; therefore, to allow comparison between CGS 21680 effects in 
different drug conditions, and unless otherwise stated, the effect of 
CGS 21680 was quantified in each experiment by taking the current 
amplitude values recorded during the last three time points of a 40-min 
perfusion. 
As expected, AMPA current facilitation by CGS 21680 was fully 
prevented when a selective A2A antagonist, SCH 58261 (100 nM; 
Zocchi et al., 1996), was added to the superfusion medium for at least 
30 min prior to CGS 21680 application (n=5, Figure 5.1.2B). In some 
of the experiments and to save recording time, SCH 58261 was added 
to the superfusion immediately after establishing whole-cell 
configuration. However, in a subset of experiments, responses were 
allowed to stabilize before addition of the A2A antagonist and in no case 
did its perfusion for 40 min appreciably affect the amplitude of AMPA 
currents (n=3, Figure 5.1.2C).  
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Figure 5.1.2. Activation of A2A adenosine receptors potentiates the amplitude of AMPAR-
mediated currents recorded from CA1 pyramidal cells. (A) Whole-cell voltage-clamp 
recordings of AMPA currents (right) and averaged time-course changes in AMPA current peak 
amplitude (left) caused by superfusion of the selective A2A agonist CGS 21680 (30 nM). 
Superimposed traces in the right panel represent AMPA-evoked currents obtained in one 
representative cell under control (1) and test (CGS 21680) conditions (2). In each time-course 
panel, (A,B,D,E), each point represents the average of individual macroscopic responses to 
focal pressure application of AMPA, elicited once every 2 minutes. Horizontal bars on the 
time-course panels indicate the time at which tested drugs were applied to the superfusion 
medium; 100% corresponds to the averaged amplitude calculated for the 5-10 AMPA currents 
recorded immediately before drug application. (B) Averaged time-course changes in AMPA 
current peak amplitude caused by CGS 21680 (30 nM), when added to superfusion medium 
containing a selective antagonist of A2A receptors (SCH 58261, 100 nM). (C) Individual (dots) 
and average (bars) changes in current amplitude induced by the A2A receptor ligands, as 
indicated below each data set. Values are mean ± SEM. To allow comparison between all data 
sets at the same time points, values correspond to percentage changes recorded 34-40 min after 
initiating CGS 21680 superfusion. * p<0.05 (two-tailed paired Student’s t test, compared with 
baseline, using absolute current values); δ p<0.05 (one-way ANOVA followed by Dunnett´s 
multiple comparison test). 
 
The apparent irreversibility of the increase in AMPA current amplitude 
that ensued CGS 21680 superfusion, raised the hypothesis that the A2A 
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receptor agonist would only need to be present for a short time, in order 
to trigger a response. Indeed, when CGS 21680 was superfused by only 
a brief, 10 min period, a significant facilitation of AMPA-evoked 
currents, by 21.3±6.4% (n=7, P<0.05 as compared with baseline, Figure 
5.1.3A), was still observed. The facilitation induced by a short time 
application of CGS 21680 was slightly smaller, but not significantly 
different from that observed when using longer (40 min) CGS 21680 
superfusion times (P>0.05, Figure 5.1.3D). The smaller effect of CGS 
21680 after a short time application could be expected on the basis of 
the long period needed for this ligand to reach the equilibrium with its 
receptor (Jarvis et al., 1989). Still, these results clearly show that a 
continuous activation of A2A receptors is not necessary for the increase 
in AMPA current amplitude to occur, suggesting that activation of A2A 
receptors is only required to trigger the activation of a transduction 
pathway, and from this point onwards the presence of the A2A receptor 
agonist is no longer a necessary step.  
A2A receptor-induced Potentiation of AMPA currents does not 
require NMDA or GABAA receptor activation, nor does it depend 
on synaptic activity. 
Since excitatory synaptic transmission in the hippocampus is under 
GABAergic control (Lopes da Silva et al., 1990) and GABA release 
from hippocampal nerve terminals is enhanced by A2A receptor 
activation (Cunha et al., 2000), a set of experiments was performed in 
the presence of a selective GABAA receptor antagonist (bicuculline, 20 
µM) to evaluate if the observed A2A receptor mediated facilitatory 
effect could result from any interference with GABAergic transmission. 
Also, because A2A receptors have been shown to directly affect NMDA 
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receptor function (Nikbakht and Stone, 2001; Rebola et al., 2008), a 
selective NMDA receptor antagonist (APV, 10 µM) was concurrently 
added to the superfusion medium in these experiments. The sodium 
channel blocker, tetrodotoxin (TTX, 0.5 µM) was applied as well, so as 
to prevent action potential generation, and therefore, neuronal 
communication. Under these conditions, activation of A2A receptors 
caused a 29.7±10.4% facilitation of AMPA-evoked currents (n=8, 
P<0.05, Figure 5.1.3B,D), measured 34–40 min after CGS 21680 
application, thus dismissing the possibility that the effect of the A2A 
receptor agonist is due to modified NMDA and/or GABAA receptor-
mediated transmission or to any other mechanisms requiring action 
potential dependent neuronal communication. 
A2A receptor-induced potentiation of AMPA-evoked currents is 
concentration-dependent. 
When using lower concentrations of CGS 21680 (1–10 nM), smaller 
but significant facilitations of AMPA-evoked currents were attained, 
except for the lowest concentration tested (Figure 5.1.3C). However, no 
significant effect was observed when CGS 21680 was applied at a 
concentration of 100 nM (n=4, P>0.05, Figure 5.1.3C). The absence of 
effect observed for the highest concentration could be due to 
desensitization of A2A receptors, or to A1 receptor activation due to loss 
of selectivity of the agonist at high concentration. Indeed, it has been 
reported that CGS 21680 at concentrations higher than 100 nM failed to 
increase cAMP levels at hippocampal nerve terminals (Lopes et al., 
2002) and that at micromolar concentrations it even inhibited 
hippocampal synaptic transmission through an A1 receptor-related 
mechanism (Lupica et al., 1990).  
Modulation of AMPA receptors by adenosine 
 104 
 
Figure 5.1.3. A2A receptor- induced potentiation of AMPA currents does not depend on 
NMDA or GABAA receptor activation, nor does it depend on synaptic activity. (A) Time-
course changes (left) and recordings (right) of AMPA-evoked currents in experiments where 
CGS 21680 (30 nM) was added to the superfusion medium for only a 10 min period. Note that 
under these conditions, CGS 21680 triggered a facilitation of AMPA currents that was not 
statistically different (D) from that caused by longer applications of CGS 21680. (B) Averaged 
time-course panel and recordings (right) of current amplitude changes caused by 30 nM CGS 
21680 when applied in the presence of a selective GABAA receptor antagonist bicuculline 
(Bicc, 20 µM), the sodium channel blocker tetrodotoxin (TTX, 0.5 µM) and the NMDA 
receptor antagonist 2-amino-5-phosphonovaleric acid (APV, 10 µM). Average facilitation of 
AMPA-evoked currents in these conditions was not significantly different from that measured 
in the absence of the blockers (D). (C) Concentration-response curve for the effect of the A2A 
receptor agonist. Facilitation of AMPA current peak amplitude was significant for all 
concentrations tested (p<0.05, two-tailed paired t test, compared with baseline), except for the 
lowest (1 nM) and the highest (100 nM). The number of experiments for each concentration is 
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indicated between parentheses. Each point is the averaged effect attained 40 min after initiating 
CGS 21680 superfusion. (D) Values are mean ± SEM. To allow comparison between all data 
sets at the same time points, values correspond to percentage changes recorded 34-40 min after 
initiating CGS 21680 superfusion. * p<0.05 (two-tailed paired Student’s t test, compared with 
baseline, using absolute current values); n.s. p>0.05 (one-way ANOVA followed by Dunnett´s 
multiple comparison test). 
 
Activation of A1 adenosine receptors inhibits the amplitude of 
AMPA-evoked postsynaptic currents in CA1 pyramidal cells. 
Although the focus of the work described in this chapter concerned A2A 
receptor-mediated modulation of AMPA currents, adenosine A1 
receptors are also expressed in the hippocampus and frequently operate 
to counteract A2A actions, as they are able to inhibit AC/PKA 
dependent mechanisms (van Calker et al., 1979). 
I therefore decided to evaluate a putative modulation of postsynaptic 
AMPA currents by A1 receptors and observed that superfusion of a 
selective A1 receptor agonist, N6-cyclopentyladenosine (CPA, 100 nM; 
Williams et al., 1986) caused a decrease in peak current amplitude 
(Figure 5.1.4A). Since A1 and A2A receptor agonists are both able to 
influence AMPA currents recorded from CA1 pyramidal cells, and 
given previous reports on A2A receptor-mediated actions in the 
hippocampus requiring tonic A1 receptor activation (Lopes et al., 
2002), it was considered relevant to evaluate if A1 receptor activation is 
necessary for CGS 21680-induced potentiation of AMPA responses. 
Should this hypothesis apply, then an A1 receptor antagonist would be 
expected to block the effect of CGS 21680. A selective A1 receptor 
antagonist, 8-cyclopentyl-1,3-dipropylxanthine (DPCPX), was 
therefore used at a concentration (100 nM) nearly 200 times its Ki value 
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for A1 receptors at the hippocampus (Sebastião et al., 1990). At this 
concentration, DPCPX had no appreciable effect upon AMPA current 
amplitude (Figure 5.1.4B) and did not prevent CGS 21680-induced 
facilitation of AMPA currents (Figure 5.1.4C), precluding the 
possibility that the now reported neuromodulatory action of A2A 
receptors results from an interaction with A1 receptors. 
 
Figure 5.1.4. Activation of A1 adenosine receptors inhibits the amplitude of AMPA-
evoked postsynaptic currents in CA1 pyramidal cells. (A) Average time-course changes in 
AMPA current amplitude caused by superfusion of the selective A1 adenosine receptor agonist 
N6-cyclopentyladenosine (CPA, 100 nM, n=6). Each point represents the average of individual 
macroscopic responses to focal pressure application of AMPA, elicited once every minute. The 
right panel shows superimposed tracings from a representative cell, illustrating an AMPA-
evoked current recorded in the control period and one obtained 30 min upon adding CPA to the 
superfusion solution. (B) Superfusion of the A1 receptor antagonist, 8-cyclopentyl-1,3-
dipropylxanthine (DPCPX, 100 nM) did not significantly affect AMPA-evoked currents (n=3), 
and in its presence, the ability of the A2A receptor agonist to facilitate current amplitude was 
preserved (n=4) (C). In the right panel are shown representative current tracings recorded in the 
control period (1) and 30-40 min after initiating CGS 21680 superfusion. For B and C, each 
point represents the average of individual macroscopic responses to focal pressure application 
of AMPA, elicited once every 2 minutes. 
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A2A receptor-induced potentiation of AMPA-evoked currents does 
not occur in stratum radiatum interneurons. 
Pyramidal neurons of the CA1 hippocampal area are responsible for the 
excitatory output of the hippocampus and are under control of 
inhibitory GABAergic interneurons. Interneurons at the stratum 
radiatum receive glutamatergic inputs from CA3 pyramidal cells and 
impinge their inhibitory output to other interneurons and to CA1 
pyramidal cells (Lopes da Silva et al., 1990). Therefore, changes in the 
responsiveness of interneurons to excitatory inputs may have profound 
and diverse influence on hippocampal output signaling. We thus 
evaluated whether A2A receptors could also modulate AMPA currents 
at stratum radiatum interneurons. Experiments were carried out in as in 
pyramidal cells except that the electrodes were placed over a stratum 
radiatum interneuron. CGS 21680 (30 nM) was tested in seven cells 
from slices prepared from five different animals, and in no case did its 
perfusion for 40 min appreciably affect the amplitude of recorded 
AMPA-evoked currents (n=7, Figure 5.1.5A-B). Similarly, when 
evaluating the effect of the A2A receptor agonist upon AMPA-evoked 
currents recorded from stratum oriens interneurons, no significant 
effect was observed either (n=8; 7 animals; Figure 5.1.5C-D). 
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Figure 5.1.5. Activation of A2A adenosine receptors does not affect the amplitude of 
AMPA-evoked postsynaptic currents recorded from stratum radiatum or stratum oriens 
interneurons. (A) Morphological features and location of a stratum radiatum interneuron 
below the pyramidal cell layer, in the hippocampal slice. (B) Averaged time-course changes in 
AMPA-evoked current amplitude caused by superfusion of CGS 21680 (30 nM, n=7). Current 
tracings (lower panel) of AMPA-PSCs recorded from a representative cell before (1) and 40 
min after (2) starting superfusion of the A2A receptor agonist. (C) Morphological features of a 
stratum oriens interneuron. (D) Averaged time-course changes in AMPA-evoked current 
amplitude caused by superfusion of CGS 21680 (30 nM), from 8 stratum oriens interneurons. 
 
Having established that A2A receptor-mediated facilitation of 
postsynaptic AMPA receptors was not extended to other cell types in 
the hippocampus, such as stratum radiatum (Figure 5.1.5A-B) or 
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stratum oriens interneurons (Figure 5.1.5C-D), experiments were 
designed to ascertain the mechanisms underlying the effects observed 
in CA1 pyramidal cells. 
 
Activation of A2A Receptors increases the amplitude, but not the 
frequency, of spontaneous miniature Excitatory Miniature 
Currents (mEPSCs) 
Results reported above (Figure 5.1.3B) showing that facilitation of 
AMPA-evoked currents was preserved in conditions of impaired action 
potential-dependent neuronal communication, strongly indicated that it 
was brought about by changes in the postsynaptic cell. To further test 
whether A2A receptor-mediated facilitation of AMPA-evoked currents 
was due to a postsynaptic mechanism, I evaluated changes in the 
frequency and amplitude of miniature excitatory postsynaptic currents 
caused by superfusion of the A2A receptor agonist. These experiments 
were performed in aCSF supplemented with TTX (0.5 µM) and 
bicuculline (20 µM) to prevent both spontaneous firing of neurons and 
contribution of GABAergic transmission. Superfusion of CGS 21680 
(30 nM) resulted in an increase in the amplitude of TTX-resistant 
mEPSCs by 10.2±3.3% (n=11, P<0.05 when compared with absolute 
baseline values, Figure 5.1.6), measured 30–40 min after starting CGS 
21680 superfusion, as compared to mEPSCs recorded in the 10 min 
previous to it. In absolute values, mEPSC amplitude was 9.9±0.9 pA in 
the baseline period and 11.0±1.1 pA, 30–40 min after addition of the 
A2A receptor agonist to the superfusion. mEPSC frequency was not 
affected by CGS 21680 superfusion, as it was 100.1±8.0% of baseline 
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values (0.44±0.07 Hz before and 0.43±0.08 Hz after CGS 21680; n=11, 
Figure 5.1.6). To control for the possibility that this change in mEPSC 
amplitude could result from time-dependent changes rather than CGS 
21680 application, we repeated the experimental design (bicuculline 
present), but omitting the addition of the A2A receptor agonist to the 
bath solution. A comparison of the changes observed in mEPSC 
amplitude and frequency in these control experiments (n=7) with those 
observed at the same time point (40 min), but in the presence of CGS 
21680, is shown in Figure 5.1.6. Amplitude variation, but not 
frequency, was significantly different in both groups (Figure 5.1.6B).  
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Figure 5.1.6. Activation of A2A receptors increases the amplitude, but not the frequency, 
of spontaneous miniature excitatory postsynaptic currents (mEPSCs). (A) In the upper 
panel are shown representative tracings of mEPSCs recorded in whole-cell configuration from 
a CA1 pyramidal cell, in the absence (upper trace) and presence (lower trace) of the A2A 
receptor agonist CGS 21680 (30 nM). The two superimposed events depicted in the lower panel 
illustrate one mEPSC recorded in control conditions (1) and one recorded in the presence of the 
A2A agonist (2), from the same cell as in the upper panel. The sodium channel blocker, 
tetrodotoxin (TTX, 0.5 µM) and the GABAA receptor antagonist bicuculline (bicc, 20 µM) 
were present throughout recordings of spontaneous events. mEPSC frequency and amplitude 
changes were quantified by analyzing two 10 min periods, one immediately before addition of 
the A2A receptor agonist and the other corresponding to the final 10 min period recorded in its 
presence. These variations were compared with those measured in the absence of the A2AR 
agonist (control experiments), in the same time points of recording. (B) Values are shown as 
mean ± SEM, as well as individual data obtained in the absence (n=7) and presence (n=11) of 
CGS 21680, as indicated below each data set. Each point represents the averaged mEPSC 
amplitude (left) or frequency (right) recorded from each cell 30-40 min after adding CGS 
21680 or after the same time of recording, but in the absence of CGS 21680, as indicated below 
Modulation of AMPA receptors by adenosine 
 112 
each data set; 100% corresponds to data recorded before adding/not adding CGS 21680. 
Individual run down for each cell and in each condition can be evaluated by the deviation of 
each point from 100%. n.s. p>0.05 and * p<0.05 (two-tailed unpaired Student´s t-test, 
compared with control experiments). 
 
Altogether, these data provide a further indication that A2A receptor 
activation postsynaptically enhances AMPA receptor-mediated events. 
However, considering that neither the expression of A2A receptors in 
hippocampal neurons (Lee et al., 2003b), nor that of AMPA receptors 
(e.g., Shi et al., 1999) is restricted to a synaptic level, it would be 
highly unlikely that changes in mEPSC amplitude alone could fully 
account for the observed facilitation of AMPA-evoked currents by A2A 
receptor activation. Indeed, the difference of magnitude between the 
effects observed in mEPSC amplitude and those obtained when 
measuring AMPA-evoked currents suggests the involvement of 
changes not only in the synaptic AMPA receptor pool, as also in the 
peri-synaptic and extrasynaptic receptor populations.  
Intracellular Blockade of PKA Activity Prevents AMPA Current 
Potentiation 
An enhancement of AMPA receptor function as a result of Ser 831 
and/or Ser 845 phosphorylation has been reported (Banke et al., 2000; 
Derkach et al., 1999). Ser 831 can be phosphorylated by both PKC and 
CaMKII, resulting in increased AMPA receptor single-channel 
conductance, while Ser 845 phosphorylation by PKA increases open-
channel probability (Banke et al., 2000) and enhances delivery of 
GluR1-containing AMPA receptors to extrasynaptic sites (Oh et al., 
2006). Also, several early studies reported increases in the amplitude of 
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AMPA receptor-mediated responses in cultured hippocampal neurons, 
upon activation of PKA (Greengard et al., 1991; Wang et al., 1991; 
Rosenmund et al., 1994). Interestingly, it was recently found that the 
neuropeptide PACAP can enhance postsynaptic AMPA receptor 
function in the hippocampus, in a PKA-dependent way (Costa et al., 
2009). Considering that A2A receptors are also coupled to excitatory G 
proteins which most frequently leads to a raise in intracellular cyclic 
AMP levels (Fredholm et al., 2001), we hypothesized that the A2A 
receptor agonist could be potentiating AMPA receptor function by 
means of a PKA-dependent mechanism. To address this possibility, 
cells were loaded with protein kinase inhibitors through the patch 
pipette solution. When a selective PKC inhibitor (GF109203X, 1 µM; 
Toullec et al., 1991) was present in the pipette filling solution, CGS 
21680 significantly potentiated AMPA current amplitude by 
21.0±5.9%, after 34–40 min of agonist superfusion (n=8, P<0.05, 
Figure 5.1.7A). This facilitation is slightly smaller but not significantly 
different from that observed in the absence of the inhibitor after the 
same time of perfusion (P>0.05, Figure 5.1.7C). When PKA activity 
was impaired by addition of the PKA inhibitor, H-89 (1 µM; Chijiwa et 
al., 1990), to the pipette filling solution, facilitation of AMPA-evoked 
currents was completely abolished (n=6, Figure 5.1.7B,C). These data 
strongly indicated that PKA activity was required for the facilitation of 
AMPA-evoked current amplitude observed after addition of the A2AR 
agonist to the superfusion medium. However, they did not support that 
activation of the PKA pathway alone was sufficient to trigger an 
increase in AMPA-mediated responses, recorded in our experimental 
conditions. For this reason, we tested the effect of an adenylate cyclase 
activator, forskolin, in AMPA-evoked currents (Figure 5.1.7).  
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Figure 5.1.7. Facilitation of AMPA-evoked currents by A2A receptor activation is 
dependent on postsynaptic PKA, but not PKC, activity. In A and B are shown averaged 
time-courses of current amplitude changes caused by 30 nM CGS 21680 after loading of 
recorded cells with either a selective PKC inhibitor (GF109203X, 1 µM) (A) or a selective 
PKA inhibitor (H-89, 1 µM) (B). In panel A (right) are also shown superimposed current 
tracings of AMPA-evoked currents obtained from a representative GF109203X-loaded cell, in 
the absence (1) and presence (2) of the A2A receptor agonist. In all experiments, a 30 min 
period prior to CGS 21680 application was allowed for diffusion of the inhibitor into the 
intracellular milieu of recorded cells. In each experiment, the involvement of PKA and of PKC 
activity was tested in different slices taken from the same hippocampus; a positive control for a 
GF109203X-loaded cell was a pre-requisite to pursue with testing the influence of H-89 in 
another cell. (C) Averaged and individual effects of CGS 21680 when applied alone, or in the 
presence of protein kinase inhibitors, as indicated below each data set. Effects were quantified 
at 34-40 min after CGS 21680 addition. Values are mean ± SEM. * p<0.05 (two-tailed paired t-
test, compared with baseline, using absolute current values); n.s. p>0.05 and δ p<0.05 (one-way 
ANOVA followed by Dunnet´s multiple comparison test). 
 
Bath application of forskolin (1 µM; Seamon et al., 1981) caused a 
facilitation of AMPA current amplitude by 33.7±8.7% when applied for 
40–50 min (n=10, P<0.05, Figure 5.1.8A) and by 25.4±7.2%, when 
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applied for only 10 min (n=6, Figure 5.1.8B), as measured 34–40 min 
after adding forskolin to the aCSF. Therefore, PKA is required for the 
enhancement of AMPA currents by the A2A receptor agonist, and 
adenylate cyclase activation mimics A2A receptor activation. In 
contrast, PKC activity does not seem to be required for A2A receptor-
induced enhancement of AMPA currents, with the slightly smaller CGS 
21680 effect observed upon PKC activity inhibition being probably due 
to interaction of the two transduction pathways, as has been described 
for the regulation of Na(v)1.2 sodium channels (Cantrell et al., 2002) 
and GAT-1 GABA transporters (Cristóvão-Ferreira et al., 2009). 
Altogether, data support the idea that A2A receptors facilitate AMPA 
currents through a mechanism that involves adenylate cyclase 
activation, cyclic AMP formation and PKA activation.  
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Figure 5.1.8. AMPA-evoked currents are potentiated by superfusion of an adenylate 
cyclase activator. Superfusion of an adenylate cyclase activator (forskolin, 1 µM) for 40 min 
(A) or 10 min (B) significantly increased the amplitude of postsynaptic AMPA currents, when 
compared with baseline. (C) Values are mean ± SEM of the effects observed following 
forskolin application by the period indicated below each data set, measured 34-40 min after 
starting its perfusion. * p<0.05 (two-tailed paired t-test, compared with baseline, using absolute 
current values. 
 
These results raised the hypothesis that enhancement of AMPA 
currents induced by A2A receptor activation could result from PKA-
induced phosphorylation of GluR1 AMPA subunits with subsequent 
increase in surface expression of GluR1 subunits (Oh et al., 2006).  
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The A2A Receptor Agonist CGS 21680 Increases GluR1 Surface 
Expression 
GluR1 recycling between the plasma membrane and endossomal 
compartments has been shown to be controlled by PKA 
phosphorylation in dissociated hippocampal neurons (Ehlers, 2000). 
Even more relevant to this work is the finding that GluR1 
phosphorylation by PKA activation in intact hippocampal slices 
correlates with increased expression of GluR1-containing AMPA 
receptors in extrasynaptic sites (Oh et al., 2006). To directly test the 
hypothesis that A2A receptor activation could lead to an enhancement of 
the surface expression GluR1 receptor subunits, slices were incubated 
with or without CGS 21680 (30 nM) for 40 min, biotinylated samples 
were prepared and run on 8% SDS-PAGEs. Expression of the GluR1 
AMPA receptor subunit was analyzed by western blot, as were the 
levels of GluR1 phosphorylated at Ser 845, known as the PKA 
phosphorylation site (Roche et al., 1996), by using an antibody that 
specifically recognizes that subunit form (Mammen et al., 1997). In 
slices incubated with the A2A receptor agonist, the surface expression of 
GluR1 phosphorylated at Ser 845 was increased by 18.8±4.0% when 
compared with control slices (n=5, P<0.05, Figure 5.1.9A). This 
increase occurred in the biotinilated fraction, but not in the whole-cell 
fraction (% change: -2.3±4.4%). Furthermore, when the biotinylated 
fractions were tested for total GluR1 immunoreactivity, those that had 
been prepared from slices exposed to the A2A receptor agonist revealed 
a 17.5±2.1% increase in the membrane expression of GluR1 when 
compared to control slices (n=5, P<0.05, Figure 5.1.9B). These findings 
suggest an association between A2A receptor activation, GluR1 
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phosphorylation at the Ser 845 residue and an increase in the membrane 
expression of GluR1-containing AMPA receptors. 
 
Figure 5.1.9. Activation of A2A receptors enhances membrane expression of phospho 
Ser845 GluR1. Expression of (A) GluR1 subunits phospshorylated at Ser 845 (pGluR1 Ser845, 
n=5) or (B) total GluR1 in biotinilated fractions (n=5) isolated from slices that had been 
incubated for 40 min in the absence or in the presence of the A2A receptor agonist, CGS 21680 
(30 nM), as indicated below the columns. The same membrane extracts were used for analysis 
in (A) an (B). Lower panels in both (A) and (B) show representative Western Blots obtained 
from control slices (left lane) and from slices treated with CGS 21680 (30 nM) for 40 min 
(right lane). β-actin was used as a loading control (bottom lanes). Values are average pGluR1 
Ser 845 (A) or GluR1 (B) immunoreactivity, normalized to β-actin. * p<0.05; two-tailed paired 
Student´s t-test. 
 
A2A Receptor-Induced Potentiation of AMPA Currents Does Not 
Depend on Postsynaptic Protein Synthesis 
The insertion of newly synthesized glutamate receptors in the 
postsynaptic membrane can occur within a few minutes (Huber et al., 
2000). This prompted us to check whether de novo synthesis of AMPA 
receptor subunits was required for the observed A2A receptor-induced 
enhancement of AMPA-evoked currents. Recorded cells were loaded 
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with the protein synthesis inhibitor cycloheximide, which was applied 
through the patch pipette filling solution in order to inhibit protein 
synthesis in the recorded cell only, without affecting the remaining 
cells in the slice. This method of cycloheximide application has been 
previously shown to efficiently inhibit protein synthesis with 
consequences for LTP and spine expansion (Yang et al., 2008a). We 
used a 10 µM cycloheximide concentration because application of even 
a lower cycloheximide concentration (3.5 µM) for 30 min proved to 
efficiently inhibit protein synthesis in hippocampal slices, as measured 
by 3H-valine incorporation (Stanton and Sarvey, 1984). A minimum 
time of 30 min between establishing whole cell configuration and 
application of CGS 21680 was used to allow diffusion of the drug into 
the cell (Lüscher et al., 1999). Under such conditions, CGS 21680 (30 
nM) caused a significant facilitation of evoked AMPA current 
amplitude (27±5.2%, measured 34–40 min after application of the A2A 
agonist, n=13, P<0.05, Figure 5.1.10A), which was not significantly 
different from that obtained after similar exposure time in cells not 
loaded with the protein synthesis inhibitor (P>0.05, Figure 5.1.10B). 
This indicates that, at least within a time frame of 40 min, A2A receptor-
mediated facilitation of AMPA function does not require de novo 
synthesis of AMPA receptor subunits and, therefore, suggests that the 
increase in surface GluR1 expression observed upon A2A receptor 
activation results from the externalization of pre-existing AMPA 
receptors and/or prevention of their internalization. Interestingly, 
increased availability of membrane AMPA receptors, brought about by 
changes in receptor trafficking dynamics, has been shown to positively 
modulate LTP expression in the hippocampus (Gao et al., 2006; Oh et 
al., 2006). In order to ascertain whether A2A receptors might affect 
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synaptic transmission with implications for plasticity phenomena, 
subsequent experiments employed electrical stimulation of the CA1 
afferent fibers and synaptically evoked excitatory postsynaptic currents 
(EPSCs) were recorded from CA1 pyramidal neurons.  
 
Figure 5.1.10. Facilitation of AMPA-evoked currents by A2A receptor activation is not 
dependent on postsynaptic protein synthesis. (A) Averaged time-course of current amplitude 
changes caused by 30 nM CGS 21680 upon loading of recorded cells with a protein synthesis 
inhibitor (cycloheximide, 10 µM). The right panel in (A) shows superimposed current tracings 
of AMPA-evoked currents recorded in the absence (1) and presence (2) of CGS 21680, from a 
representative cycloheximide-loaded cell. In all experiments, a 30 min period prior to CGS 
21680 application was allowed for diffusion of cycloheximide into the intracellular milieu of 
recorded cells. (B) Averaged and individual effects of CGS 21680 when applied in the absence 
or in the presence of cycloheximide, as indicated below each data set. Effects were quantified at 
34-40 min after CGS 21680 addition. Values are mean ± SEM. n.s. p>0.05, two-tailed unpaired 
t-test; * p<0.05 (two-tailed paired t-test, compared to baseline, using absolute current values). 
 
A2A receptors modulate basal synaptic transmission and LTP 
expression 
When recording excitatory synaptic responses from CA1 pyramidal 
cells, superfusion of the A2A receptor agonist was found to cause a 
small, but significant, potentiation of EPSC peak amplitude by 
9.7±3.6%, at the end of 34–40 min (n=11, P<0.05, Figure 5.1.11A). 
This facilitation of afferent-evoked EPSCs by CGS 21680 was about 
the same as the A2A agonist-induced enhancement of mEPSC amplitude 
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(Figure 5.1.6B), but significantly smaller than that measured in 
chemically evoked AMPA currents (p<0.05, Figure 5.1.11C). This 
difference in the magnitude of effects observed in both mEPSCs and 
EPSC recordings, when compared to those observed in AMPA-evoked 
currents, suggests distinct contributions by post- and extrasynaptic A2A 
receptors may converge to regulate AMPA receptor function in the 
postsynaptic neuron (see Discussion). 
To evaluate consequences for synaptic plasticity, we induced LTP by 
using a protocol (see Methods) that couples bursts of high frequency 
stimulation with postsynaptic depolarization of the recorded neuron 
(Chen et al., 1999b). To minimize failures in LTP induction, these 
experiments were performed in aCSF containing 4 mM Ca2+, based on 
early evidence that inputs tetanized in high (4 mM) Ca2+ aCSF 
displayed greater amounts of potentiation than those tetanized in 
control (2 mM Ca2+) solution (Huang et al., 1988). Makhinson et al. 
(1999) reported that a 10 min superfusion of aCSF with high (5 and 10 
mM) Ca2+ -containing aCSF induced a small and transient potentiation 
of synaptic transmission that was converted to a lasting, LTP-like 
potentiation when the slice had been previously exposed to the AC 
activator forskolin. Importantly, superfusion of aCSF with high calcium 
by itself did not induce sustained LTP (Huang et al., 1988; Makhinson 
et al., 1999). Accordingly, in control slices, this pairing protocol 
induced a 13.1±4.7% increase in EPSC peak amplitude (n=6, Figure 
5.1.11B), measured 40–50 min after delivery of the LTP-inducing 
stimuli. However, in slices taken from the same hippocampus but that 
had been briefly (10 min superfusion) exposed to the A2A receptor 
agonist (30 nM CGS 21680, 20–30 min before LTP induction), the 
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peak EPSC amplitude was increased by 52.1±12%, 40–50 min after 
LTP induction (n=6, P<0.05 compared with baseline; P<0.05 as 
compared with absence of CGS 21680, Figure 5.1.11B, D). These data, 
taken together with evidence that CGS 21680 leads to increased surface 
expression of the GluR1 subunit, strongly suggest that A2A receptor 
activation is important for the maintenance of LTP in the hippocampus, 
perhaps by regulating the extrasynaptic contingent of GluR1- 
containing AMPA receptors, which are continuously recycling with 
intracellular pools (Adesnik et al., 2005; Oh et al., 2006). 
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Figure 5.1.11. Activation of A2A receptors facilitates afferent-evoked EPSCs and Long 
Term Potentiation (LTP). (A) Averaged time-course of afferent evoked excitatory 
postsynaptic current (EPSC) peak amplitude changes caused by CGS 21680 (30 nM). In the 
right panel are shown superimposed current tracings of EPSCs recorded at the time-points 
indicated in A, for a representative cell. Current facilitation by CGS 21680 was significantly 
smaller (C) when recording afferent-evoked EPSCs (right columns) than that attained when 
recording AMPA-PSCs (left columns). (B) Averaged time-course of EPSC peak amplitude 
changes induced by a pairing LTP protocol in the absence (◊) or after (♦) a brief exposure to 
CGS 21680 (30 nM), 20-30 min before LTP induction; in each experiment, LTP with and 
without brief exposure to CGS 21680 was tested in two slices from the same hippocampus. In 
some experiments LTP was elicited first in the test slice (exposed to CGS 21680) while in 
others it was first induced in control slices, with similar results. To save recording time, 
Modulation of AMPA receptors by adenosine 
 124 
exposure to CGS 21680 for 10 min started immediately after going to whole cell configuration; 
the agonist was then removed from the bath and LTP induced 20-30 min after. Amplitude 
EPSC values recorded for 10 min before LTP induction were normalized to 100% and were 
98.4±8.6 pA in cells that had been pre-exposed to CGS 21680, and 111±16.5 pA in control 
ones. In the right panel are shown superimposed current tracings of EPSCs recorded before 
(1,2) and 40-50 min after induction of LTP (3,4), from control (1,3; ◊) and CGS 21680-exposed 
cells (2,4; ♦). Note that the magnitude of LTP was significantly higher (D) when a 10 min 
superfusion of CGS 21680 preceded delivery of the LTP-inducing protocol. Values are mean ± 
SEM. * p<0.05 (two-tailed paired t test, compared with baseline); δ p<0.05 (two-tailed 
unpaired t test, compared with CGS 21680 effect upon AMPA-PSCs); φ p<0.05 (two-tailed 
paired t test, compared with control LTP). 
 
Given that high-frequency neuronal stimulation leads to synaptic 
release of the adenosine precursor, ATP (Wieraszko et al., 1989), 
which leads to extracellular accumulation of adenosine favoring A2A 
receptor activation (Cunha et al., 1996; Correia-de-Sá et al., 1996), we 
further hypothesized that an endogenous A2A receptor-mediated 
potentiation of AMPA function could impact upon LTP expression. We 
therefore evaluated the influence of the selective A2A receptor 
antagonist, SCH 58261 (100 nM) upon LTP. These experiments were 
conducted in the presence of a GABAA receptor blocker (bicuculline, 
20 µM) which, by precluding inhibition of pyramidal cells by 
GABAergic neurons, allowed the expression of a more robust LTP, 
being therefore a suitable protocol to evaluate a putative tonic LTP 
inhibition. LTP was induced as above (Figure 5.1.11). Under these 
conditions, an 87.2±19% increase in EPSC amplitude was observed in 
control slices 40–50 min after stimulus delivery (n=4, Figure 5.1.12), a 
facilitation that was significantly different from that observed in the 
absence of bicuculline (Figure 5.1.12B). In contrast, in conditions of 
continuous superfusion of A2A receptor antagonist (SCH 58261, 100 
nM), the magnitude of LTP was found to be significantly lower than 
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that observed in control conditions (21.8±6.4% increase, 40-50 min 
after induction; n=4, Figure 5.1.12A,C).  
A
B C
 
Figure 5.1.12 Endogenous modulation of LTP expression by A2A receptor activation. (A) 
Averaged time-course and current tracings of EPSC amplitude changes induced by the same 
pairing LTP protocol in the presence of bicuculline (20 µM), from control slices (○) and those 
continuously exposed to a selective A2A antagonist, SCH 58261 (●). Baseline amplitude EPSC 
values were 132±25.9 pA in cells exposed to SCH 58261, and 123±29.6 pA in control ones. For 
each n, LTP in the presence or absence of the A2A receptor antagonist was tested in two slices 
from the same hippocampus; in some experiments LTP was elicited first in the test slice 
(exposed to SCH 58261) while in others it was first induced in control slices, with similar 
results. (B) LTP elicited in the presence of bicuculline was significantly higher than that 
obtained by the same protocol, in its absence. (C) A2Α receptor blockade significantly 
diminishes LTP expression, in the presence of bicuculline. Values are mean ± SEM. * p<0.05 
(two-tailed paired t test, compared with baseline, using absolute current values); δ p<0.05 (two-
tailed unpaired t test, compared with LTP elicited in the absence of bicuclline); φ p<0.05 (two-
tailed paired t test, compared with control LTP). 
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Taken together, these results show that not only can an exogenously 
applied A2A receptor agonist enhance LTP, but also and more 
importantly, its expression is considerably diminished by A2A receptor 
blockade, highlighting an important endogenous regulatory role of 
adenosine A2A receptors upon LTP. In addition, the fact that A2A 
receptor-mediated changes in LTP expression were observed in the 
presence of a GABAA receptor blocker, allows us to exclude the 
possibility that these changes might arise from modifications in the 
GABAergic circuits of the hippocampus. 
Results 
 127 
Discussion 
The main findings that arose from the work described in this chapter 
were that activation of adenosine A2A receptors postsynaptically 
enhances AMPA receptor mediated responses in the hippocampus, by 
means of a PKA-dependent mechanism, and that this correlates with 
increases in the surface expression of GluR1 subunits phosphorylated at 
the Ser 845 residue, as well as with enhancements in synaptic 
transmission and plasticity. After first evidence that adenosine A2A 
receptors at the hippocampus can enhance synaptic transmission 
(Sebastião and Ribeiro, 1992), subsequent studies mostly assume that 
excitatory actions following A2A receptor activation derive from an 
attenuation of A1 receptor-mediated inhibition of excitatory 
transmission (Cunha et al., 1994). Indeed, this kind of interaction is 
known to underlie A2A receptor-mediated facilitation of glutamate 
release (Lopes et al., 2002). In order to investigate whether such an 
interaction would also apply for adenosine receptor-mediated tuning of 
the postsynaptic responsiveness to glutamate release (which is, at the 
resting potential, mostly mediated by AMPA receptors), patch-clamp 
recordings of AMPA-evoked currents or afferent-evoked excitatory 
synaptic currents (EPSCs) were performed and its modulation by A2A 
receptors, analyzed.  
Our results show that adenosine A2A receptors postsynaptically 
facilitate AMPA receptor functioning and phosphorylation, an action 
that does not require de novo protein synthesis, thus suggestive of 
enhanced surface expression of already existing receptors. The PKA 
dependency of these effects could be concluded from the loss of effect 
of the A2A receptor agonist in cells loaded with a PKA inhibitor, as well 
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as from the CGS 21680-induced increase in the expression of 
membrane GluR1 subunits phosphorylated at the PKA site. 
Furthermore, postsynaptic PKC inhibition did not significantly affect 
the facilitation of AMPA currents by CGS 21680. However, A2A 
receptors can couple to different G proteins (Fredholm et al., 2001) and 
the signal transducing pathway operated may depend on both the nature 
of the effector system and the availability of G proteins and kinases in 
the receptor’s vicinity. Accordingly, presynaptic PKA- (Cristóvão-
Ferreira et al., 2009) and PKC- mediated (Lopes et al., 2002; Pinto-
Duarte et al., 2005) A2A receptor actions have been identified in the 
hippocampus. 
Blockade of A2A receptors prevented the facilitatory action of CGS 
21680 on AMPA currents but was devoid of effect when added in its 
absence. This may imply that (1) under the superfusion conditions 
used, endogenous extracellular adenosine, through A2A receptor 
activation, was not tonically modulating AMPA receptors or (2) any 
pre-existing modulation by endogenous adenosine is hard to revert by 
later addition of the antagonist. The second possibility seems plausible 
since the consequences of A2A receptor activation with the exogenous 
agonist, CGS 21680, were hardly reversible. Furthermore, even a brief 
exposure to the agonist was enough to trigger a sustained facilitation of 
AMPA receptor-mediated responses. This long lasting modulation of 
AMPA currents might be particularly relevant in conditions of 
coincident transient increases in the extracellular levels of adenosine 
and glutamate, such as occurs during high-frequency neuronal firing, 
when A2A receptors could provide a positive feedback loop to reinforce 
glutamate-induced plasticity.  
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Previous evidence for an enhancement of LTP in the CA1 area after 
A2A receptor activation has already been reported (de Mendonça and 
Ribeiro, 1994), as adenosine deaminase (that degrades endogenous 
extracellular adenosine into inosine) failed to affect LTP, which was 
facilitated by A1 receptor blockade. Similarly, Forghani and Krnjevic 
(1995) found that a mixed A1/A2 adenosine receptor antagonist (8(p-
sulfophenyl)theophylline) did not facilitate LTP, despite the fact that 
perfusion of a selective A1 receptor antagonist did enhance it. It was, 
therefore, proposed that A2 receptor activation by endogenous 
adenosine was counteracting tonic A1 receptor mediated inhibition of 
LTP. Others reported that A2 receptor antagonists can depress CA1 
hippocampal LTP of fEPSPs (Sekino et al., 1991; Fujii et al., 2000), 
suggestive of a tonic facilitatory action by endogenous adenosine. 
Accordingly, in the nucleus accumbens, A2A receptor blockade and 
receptor deletion have been shown to impair LTP (D’Alcantara et al., 
2001). A2A receptors are also essential for high-frequency induced LTP 
of NMDA EPSCs at the CA3 hippocampal area (Rebola et al., 2008). 
Being established that A2A receptor activation facilitates plasticity 
phenomena, our goal with the experiments now described was not to 
exhaustively evaluate this process but, instead, to know if conditions 
that lead to an A2A receptor-mediated increase in the membrane 
expression of GluR1 subunits and postsynaptic AMPA receptor 
function in the CA1 area, also caused LTP facilitation. Most noticeable, 
we could observe LTP potentiation even after a brief exposure to the 
A2A receptor agonist prior to LTP induction, and the effect was 
particularly evident at late time points of recording, consistent with the 
relevance of AMPA receptor membrane insertion for LTP expression 
and consolidation (Chowdhury et al., 2006; Yang et al., 2008b). A 
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relevant contribution of endogenous A2A receptor activation can be 
concluded from the present findings that A2A receptor blockade leads to 
an attenuation of LTP, which was also more evident at late time points 
of recording, again indicating that the role of A2A receptors is more 
related to facilitation of LTP expression and consolidation than to LTP 
induction. Changes in LTP might reflect in learning. Interestingly, 
blockade of A2A receptors in mice leads to associative learning 
impairment (Fontinha et al., 2008).  
Receptor delivery to extrasynaptic sites, followed by lateral diffusion 
towards synaptic localizations, is a crucial step for synaptic 
reinforcement and plasticity (Triller and Choquet, 2005). Strikingly, the 
extrasynaptic pool of AMPA receptors in CA1 pyramidal neurons is 
almost exclusively composed of GluR1-containing receptors, which are 
also a significant part of the synaptic pool, thus playing a major role in 
synaptic strength regulation (Andrasfalvy et al., 2003). The finding that 
CGS 21680 caused a more pronounced facilitation of AMPA-evoked 
currents (accounting for synaptic, perisynaptic and extrasynaptic 
AMPA currents) than afferent-evoked EPSCs (mostly synaptic 
currents) is suggestive of a facilitation of both perisomatic and 
extrasynaptic AMPA receptors by A2A receptors, which have been 
shown to be expressed in these fractions (Lee et al., 2003b; Rebola et 
al., 2005b). Furthermore, phosphorylation of GluR1 subunits at Ser 845 
significantly correlates with selective delivery of GluR1-containing 
AMPA receptors to extrasynaptic sites (Oh et al., 2006). In light of this, 
our data suggests that A2A receptors, through PKA activation and 
subsequent GluR1 phosphorylation, may facilitate AMPA receptor 
delivery to extrasynaptic sites, therefore priming a step that reinforces 
LTP. 
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Being clear from the present results that A2A receptors promote 
facilitation of AMPA currents, enhance surface expression of GluR1 
containing AMPA receptors and facilitate LTP, it has to be pointed out 
that enhanced surface expression of AMPA receptors might not be the 
sole mechanism by which A2A receptors affect LTP. Indeed, CA1 LTP 
is a complex phenomenon that involves pre- and postsynaptic 
processes, requiring activation of NMDA receptors followed by 
increased cytoplasmatic calcium levels and subsequent activation of 
different transducing systems, including PKA and CamKII (Esteban et 
al., 2003); ultimately leading to changes in AMPA receptor expression 
at synaptic sites (Malenka and Nicoll, 1999). So, any influence of A2A 
receptors in these steps might result in changes in LTP. Direct 
presynaptic mechanisms are unlikely since the A2A receptor agonist did 
not affect mEPSC frequency, which agrees with previous reports that in 
very young animals A2A receptors do not directly influence glutamate 
release (Lopes et al., 2002).  
Modulation of NMDA receptor function by A2A receptors in CA3 
pyramidal neurons, with consequences for plasticity induced by mossy 
fiber stimulation, has been reported (Rebola et al., 2008). This LTP of 
NMDA-EPSCs also requires activation of mGluR5 receptors, with 
which A2A receptors colocalize and functionally interact, by playing a 
permissive role in mGluR5 receptor-mediated potentiation of NMDA 
effects in the hippocampus (Tebano et al., 2005). Additionally, 
endogenous A2A receptor activation, through a PKA-dependent process, 
triggers Brain-derived neurotrophic factor (BDNF) facilitatory 
influences upon CA1 LTP (Fontinha et al., 2008; Assaife-Lopes et al., 
2010), being well established that hippocampal LTP is strongly 
impaired in both BDNF (Patterson et al., 1996) and TrkB (Minichiello 
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et al., 1999) knockout mice. While it is not possible, with the work 
herein described, to ascertain the extent to which any of these 
mechanisms (and possibly others) contributes to the A2A receptor-
induced modulation of LTP, it seems highly unlikely that it should be 
unrelated to the PKA-dependent enhancement of extrasynaptic AMPA 
receptor reserve and GluR1 externalization. 
Gao et al. (2006) found that D1 dopamine receptor activation increases 
the size of the GluR1 extrasynaptic pool in a PKA-dependent way, 
which significantly promoted LTP in cultured hippocampal neurons. 
D1 dopamine receptors, like adenosine A2A receptors, are positively 
coupled to adenylate cyclase. However, dopaminergic inputs to the 
hippocampus are scarce (Lopes da Silva et al., 1990), while adenosine 
is present and released by glia and neurons, from pre-, post-, and 
nonsynaptic sites. Furthermore, extracellular adenosine can also be 
formed from the catabolism of adenine nucleotides, known to be 
released together with neurotransmitters and in particular during high-
frequency neuronal firing (see Sebastião and Ribeiro, 2009). Therefore, 
the present findings that A2A receptor activation enhances AMPA 
evoked currents, GluR1 membrane expression and LTP, allow the 
identification of a modulator of AMPA receptor function that is 
ubiquitous at the extracellular space, in particular at synapses firing at 
high frequency, under conditions particularly prone for synaptic 
reinforcement. One can therefore propose that adenosine is one of the 
endogenous substances responsible for regulation of GluR1 Ser-845 
phosphorylation tonus and hence, for the reserve of GluR1-containing 
AMPA receptors at extrasynaptic pools, priming them for synaptic 
insertion and reinforcement of synaptic strength. 
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5.2 A2A Adenosine receptor activation Modulates Ischemia-
induced Plasticity in the CA1 area  
 
Rationale:  
Adenosine, through activation of A2A receptors, can affect delivery of 
AMPA receptors to the membrane, with impact for plasticity 
phenomena (chapter 5.1). Initially, the enhancement in glutamate and 
ATP release that characterizes the onset of an ischemic insult is not 
fundamentally different from the increased synaptic activity conditions 
that trigger physiological LTP. Accordingly, many of the cellular 
scaffolds of LTP expression, such as changes in the synaptic AMPA 
receptor population (Malenka and Nicoll., 1999), have also been found 
to occur after ischemic insults (Quintana et al., 2006; Dixon et al., 
2009) and have even been proposed to be key determinants for 
neuronal fate (Pellegrini-Giampetro et al., 1997). Further, ischemic 
events are known to influence the biochemical pathways that are 
required for translating transient calcium signals into persistent 
increases in synaptic strength (Di Filippo et al., 2008). In line with this, 
there is ample evidence that oxygen/glucose deprivation exerts long-
term effects on the efficacy of synaptic transmission, by triggering a 
post-ischemic long-term potentiation phenomenon (i-LTP), which may 
serve to shape redundant connectivity into new functional and 
structural circuits, capable of recovering specific functions (Murphy 
and Corbett, 2009). Perilesional areas, where blood flow is less 
severely impaired as a result of an ischemic stroke, are thought to be 
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particularly suitable for recovery through plastic rewiring (Di Filippo et 
al., 2008; Murphy and Corbett, 2009). In the context of middle cerebral 
artery (MCA) occlusion (the most frequent cause for ischemic stroke in 
humans), such perilesional areas correspond to structures which, 
although not directly supplied by the occluded vessel, are nonetheless 
affected by blood flow restriction, in a delayed manner. In accordance 
with this, experimental MCA occlusion most severely affects the 
temporal and parietal cortices, the basal ganglia and the internal 
capsule, but also and less severely, nearby structures such as the 
hippocampus (Popp et al., 2009). Such perilesional areas have been the 
focus of neuroprotective approaches aiming at reducing delayed cell 
death in the aftermath of an ischemic stroke. Recently, it has been 
proposed that neuroregenerative strategies, focusing on rehabilitative 
physical therapy, post-injury enhancement of neurogenesis and 
pharmacological modulation of ischemia-induced plasticity, may 
constitute a viable option to neuroprotective approaches (Murphy and 
Corbett, 2009). This prompts the need to better characterize the extent 
to which ischemia-induced plasticity relies upon the cellular 
mechanisms underlying physiological LTP, which can hopefully serve 
to identify candidate regulatory molecules of therapeutic interest.  
Bearing in mind that ischemia triggers the release of high amounts of 
adenosine (Dunwiddie and Masino, 2001), as well as plastic 
remodeling of excitatory synaptic contacts (Di Filippo et al., 2008), I 
hypothesized that neuromodulation by A2A receptors might impose 
changes in synaptic transmission after transient oxygen and glucose 
deprivation. Furthermore, the experimental work described in this 
chapter pursued the requirement of alterations in postsynaptic AMPA 
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receptor functioning for ischemia-induced tuning of synaptic 
transmission efficiency. Experiments were therefore performed on 
acute hippocampal slices, subjected to brief oxygen and glucose 
deprivation insults, while continuously recording AMPA receptor-
mediated afferent evoked currents (EPSCs) from CA1 pyramidal 
neurons. 
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Transient oxygen-glucose deprivation triggers changes in afferent-
evoked excitatory transmission 
The effects of a transient ischemic episode on excitatory synaptic 
transmission were studied in CA1 pyramidal cells, by switching the 
extracellular, superfusion solution, to one that mimicked ischemia 
conditions, for a 10 min period (protocol adapted from Rossi et al., 
2000). After allowing afferent-evoked responses to stabilize, 
application of such a transient ischemic insult caused a marked 
reduction in EPSC amplitude, which reached a 85±3.7% decrease from 
baseline values within 10 min (n=14, P<0.05, Figure 5.2.1C). Upon re-
oxygenation, there was a gradual recovery of synaptic responses such 
that 50-60 min after intiating the ischemic insult, a rebounding 
excitation led average EPSC amplitudes to be 157±17.4% of baseline 
values (n=7, P<0.05, Figure 5.2.1D). These findings are in line with 
those previously observed in organotypic hippocampal slice cultures, 
where administration of a similar in vitro ischemia protocol resulted in 
a comparable lasting enhancement of excitatory transmission (Quintana 
et al., 2006).  
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Figure 5.2.1. Transient in vitro ischemia causes a significant increase in afferent-evoked 
Excitatory Postsynaptic Current (EPSC) amplitude. (A) EPSC current tracings from a 
representative CA1 pyramidal cell illustrate the inhibition of baseline synaptic responses (1) 
after delivery of a transient ischemic episode (2), as well as signal recovery upon reoxygenation 
(3) which even leads to an increase in EPSC amplitude (4), when compared to baseline values. 
(B) Averaged time-course of EPSC peak amplitude changes caused by brief ischemia (induced 
by replacing 10 mM glucose-containing aCSF with that containing 7mM sucrose plus 3mM 
glucose, gassed with 95%N2/5% CO2, for 10 min). The time-points depicted refer to those 
illustrated by representative tracings in (A). Inhibition of synaptic responses was measured in 
14 cells and was found to be significant, when compared to absolute baseline EPSC values - 
calculated from the 10-20 min period recorded before ischemia delivery (C). Initial experiments 
performed to characterize the ischemia protocol did not extend until 50-60 min of recording, 
but for the 7 cells allowed to proceed thus far and which remained stable until this time-point, 
the increase in EPSC amplitude was found to be significant, when compared to absolute 
baseline values (D). Values on the left columns (C,D) represent individual EPSC peak 
amplitude values recorded in the baseline period, whereas those on the right refer to individual 
current values recorded either after 10 min ischemia (C) or after 40-50 min reoxygenation (50-
60 min period in (B)). * p<0.05 (two-tailed paired t test, compared with absolute baseline 
values).  
 
Furthermore, when routinely superfusing a selective AMPA receptor 
blocker (CNQX, 50 µM) at the end of the recording period, virtually all 
of the recorded synaptic response was abolished (Figure 5.2.2). This 
indicates that for these experimental conditions (holding potential of -
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70 mV and in the presence of 1mM external Mg2+), most of the EPSC 
response corresponds to the AMPA-mediated postsynaptic component 
of synaptic transmission.  
 
Figure 5.2.2. Afferent-evoked EPSCs mainly comprise 
a postsynaptic AMPA component. EPSC current 
tracings from a representative CA1 pyramidal cell 
illustrate how superfusion of a selective AMPA receptor 
antagonist (CNQX, 50 µM) completely abolishes evoked 
synaptic responses. 
 
Ischemia-induced facilitation of afferent-evoked synaptic responses 
requires calcium-permeable AMPA receptors. 
In CA1 pyramidal cells, GluR2-lacking, calcium permeable AMPA 
receptors have been show to be transiently incorporated into synapses 
upon LTP induction and their function has been proposed to be 
required for LTP consolidation (Plant et al., 2006; Guire et al., 2008). 
Reports of a similar switch in synaptic AMPA receptor subunit 
composition after in vitro ischemia have recently emerged (Dixon et 
al., 2009), although its significance for ischemia-induced plastic 
changes was not pursued. To test whether the increase in EPSC 
amplitude which was elicited by a brief ischemic insult in our 
experimental conditions might be dependent upon GluR2-lacking 
AMPA receptors, experiments in which the pipette solution contained 
spermine were performed. Positively charged spermine (and to a lesser 
extent, other poylamines such as spermidine) selectively blocks GluR2-
lacking receptors, because it is attracted by the negatively charged ring 
of carbonyl-oxygen groups present in the glutamine residues of GluR1, 
50 ms
100 pA
CNQX (50 µM)
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GluR3 and GluR4 subunits. In contrast, spermine is repelled by the 
positively charged arginine residue in GluR2 subunits and will thus not 
bind GluR2-containing receptors (reviewed by Pellegrini-Giampetro, 
2003). In whole-cell configuration, dialysis of endogenous polyamines 
occurs within the first 5-10 minutes of recording, thereby reducing their 
ability to inhibit calcium-permeableAMPA receptors (Kamboj et al., 
1995). A strategy that allows circumventing this problem is to include 
exogenous spermine in the pipette solution (e.g., Donevan and 
Rogawski, 1995). Indeed, 100 µM of intracellular spermine have been 
reported to block GluR2-lacking AMPA receptor channels by 18–36% 
at resting potentials, with the proportion of blocked channels increasing 
with membrane depolarization (Bowie and Mayer, 1995). When 
spermine (500 µM) was added to the intracellular solution, transient 
ischemia caused an average 82±3.9% depression of EPSC amplitude 
(n=9, Figure 5.2.3B), a similar value to that observed in the absence of 
spermine (Figure 5.2.1B). However, even though synaptic responses 
gradually recovered toward baseline values, no facilitation of afferent-
evoked responses was observed upon 40-50 min of reoxygenation, 
unlike what occurred in the absence of spermine (n=6, P<0.05, Figure 
5.2.3C). 
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Figure 5.2.3. Intracellular spermine prevents ischemia-induced increase in afferent 
evoked EPSCs. (A) EPSC current tracings from a representative CA1 pyramidal cell illustrate 
the inhibition of baseline synaptic responses (1) after delivery of a transient ischemic episode 
(2), as well as signal recovery upon reoxygenation (3,4), in the presence of internal spermine 
(500 µM). (B) Averaged time-course of EPSC peak amplitude changes caused by brief 
ischemia, induced as before. The time-points depicted refer to those illustrated by 
representative tracings in (A). Average EPSC values measured after 40-50 min reoxygenation 
in the presence of internal spermine, were significantly smaller than those obtained in control 
conditions (C). Values are mean±SEM of EPSC amplitudes recorded after 40-50 min of 
reoxygenation. * P<0.05 (two-tailed unpaired t-test; compared to EPSC recovery measured 
with a control pipette solution).  
 
These findings support the notion that activation of GluR2-lacking, 
calcium permeable AMPA receptors is required for ischemia-induced 
facilitation of excitatory synaptic transmission in the hippocampus, 
suggesting this is another cellular mechanism utilized by both forms of 
plasticity. Taking into account the role of A2A receptor activation for 
surface expression of AMPA receptors and its influence upon LTP 
(chapter 5.1) and that the impairment in energy metabolism triggered 
by ischemia leads to increased extracellular adenosine levels, I next 
evaluated whether activation of A2A adenosine receptors could account 
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for the enhancement of excitatory synaptic transmission observed after 
brief ischemia. 
Blockade of A2A receptors prevents ischemia-induced facilitation of 
afferent evoked synaptic responses. 
When a selective A2A receptor antagonist was added at least 20 min 
before inducing ischemia and was present throughout the remaining 
experiment, transient ischemia caused an average 85±3.3% depression 
of EPSC amplitude (n=7, Figure 5.2.4B), a similar value to that 
observed in control conditions (Figure 5.2.1B). However, and as it was 
observed in the presence of internal spermine, no facilitation of 
afferent-evoked responses was obtained upon 40-50 min of 
reoxygenation (n=6, P<0.05, Figure 5.2.4C).  
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Figure 5.2.4. A2A receptor blockade prevents ischemia-induced increase in afferent evoked 
EPSCs. (A) EPSC current tracings from a representative CA1 pyramidal cell illustrate the 
inhibition of baseline synaptic responses (1) after delivery of a transient ischemic episode (2), 
as well as signal recovery upon reoxygenation (3,4), in the presence of a selective A2A receptor 
antagonist (SCH 58261, 100 nM). (B) Averaged time-course of EPSC peak amplitude changes 
caused by brief ischemia in the presence (▼) or absence (●) of SCH 58261 (100 nM). The 
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time-points depicted refer to those illustrated by representative tracings in (A). Average EPSC 
values measured after 40-50 min reoxygenation in the presence of the A2A receptor antagonist 
were significantly smaller than those obtained in control conditions (C). Values are mean±SEM 
of EPSC amplitudes recorded after 40-50 min of reoxygenation. * P<0.05 (two-tailed unpaired 
t-test, compared to EPSC recovery measured in the absence of the A2A receptor antagonist). 
 
In the same experimental conditions (SCH 58261 applied throughout 
the experiment) but in the concurrent presence of internal spermine, 
EPSC recovery upon 40-50 min of reoxygenation was not significantly 
different from that obtained in the absence of internal polyamines (n=4; 
P>0.05, Figure 5.2.5C).  
 
Figure 5.2.5. Prevention of ischemia-induced facilitation of EPSC amplitude by A2A 
receptor blockade is preserved in the presence of internal spermine. (A) EPSC current 
tracings from a representative CA1 pyramidal cell illustrate the inhibition of baseline synaptic 
responses (1) after delivery of a transient ischemic episode (2), as well as signal recovery upon 
reoxygenation (3,4), in the presence of a selective A2A receptor antagonist (100 nM) and in the 
concurrent presence of internal spermine (500 µM). (B) Averaged time-course of EPSC peak 
amplitude changes caused by brief ischemia in the presence of SCH 58261 and in the presence 
(▲) or absence (●) of internal spermine. The time-points depicted refer to those illustrated by 
representative tracings in (A). EPSC recovery after 40-50 min of reoxygenation was not 
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significantly different between experimental conditions (C). Values are mean±SEM of EPSC 
amplitudes recorded after 40-50 min of reoxygenation. n.s. P>0.05 (two-tailed unpaired t-test, 
compared to EPSC recovery in the presence of SCH 58261 but in the absence of internal 
spermine). 
It thus seems that either blocking calcium-permeable AMPA receptors 
with internal spermine, as well as preventing activation of adenosine 
A2A receptors during and after ischemia has the same effect upon EPSC 
recovery as does simultaneously blockade of both kinds of receptors. 
These findings suggest that either 1) A2A receptor blockade and internal 
spermine block ischemia-induced facilitation of EPSC amplitude by 
acting upon the same cellular process or 2) blockade of one kind of 
receptor maximally impairs ischemia-induced EPSC facilitation, such 
that further blockade of the second receptor type exerts a redundant 
effect, even though it may act through an independent mechanism. 
Sequential effects in consecutive steps, with the same final functional 
consequences, may also occur. For instance, the above results would be 
compatible with a sequential interference of the A2A receptor antagonist 
and internal spermine in the externalization, synaptic delivery and 
activation of calcium-permeable AMPA receptors. According to this 
hypothesis, A2A receptor activation would first regulate delivery of 
GluR1-containing AMPA receptors to extrasynaptic membrane pools, 
which, upon recruitment to the postsynaptic density, would then be 
amenable to blockade by internal spermine. 
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Discussion 
The main findings that arose from the work described in the present 
chapter are that activation of calcium-permeable AMPA receptors is 
required for ischemia-induced facilitation of excitatory synaptic 
transmission in the hippocampus, which also depends upon adenosine 
A2A receptor activation.  
It has long since been known that global ischemia, leading to delayed 
cell death in the CA1 area, can suppress GluR2 subunit mRNA and 
protein expression, thus increasing AMPA receptor-mediated Ca2+ 
influx into vulnerable neurons (Liu and Zukin, 2007). Furthermore, 
experimental downregulation of GluR2 expression (by knockdown 
experiments) is sufficient to induce delayed death of CA1 neurons 
(Oguro et al., 1999). However, although there is considerable evidence 
for alterations in AMPAR subunit composition and function from hours 
or even days after injury, receptor changes at early times after ischemia 
remain unclear. Indeed, little is known about changes in the AMPA 
receptor synaptic population that may underlie the plasticity 
phenomena triggered by ischemia, although strong evidence supports 
that i-LTP shares quite a few other hallmarks of physiological LTP (Di 
Filippo et al., 2008).  
Recently, Guire and colleagues have proposed that in the CA1 area, a 
transient addition of calcium-permeable AMPA (homomeric GluR1) 
receptors to the synaptic population, even when only accounting for 
~5% of the existing synaptic population, is enough to produce the 
potentiation observed after LTP (Guire et al., 2008). In fact, GluR2-
lacking AMPA receptors have significantly higher channel conductance 
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than do GluR2-containing receptors (Swanson et al., 1997) and such 
changes in channel properties are one of the mechanisms by which 
synaptic AMPA receptor-mediated responses can be potentiated 
(Derkach et al., 2007). It is also well established that CA1 pyramidal 
neurons do not contain calcium-permeable AMPA receptors in basal 
conditions (Monyer et al., 1991; Wenthold et al., 1996) and their rapid 
insertion in the synapse during LTP most likely relies upon prompt 
lateral diffusion of GluR1-containing calcium-permeable receptors 
from extrasynaptic pools (Guire et al., 2008). The present finding that 
ischemia-induced enhancement of excitatory synaptic transmission is 
abolished by internal spermine (loaded into the postsynaptic neuron at a 
concentration capable of blocking a significant proportion of calcium-
permeable AMPA receptors) constitutes, to the best of my knowledge, 
the first evidence of a very early common feature between i-LTP and 
its physiological counterpart (i.e., synaptic activation of GluR2-lacking 
AMPA receptors). These results also highlight an important 
postsynaptic component in ischemia-induced facilitation of synaptic 
transmission, since it was impaired by loading of spermine onto the 
postsynaptic neuron alone.  
Noteworthy, although the present results implicate activation of 
calcium-permeable AMPA receptors in ischemia-induced facilitation of 
excitatory transmission, they give no detailed information about the 
time-course according to which synaptic recruitment of these receptors 
may occur. This question could be addressed by using patch-clamp 
recordings of spontaneous miniature excitatory postsynaptic currents 
(mEPSCs), to follow changes in synaptic calcium-permeable AMPA 
receptor content over time, after ischemia. In fact, because calcium-
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permeable AMPA receptors exhibit more rapid deactivation kinetics 
than GluR2-containing ones (Grosskreutz et al., 2003), a decrease in 
average mEPSC decay time (dependent on the deactivation kinetics of 
the synaptic AMPA receptor population) can be taken to account for an 
increase in the number of calcium-permeable AMPA receptors present 
at synapses (Guire et al., 2008). The data to be obtained with such 
experiments may help to elucidate whether ischemic insults of a greater 
severity can trigger the sustained recruitment of calcium-permeable 
AMPA receptors, in contrast to their transient incorporation in 
physiological LTP-inducing conditions or in contrast to what may 
happen when ischemia is less severe. If confirmed, this would explain 
why in some conditions transient ischemia unleashes delayed death by 
excitotoxicity, while in others it triggers plastic changes compatible 
with a neuroregenerative rewiring of redundant circuitry, enabling 
recovery of lost synaptic contacts (Murphy and Corbett, 2009). It is 
known that in physiological conditions, neuronal activity regulates the 
subunit composition of synaptic AMPA receptors by a homeostatic 
plasticity process, according to which repetitive activity or sensory 
experience favors synaptic incorporation of calcium-impermeable 
AMPA receptors (downregulating synaptic strength), while activity 
blockade leads to incorporation of calcium-permeable receptors (thus 
scaling up synaptic transmission). In line with this, synaptic insertion of 
GluR1 homomeric AMPA receptors has been proposed to be required 
for subsequent synaptic recruitment of GluR2-containing AMPA 
receptors, so as to counteract increased calcium permeability (see Pozo 
and Goda, 2010). It is reasonable to expect that failure of this auto-
regulatory mechanism can lead to sustained changes in synaptic AMPA 
receptor composition after severe ischemia, which would then render 
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neurons more susceptible to death by excitotoxicity (Pellegrini-
Giampetro et al., 1997).  
It should be noted that endogenous polyamines can also modulate other 
types of cation channels, such as inwardly rectifying potassium 
channels and NMDA receptors (reviewed by Williams, 1997). In fact, 
intracellular spermine contributes to intrinsic gating and rectification 
properties of strong inward rectifier K+ channels and its addition to the 
pipette solution can be used to maintain the rectifying character of these 
currents (Ficker et al., 1994). Also, spermine can potentiate NMDA 
receptor activity, by acting on at least two extracellular polyamine 
binding sites (Williams et al., 1997). Still, since changes in inward 
rectifying potassium channels are mostly expected to affect the resting 
potential of the neuron, any putative resulting effect of internal 
spermine at this level should be controlled by having performed all 
ischemia experiments under voltage-clamp mode. In what concerns 
interactions with NMDA receptors, although primarily active at 
extracellular sites, high concentrations of intracellular spermine (1-10 
mM) can also reduce unitary conductance through recombinant NMDA 
receptors at positive potentials (Araneda et al., 1999). However, even 
the highest concentration used (10 mM) by others brought about only a 
minimal reduction in current measured at negative membrane potentials 
(Araneda et al., 1999). 
The role of A2A receptors in ischemia remains a controversial one 
(Jacobson and Gao, 2006; de Mendonça et al., 2000), but inequivocal 
evidence for their deleterious role in cerebral ischemia arose from the 
observation that both cerebral infarction and neurological deficits were 
attenuated in A2A receptor knock-out mice mice subjected to temporary 
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middle cerebral artery occlusion, when compared with wild-type 
littermates (Chen et al., 1999b). In what concerns the mechanisms 
underlying protection from ischemia-induced damage in the presence 
of A2A receptor antagonists, it has been proposed that they may rely 
upon an impairment of glutamate release facilitation (Simpson et al., 
1992), but also in modulation of postsynaptic glutamate receptor 
function (Pugliese et al., 2009). Loading of the postsynaptic neuron 
with spermine (which blocks GluR2-lacking, calcium-permeable 
AMPA receptors) had the same effect upon EPSC recovery and 
facilitation after ischemia, as did A2A receptor blockade with a selective 
antagonist. As mentioned, this could be explained by A2A receptor-
mediated regulation of GluR1-containing AMPA receptor delivery to 
extrasynaptic membrane pools, which, upon recruitment to the 
postsynaptic density, would subsequently be amenable to blockade by 
internal spermine. While it would be tempting to speculate that 
prevention of ischemia-induced facilitation of EPSCs may rely upon 
activation of PKA signaling with consequences for membrane insertion 
of GluR1-containing AMPA receptors, such a claim warrants further 
experiments, resourcing first to postsynaptic loading of PKA inhibitors. 
Secondly, a direct assessment of A2A receptor-mediated regulation of 
the calcium-permeable AMPA receptor pool available for synaptic 
recruitment could be achieved by comparing ischemia-induced changes 
in mEPSC decay time, in the presence and absence of selective A2A 
receptor antagonists. 
From the present results, it is not possible to conclude whether A2A 
receptor activation plays a deleterious or a protective role from the 
ischemic insult used. It would first be necessary to elucidate whether or 
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not the observed ischemia-induced increase in excitatory transmission 
efficiency is detrimental, by following neuron outcome upon the initial 
insult, for a longer timescale. Modulation of neuronal viability by A2A 
receptors could then be pursued by performing the same ischemia 
protocol, in the presence or absence of selective antagonists. These 
experiments could be performed on organotypical slices or cultured 
hippocampal cells, but with caution directed toward its limitations. 
Indeed, if dissociate neuronal cultures lack network architecture typical 
of the intact brain and a physiological balance between excitatory and 
inhibitory transmission (Pozo and Goda, 2010), organotypic slices 
gradually adapt their circuitry to the absence of physiological input and 
output structures, which originates abnormal reverberating circuits. In 
fact, plastic compensatory plasticity can itself become detrimental and 
even represent a cause for acquired epilepsy. A well documented 
example refers to injury-induced axonal sprouting in hippocampal 
dentate granule cells and the consequent formation of recurrent 
excitatory synapses, which is thought to convert them into an 
epileptogenic population of neurons, capable of promoting seizure 
initiation and/or propagation through the hippocampal pathway 
(reviewed by McNamara, 1999). 
Despite all the important questions that wait to be answered, the herein 
presented results strongly support a major role for A2A receptor 
activation in ischemia-induced facilitation of synaptic excitatory 
responses, highlighting their role in i-LTP, which adds to the one they 
play in physiological LTP (chapter 5.1).  
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5.3 Crosstalk between immunoregulatory cytokines of the 
Interleukin-6 family and neuronal adenosine A1 receptor 
function: implications for synaptic transmission regulation 
and neuroprotection from excitotoxic damage 
 
Rationale: 
Depression of synaptic transmission during hypoxic/ischemic insults is 
at least in part mediated by a marked increase in the extracellular 
adenosine concentration and consequent activation of A1 adenosine 
receptors (Fowler, 1989). Extracellular adenosine can tune down 
neuronal activity by at least three cellular mechanisms: presynaptic 
inhibition of neurotransmitter release; postsynaptic inhibition of 
calcium influx (through NMDA receptors and voltage-dependent 
calcium channels) and activation of G protein-dependent inwardly 
rectifying K+ channels that mediate postsynaptic membrane 
hyperpolarization (De Mendonça et al., 2000; Dunwiddie and Masino, 
2001). By reducing metabolic demand, adenosine thus preserves ATP 
stores, while also supressing glutamatergic transmission, ultimately 
protecting neurons from excitotoxicity. Extracellular adenosine is 
thought to exert these acute neuroprotective actions mainly through 
activation of high-affinity A1 receptors. Indeed, A1 receptor blockade 
has been shown to reduce depression of synaptic transmission during 
prolonged hypoxia and to prevent transmission recovery upon 
reoxygenation (Sebastião et al., 2001). However, as mentioned before 
(Introduction, subchapter 1.3.2), clinical translation of the consistent 
neuroprotection afforded by A1 receptor agonists in animal models of 
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ischemia has been made difficult by severe peripheral side effects 
and/or receptor desensitization (De Mendonça et al., 2000).  
Aside from adenosine, other neuroprotective factors include members 
of the IL-6 cytokine family, such as IL-6, IL-11, leukemia inhibitory 
factor (LIF), oncostatin M (OSM), ciliary neurotrophic factor, novel 
neurotrophin-1 and cardiotropin-1, which have been reported to exert 
neuroprotective actions in various neuronal subpopulations (Holtmann 
et al., 2005; Wen et al., 2005; Weiss et al., 2006; Gurfein et al., 2009; 
Suzuki et al., 2009). Still, the mechanisms by which different IL-6 
family members afford neuroprotection are not well understood.  
Cytokines of the IL-6 family exert their effects through activation of 
three different receptor complexes. In fact, IL-6 and IL-11 are the only 
IL-6 type cytokines that signal via gp130 homodimers, while the 
remaining members activate heterodimers of either gp130 and LIFr 
(LIF, ciliary neurotrophic factor, cardiotropin-1 and novel 
neurotrophin-1) or gp130 and OSMr (OSM) (Bauer et al., 2007). It has 
been proposed that the shared activation of gp130 receptor subunit-
mediated signalling may account for many redundant properties among 
the members of the IL-6 family. Evidence that treatment with IL-6 can 
afford neuroprotection by enhancing the expression and function of 
neuronal A1 receptors (Biber et al., 2008) therefore prompted the 
hypothesis that IL-6 type cytokines in general might be able to exert 
their neuroprotective properties via facilitation of neuronal A1R 
function. To address this hypothesis, a collaboration with Knut Biber´s 
lab was initiated, in which I compared the influence that treatment with 
OSM and LIF exerted upon A1 receptor-dependent depression of 
synaptic transmission, in mouse hippocampal slices. Indeed, work done 
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by the other collaboration partner has provided evidence for 
fundamental differences in the mechanisms underlying neuroprotection 
conferred by either LIF or OSM, against glutamate-induced toxicity, in 
cultured cortical neurons (Moidunny et al., 2010). 
 These cytokines were chosen because, given the three possible 
receptor complexes, by addressing neuroprotection by LIF and OSM 
and crossing information with what is already known for IL-6, one can 
investigate every receptor/signaling combination known to be activated 
by IL-6 family cytokines. Furthermore, even though LIF expression is 
very low in the central nervous system under physiological conditions, 
it is rapidly increased upon exposure to ischemic insults (Suzuki et al., 
2000). Data obtained from an animal model of epilepsy, which also 
leads to neuronal death by excitotoxicity, has also revealed that after a 
single, prolonged seizure, there was a marked increase in LIF and OSM 
expression which was most noticeable in the hippocampus (Jankowsky 
et al., 1999). These results provide extra reason for studying the 
mechanisms underlying LIF- and OSM- mediated neuroprotection and 
to elucidate whether their actions involve facilitation of A1 receptor-
mediated responses.  
I therefore next investigated whether sustained exposure of 
hippocampal slices to OSM or LIF could modify the neuromodulatory 
actions of A1 receptors on synaptic transmission, by performing whole-
cell recordings of afferent-evoked EPSCs from CA1 pyramidal cells. 
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Modulation of A1 receptor-mediated actions on synaptic 
transmission by OSM, but not LIF 
Activation of A1 receptors is well established to decrease synaptic 
transmission in the hippocampus (Sebastião et al., 1990), which has 
been attributed to inhibition of N-type calcium channels leading to 
presynaptic glutamate release inhibition (Manita et al., 2004). It is also 
known that this A1 receptor-mediated inhibition of synaptic 
transmission protects synapses against excitotoxic insults (Sebastião et 
al., 2001). 
In the present work, and to evaluate if OSM and/or LIF could enhance 
synaptic transmission inhibition by adenosine A1 receptors, 
experimental activation of A1 receptors was induced by superfusion of 
a selective A1 receptor agonist (CPA, 30 nM). To prevent pre-
conditioned responses, the effects of CPA were investigated in only one 
neuron per slice, from control and OSM or LIF (10 ng/mL, for 4h) 
treated slices, prepared from the same hippocampus. Addition of CPA 
(30 nM) to the superfusion medium inhibited EPSC peak amplitude by 
48±7.7% (n=4), in control slices (Figure 5.3.1A). When recording from 
slices that had been pre-incubated with OSM, average EPSC inhibition 
by CPA was significantly increased to 73±6.7% (n=4, p<0.05, Figure 
5.3.1C). In contrast, average EPSC inhibition caused by superfusion of 
the A1 receptor agonist was not significantly affected (P>0.05, Figure 
5.3.2C) by pre-exposure to LIF (n=4,  Figure 5.3.2A). 
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Figure 5.3.1 OSM potentiates inhibition of synaptic transmission caused by A1 receptor 
activation. (A) Averaged time-course of afferent evoked EPSC peak amplitude changes caused 
by a 20 min application of the A1 receptor agonist cyclopentyladenosine (CPA, 30nM), in 
control (○) versus test (●) slices from the same hippocampus (n=4). Test slices were incubated 
with 10 ng/mL oncostatin, for at least 4h. In the right panel (B) are shown superimposed 
current tracings of EPSCs recorded before (1,2) and 20-30 min after (3,4) addition of CPA to 
the superfusion medium, in representative control (1,3) and test (2,4) cells. (C) Inhibition of 
synaptic transmission caused by activation of adenosine A1 receptors was significantly higher 
when recording from slices that had been previsouly exposed to oncostatin (10 ng/mL, at least 
4 hours) compared with naïve ones. The percentage of EPSC inhibition corresponds to the 
average EPSC decrease measured 20-30 minutes after starting CPA application.* P<0.05 
(paired t-test, compared with CPA-induced inhibition observed in the absence of OSM).  
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Figure 5.3.2. LIF does not alter inhibition of synaptic transmission caused by A1 receptor 
activation. (A) Averaged time-course of afferent evoked EPSC peak amplitude changes caused 
by a 20 min application of CPA  (30 nM), in control (○) versus test (●) slices. Test slices were 
incubated for at least 4 hours with LIF (10 ng/mL). In the right panel are shown superimposed 
current tracings of EPSCs recorded before (1,2) and 20-30 min after (3,4) introduction of CPA 
in the superfusion medium, in representative control (1,3) and LIF-treated, test (2,4) cells. (C) 
Average inhibition of synaptic transmission caused by activation of adenosine A1 receptors was 
not significantly different between naïve and LIF-treated slices. The percentage of EPSC 
inhibition was calculated as before; comparisons were made between control and test slices, 
taken from the same hippocampus (n=4). n.s. P>0.05 (paired t-test, compared with CPA-
induced inhibition of EPSC amplitude observed in control conditions).  
 
These results are in agreement with data obtained from RT-PCR and 
western blot analysis, according to which treatment with OSM, but not 
LIF, can selectively upregulate A1 receptor mRNA and protein levels 
(Moidunny et al,. 2010). Furthermore, the experiments with LIF 
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incubation served to control for the possibility that prolonged pre-
incubation time (4h) per se might be responsible for the potentiation of 
CPA-induced inhibition of EPSC amplitude, since this faciliation was 
observed in slices incubated with OSM but not in slices that had been 
incubated with LIF for similar time periods. 
OSM potentiates A1 receptor-mediated depression of synaptic 
transmission during hypoxia 
Modulation by OSM of A1 receptor-mediated fine-tuning actions, if 
functionally relevant, is expected to be able to also affect the decrease 
in excitatory transmission that follows the onset of a brief hypoxic 
episode. Indeed, the consistent increase in the extracellular 
concentration of endogenous adenosine that follows hypoxia and the 
subsequent A1 receptor-dependent inhibition of synaptic transmission 
(Sebastião et al., 2001) is thought to be a major neuroprotective 
mechanism against hypoxia- and ischemia-induced brain damage 
(Rudolphi et al., 1992).  
In order to investigate whether OSM-induced modulation of A1 
receptor function had any functional impact in these conditions, we 
used an hypoxia protocol of similar duration to one previously shown 
to reversibly inhibit synaptic transmission in the CA1 area, in a A1 
receptor-dependent way (Brust et al., 2006). 
In control slices, such a brief (4 min) hypoxic insult caused a 42±4.8% 
maximum inhibition of EPSC amplitude (n=7). However, in 
hippocampal slices that had previously been exposed to OSM (10 
ng/mL, for 4h), the same hypoxic insult led to a 69±3.4% inhibition of 
excitatory synpatic responses (Figure 5.3.3A), which was significantly 
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higher than that observed in control slices prepared from the same 
hippocampus (n=7, P<0.05, Figure 5.3.3C).  
 
Figure 5.3.3. Oncostatin M potentiates hypoxia-induced inhibition of synaptic 
transmission. (A) Averaged time-course of afferent evoked EPSC peak amplitude changes 
caused by a 4 min hypoxic insult, recorded from control (aCSF-treated) and test slices 
(incubated for at least 4 hours with 10ng/mL oncostatin M) prepared from the same 
hippocampus. Each point represents the average amplitude of 4 EPSCs, evoked once every 30s 
by electrical stimulation of the Schaffer collaterals; 100% corresponds to the averaged 
amplitude calculated for the 5-10 EPSCs recorded immediately before hypoxia. The hypoxic 
insult consisted of replacing oxygenated aCSF (95%O2/5%CO2) by aCSF saturated with 
95%N2/5%CO2 for 4 min. Maximum inhibition was determined as the lowest EPSC amplitude 
recorded for each experiment, at either 6 or 8 min after hypoxia onset. In the right panel (B) are 
shown superimposed current tracings of EPSCs recorded before (1,2) and 8 min after hypoxia 
(3,4) was induced, in two representative control (1,3) and test (2,4) cells. (C) Maximum 
inhibition of synaptic transmission by hypoxia was significantly higher when recording from 
slices that had been exposed to oncostatin (10ng/mL, n=7). * P < 0.05, paired t-test (compared 
with EPSC inhibition observed in control conditions, in the absence of incubation with OSM). 
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To further ensure that the hypoxia-induced inhibition of excitatory 
synaptic responses was dependent upon activation of A1 adenosine 
receptors, delivery of the hyposic insult was performed in the presence 
of a selective A1 receptor antagonist (DPCPX, 50 nM, applied 30 min 
before hypoxia induction). In these conditions, the hypoxia-induced 
depression of EPSC amplitude was greatly reduced, or even abolished, 
both in control and oncostatin-treated slices (Figure 5.3.4A). 
 
Figure 5.3.4. Hypoxia-induced inhibition of synaptic transmission is dependent on 
adenosine A1 receptor activation. (A) Averaged time-course of afferent-evoked EPSC peak 
amplitude changes caused by a 4 min hypoxic insult, delivered under conditions of A1 receptor 
blockade by the selective antagonist 1,3-dipropyl-8-cyclopentylxanthine (DPCPX, 50 nM), 
recorded from control (A) and oncostatin-treated (B) slices (n=5). Maximum inhibition 
corresponds to the lowest EPSC amplitude recorded, 8 min after hypoxia onset. (C) In either 
condition, maximum inhibition of synaptic transmission in response to hypoxia was greatly 
reduced when compared to that observed in the absence of the adenosine A1 receptor antagonist 
(see Figure 5.3.3 for comparison). 
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Discussion 
In addition to a well-documented role in infection, inflammation, bone, 
muscle and cardiovascular function, cytokines of the IL-6 family are 
also accountable for signaling functions in the developing and adult 
brain, both in physiological conditions as also in response to brain 
injury and disease (Bauer et al., 2007). In fact, neuroprotective 
properties are a feature common to different members of the IL-6 
cytokine family, that may be due to the shared usage of gp130 receptor 
subunits in their signaling cascade (Taga and Kishimoto, 1997). 
However, support for this hypothesis was lacking and the cellular 
mechanisms operated by different IL-6 type cytokines are still largely 
unknown. 
A recent study has provided a possible explanation for the mechanisms 
underlying IL-6-mediated neuroprotection. Indeed, treatment with IL-6, 
prompting gp130 homodimer activity, was found to cause an up-
regulation of neuronal A1 receptor expression and function both in vitro 
and in vivo, which was mandatory for IL-6-dependent neuroprotection 
(Biber et al., 2008). The work described in this chapter aimed at 
investigating a putative involvement of A1 receptor function in 
neuroprotection and neuromodulation by either treatment with OSM 
(OSMr/gp130 heterodimer activation) or LIF (LIFr/gp130 heterodimer 
activation). Such questions were addressed in acute hippocampal slices 
(present chapter) and in a collaboration work performed on cultured 
neurons from wild-type and A1 receptor knockout mice (Moidunny et 
al., 2010).  
Pre-treatment for 24 hours with either OSM or LIF attenuates 
excitotoxicity in cultured neurons from cortex and hippocampus 
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(Moidunny et al., 2010), which reinforces the idea of a principal 
neuroprotective effect of IL-6-type cytokines (Ransohoff et al., 2002). 
Given that both cytokines display a comparable efficacy and 
furthermore share part of their receptor complexes, similar mechanisms 
of action might be expected. However, while blockade of neuronal A1 
receptor function with a selective antagonist completely abolished the 
neuroprotective effects of OSM, LIF-induced neuroprotection was left 
unaffected. Furthermore, while the neuroprotective effect of LIF is 
preserved in A1 receptor knockout animals, pre-treatment with OSM 
failed to affect neuronal survival after glutamate toxicity in the absence 
of functional adenosine A1 receptors (Moidunny et al., 2010). 
When evaluating consequences for synaptic transmission, a 4h pre-
treatment with IL-6 was previously found to potentiate the A1 receptor-
mediated inhibition of synaptic transmission in hippocampal slices, an 
effect that was of particular importance during short periods of hypoxia 
(Biber et al. 2008). Accordingly and as described in this chapter, pre-
treatment with OSM, but not LIF, significantly increased A1 receptor-
mediated inhibition of afferent-evoked synaptic responses in the CA1 
area of the hippocampus. Such a modulation of A1 receptor function 
was also observed in response to a 4 min hypoxic insult, presumably by 
increasing the A1 receptor-mediated inhibition of synaptic responses 
that takes place in such conditions (Brust et al., 2006). Thus, OSM, but 
not LIF, sensitizes neuronal A1 receptor-mediated responses, similarly 
to what was previously observed for pre-treatment with IL-6 (Biber et 
al., 2008). Consistent with this data, real-time PCR and western blot 
analysis revealed that both A1 receptor mRNA and protein expression 
levels are increased in OSM-treated, but not in LIF-treated neurons 
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(Moidunny et al., 2010). Taken together, these findings strongly 
suggest that two members of the IL-6-type cytokine family (IL-6 and 
OSM) depend on A1 receptor function for their neuroprotective 
properties, whereas LIF induces neuroprotection via a different, 
unknown, mechanism. However, since both cytokines are 
neuroprotective in vitro and may reduce ischemic damage in vivo 
(Suzuki et al., 2009), a further understanding of operated signaling 
pathways and mechanisms of action may prove useful for their 
establishment as possible therapeutic candidate molecules. It should 
also be noted that the role of “pro-inflammatory” cytokines in stroke is 
still a controversial subject. For instance, increased formation of TNF-α 
can aggravate excitotoxicity by inhibiting glutamate uptake, but it may 
also favor recovery from stroke by enhancing the production of 
neurotrophic factors, such as BDNF (see Ceulemans et al., 2010). The 
same duality of functions has also been described for other acute 
“inflammatory” mediators like NO and IL-6, reflecting the complex 
role of brain inflammation after injury (e.g., Ekdahl et al., 2009). Future 
therapeutic approaches must thus always take into account the balance 
between inflammatory versus protective features of different IL-6-type 
cytokine family members and hopefully, appropriate cytokine 
combinations may provide the most efficient alternative. 
Although LIF and OSM are highly related members of the IL-6 type 
cytokine family (Jeffery et al., 1993; Nicola et al., 1993) sharing most 
properties, distinct effects upon activation of LIF and OSM receptor 
complexes have been reported before. For example, only OSMr/gp130 
heterodimer activation is able to promote osteoblast differentiation, 
whereas activation of both OSMr/gp130 and LIFr/gp130 heterodimers 
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in these cells inhibited the expression of osteocalcin, a protein required 
for bone-building (Malaval et al., 2005). Also, evidence for selective 
roles of OSM and LIF during haematopoiesis and their effects upon the 
regulation of certain target genes has been provided (Tanaka et al., 
2003; Weiss et al., 2005), reinforcing the idea that different IL-6-type 
cytokine receptor complexes may activate specific signaling cascades. 
It is at the moment unclear which signaling pathways are important for 
the neuroprotective effects of treatment with LIF, OSM and IL-6. Still, 
it has recently been shown that the basal as well as induced expression 
of A1 receptors is regulated by the nuclear transcription factor - kappa 
B (NFkB) (Jhaveri et al., 2007). Noteworthy, OSM can regulate protein 
synthesis, through NFkB activation, in smooth muscle cells (Nishibe et 
al., 2001). When subjected to oxidative stress, these cells display an 
increase in A1 receptor mRNA levels that is prevented by NFkB 
inhibitors (Nie et al., 1998). IL-6 has also been shown to activate NFkB 
in intestinal cells (Wang et al., 2003). Therefore, it seems likely that 
increased expression of A1 receptors by OSM and IL-6 is also, at least 
partially, regulated by NFkB activation.  
Regardless of which signaling pathways may be underlying differential 
effects of the three possible receptor complexes for IL-6 type cytokines, 
it is irrefutable that adenosine A1 receptors arise as key players in 
neuroprotection against excitotoxicity induced by both OSM and IL-6. 
It has long been known that neuronal A1 receptor activation can 
suppress neuronal activity and glutamatergic transmission, reduce 
oxidative stress, minimize metabolic demand and hence preserve ATP 
stores, protecting neurons from excitotoxicity (Schubert et al., 1997). 
Importantly, the data obtained raises the question of whether 
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shortcomes in prevention of ischemia-induced neuronal damage by 
treatment with A1 receptor agonists may be potentially overcome by 
using strategies that indirectly enhance the expression of these 
receptors, such as treatment with IL-6 or OSM. Therefore, it is very 
important to further explore the acute effects of these cytokines upon 
the progression of neuronal viability, when the exposure is made 
posteriorly to the initial ischemic or excitotoxic insult. Finally, given 
the pleiotropy of these cytokines, before they can be regarded as 
therapeutic options, appropriate doses need to be accurately 
established, so as to avoid detrimental inflammatory responses.  
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6 General Conclusions 
 
On the course of little more than two decades, research in neuroscience 
has catapulted glutamatergic transmission, and in particular AMPA 
receptors, to the spotlight. Because they carry the bulk of excitatory 
transmission throughout the central nervous system, their modulation 
profoundly affects neuronal signalling, as well as the changes it 
undergoes under physiological (LTP) and pathological (ischemia) 
conditions.  
The work contained in this thesis first pursued the hypothesis that 
adenosine, an ubiquituous modulator of neuronal activity and 
communication, might directly affect AMPA receptor function, in the 
hippocampus. The results obtained unequivocally show that exogenous 
activation of A2A receptors modulates AMPA receptor function in CA1 
pyramidal cells, by a postsynaptic mechanism dependent on PKA 
activity, but that most probably does not require protein synthesis. 
Exogenous activation of A2A receptors was furthermore found to 
correlate with increased expression of total and phosphorylated GluR1 
subunits, at the membrane level. Finally, the physiological relevance of 
this A2A receptor-mediated modulation of the postsynaptic AMPA 
component was highlighted by the significant inhibition of LTP 
expression that ocurred in conditions of A2A receptor blockade. These 
findings thus enabled the identification of a novel modulator of AMPA 
receptor function that is ubiquituous in the extracellular space – 
particularly in synapses firing at high frequency, prone to undergo 
Modulation of AMPA receptors by adenosine 
 166 
activity-dependent reinforcement. Regulation of the GluR1 Ser-845 
phosphorylation tonus controlling the reserve of GluR1-containing 
AMPA receptors at extrasynaptic pools (required for synaptic 
strengthening) may therefore constitute a new mechanism by which 
adenosine A2A receptors fine-tune synaptic transmission and even the 
ability that a particular synapse has of being reinforced.   
A2A receptors were subsequently shown to be key players in ischemia-
induced facilitation of hippocampal excitatory synaptic transmission, 
since this form of plasticity was completely abolished in the presence 
of a selective A2A receptor antagonist. Interestingly, this effect was 
mimicked by internal spermine and consequent blockade of calcium-
permeable AMPA receptors; but it was not altered when both drugs 
were applied simultaneously. It is therefore possible that A2A and 
calcium-permeable AMPA receptor blockade are operating through a 
common pathway. Furthermore, these results unequivocally show that 
again, changes at the AMPA receptor level as well as modulatory 
effects by A2A receptors are both fundamental for a form of synaptic 
plasticity.  
Finally and since the A1 receptor, the other high-affinity adenosine 
receptor subtype, is highly expressed in the hippocampus and 
constitutes a main target for adenosine released during 
hypoxic/ischemic insults, I looked at its role in the neuroprotective 
actions of two immunoregulatory cytokines. Evidence was provided for 
the ability of one of these immunoregulatory agents to exert 
neuroprotection indirectly, by causing an upregulation of adenosine A1 
receptors. Indeed, treatment with OSM, but not LIF, was clearly shown 
to enhance the A1 receptor-dependent inhibition of synaptic 
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transmission after transient hypoxia – a major mechanism by which 
adenosine is known to confer protection from excitotoxicity-induced 
damage. Although very far from providing a clinical alternative to A1 
receptor–based therapies, the latter findings show that the curtains have 
not yet closed on the A1 receptor field of neuroprotection. 
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7 Future Perspectives 
 
A central assumption in neurobiology states that changes in behavior 
are underlied by dynamic regulation of the strength of individual 
synapses. In turn, extensive research has made clear that such plastic 
changes in synaptic efficiency greatly rely upon activity-dependent 
modulation of postsynaptic AMPA receptor function. The present work 
allowed the identification of a mechanism by which adenosine, through 
A2A receptor activation, may facilitate an enhancement of the 
postsynaptic AMPA component, in conditions of increased neuronal 
activity - such as those prompting LTP induction.  
Energy imbalance in excitotoxic conditions can also trigger 
considerable adenosine release, which affords neuroprotection via 
activation of A1 receptors and prompt EPSC inhibition – in a way 
amenable to regulation by cytokines of the IL-6 family. In turn, and as 
shown here, activation of A2A receptors was shown to be necessary for 
ischemia-induced facilitation of synaptic transmission. It would 
therefore be particularly interesting to investigate whether A2A 
receptors are also able to tune AMPA receptor-mediated responses in 
excitotoxic conditions. For this purpose, patch-clamp recordings of 
AMPA-evoked currents (as in chapter 5.1) could be performed using 
the same ischemia protocol (as in chapter 5.2), in the presence or 
absence of a selective A2A receptor antagonist. Furthermore, monitoring 
of receptor trafficking, using cells transfected with fluorescent GluR1 
or GluR2 subunits, could be used to address whether or not A2A 
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receptors can affect AMPA receptor membrane delivery from internal 
pools. Such experiments would additionally provide a way to elucidate 
the extent to which plasticity induced by ischemia obeys the same 
paradigms widely described for physiological LTP.  
Indeed, strong evidence has already established several links between 
physiological LTP and its ischemia-induced counterpart. Noteworthy, 
the work contained in this thesis identifies a novel common feature 
between both forms of plasticity: the requirement for calcium-
permeable AMPA receptor signaling. Further experimental work may 
help cast light on whether or not excitotoxicity is the price to pay for 
plasticity. It seems an unlikely coincidence that a brain area where 
researchers have always found plasticity so easy to induce, should also 
constitute a most vulnerable region to excitotoxicity. Bearing in mind 
that pathology seldomly invents new mechanisms, but rather subverts 
existing ones, it may be that a continuum from physiological to 
pathological activity-induced tuning of synaptic transmission, is yet to 
emerge. This hypothesis would fit nicely with contradictory results on 
the detrimental versus beneficial nature of ischemia-induced facilitation 
of synaptic transmission.  
In fact, this form of plasticity has recently been proposed to help the 
brain cope with neuronal loss after stroke, by sculpting diffuse, 
redundant connectivity into new functional and structural circuits that 
may recover specific functions. Therefore, considerable therapeutic 
benefit may arise from the administration of pharmacological 
modulators of LTP, during the several hours to days after the initial 
incident during which regenerative approaches are hypothesized to 
enhance spontaneous functional recovery. Before attempts to identify 
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appropriate modulators are made, it is vital to elucidate when and why 
do plastic changes become a no-return path. Considering that the non-
competitive AMPA receptor antagonist, talampanel, was recently 
proposed for phase III clinical trials in patients with amyotrophic lateral 
sclerosis (a well known model of excitotoxicity), AMPA receptors and 
their modulator molecules are likely to prove key players for 
determining cell fate. Extensive experimental work is therefore 
required to begin completing this puzzle and enable an accurate 
understanding of the pathophysiological events that may constitute 
future therapeutic targets in stroke.     
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